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Abstract
Secondary lymphoid organs have a key role in the initiation of adaptive immune re-
sponses to infection. Organogenesis occurs in foetal development, and the use of ge-
netic tools, imaging technologies, and ex vivo culture systems has provided signiﬁcant
insights into the cellular components and associated signalling pathways that are in-
volved. However such approaches tend to be reductionist and descriptive, focusing
on the contribution of individual components, and cannot fully explain how lymphoid
organs develop through interaction between biological components.
In this study, a set of simulation and statistical tools have been developed that pro-
vide further insights into the molecular and biophysical mechanisms of lymphoid tissue
organogenesis. Speciﬁcally, the formation of Peyer’s Patches, gut-associated secondary
lymphoid organs, is examined. In collaboration with experimental immunologists, a
structured process in the design and calibration of a computer simulation of the bio-
logical process has been conducted, leading to the development of a publicly accessible
scientiﬁc tool where cell behaviour emerges that is statistically similar to that observed
in ex vivo culture. Robust biological hypotheses can be generated through use of the
tool to perform in silico experimentation that simulates diﬀerent physiological condi-
tions. A lack of available statistical tools to analyse in silico simulation results has
been addressed through the development and release of the spartan toolkit, a set of
techniques that can suggest the inﬂuence that pathways and components have on sim-
ulation behaviour, oﬀering valuable biological insight into the system being explored.
An analysis of simulation results using spartan suggests the inﬂuence of biological
pathways on tissue formation changes during development, in contrast to hypotheses in
the literature that suggest the process is chemokine driven. Data presented suggests the
development period is biphasic, with cell adhesion the key factor early in development,
and chemokine expression inﬂuential at later point. Through novel application of
the statistical tools in spartan to perform a time-lapse analysis of cell behaviour, it
is suggested this change in phase occurs between hours 24 and 36. Novel in silico
experimentation performed has suggested the key biological factors in causing cell
aggregation, and suggested a role for LTin cells in limiting size and number of Peyer’s
Patches. A range of potential laboratory investigations have been suggested that could
validate whether these simulation derived hypotheses are valid.
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Chapter 1
Introduction
1.1 Overview of the Immune System
The immune system is comprised of white blood cells or leukocytes that protect the
organism from disease-causing pathogens. Protective immune responses are dependent
on innate immune cells, including macrophages and dendritic cells, that present anti-
gens from pathogens to the adaptive immune system, generating protective cellular
and humoral responses. Unlike the innate immune system, adaptive immune cells, or
lymphocytes, can diﬀerentiate into memory cells that provide long term protection
from pathogens, ensuring a more rapid and stronger immune response upon future
encounters with the same antigen.
T and B lymphocytes develop in the bone marrow, and undergo a process of mat-
uration in the thymus and spleen respectively. Upon maturation lymphocytes enter
circulation and migrate to secondary lymphoid tissue including lymph nodes, Peyer’s
Patches, tonsils and the spleen. These organs are strategically located at drainage
points in lymphatic vessels to initiate protective immune responses to antigens from
peripheral tissues (Randall et al., 2008). Although each secondary lymphoid organ dif-
fers in their architecture, there are some common features, including distinct B and T
cell zones (Fu and Chaplin, 1999). The structural organisation of these tissues permits
eﬃcient interactions between antigen-presenting cells and lymphocytes, subsequently
aiding rapid removal of the pathogen at the site of infection (Goodnow, 1997). This
process is initiated in part by antigen-bearing dendritic cells that transport antigens
from surrounding tissues into the lymphoid organ, either through lymphatic vessels (in
the case of lymph nodes), or through the epithelium (in the case of Peyer’s Patches)
(Cyster, 1999). Mature lymphocytes continuously circulate through these organs via
the blood stream, constantly surveying each organ for the presence of their speciﬁc
antigen. If that lymphocyte fails to interact with antigen, the lymphocyte can remain
within the B or T cell region for up to 4 days before returning to circulation (Fu
and Chaplin, 1999; Goodnow, 1997). T cells are activated if their speciﬁc antigen is
encountered, and specialised T helper cells recruited to B cell areas by chemokines,
9
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bringing together antigen speciﬁc B and T cells to provide the signals required for an
eﬃcient adaptive immune response. This response has two distinct phases: the clonal
expansion of antigen speciﬁc B cells to secrete an antibody speciﬁc for the pathogen,
followed by the development of immune memory that permits an accelerated, higher
aﬃnity immune response in the case of re-infection (Goodnow, 1997).
Secondary lymphoid organogenesis occurs in foetal development, but formation can
also be caused by chronic infection, cancer and autoimmune disease (Randall et al.,
2008). A range of experimental studies has provided insight into the key factors re-
quired for lymph node, spleen and Peyers Patch development (Mebius, 2003; van de
Pavert and Mebius, 2010; Randall et al., 2008; Veiga-Fernandes et al., 2007). There
may be key diﬀerences between the mechanisms driving secondary lymphoid organo-
genesis in diﬀerent tissues, yet many similarities. Thus developing new insights into
the molecular and biophysical mechanisms that contribute to the formation of one set
of secondary lymphoid organs, Peyer’s Patches, will provide a platform to understand
how lymphoid tissues develop.
1.2 Intestinal Immune Responses
The intestinal mucosa is the largest area that is in contact with the exterior environ-
ment, and is constantly exposed to bacteria and other pathogens (Reis and Mucida,
2012). The potential for infection caused by bacteria, viruses, parasites, and fungi is
thus signiﬁcant. Although 100 times the area of the skin, which is protected by a phys-
ical barrier of several layers, the intestine is comprised of a single layer of absorptive
epithelial cells that create a barrier between the interior lamina propria and the exter-
nal lumen (Reis and Mucida, 2012). This may explain why up to 70% of the body’s
lymphocytes are found to reside within gut-associated lymphoid tissue (GALT) (Jung
et al., 2010).
GALT consists of Peyer’s Patches (PP), isolated lymphoid follicles, intraepithelial
lymphocytes, lamina propria leukocytes, and mesenteric lymph nodes that together
have an essential role in the generation of protective antibody responses to infection
within the gastrointestinal tract. PP are secondary lymphoid organs that were initially
described by Severino in 1645, but later named following Peyer’s investigations in
1677 (Jung et al., 2010). PP are domed structures that consist of 1-5 B cell follicles
containing follicular dendritic cells (FDC), a T cell zone and associated ﬁbroblastic
reticular cell (FRC) network (Jung et al., 2010). A schematic representation of a PP
can be seen in Figure 1.1. Lymphocytes migrate into the PP via high endothelial
venules, and continue their circulation via eﬀerent lymphatic vessels that connect to
mesenteric lymph nodes (Jung et al., 2010). Unlike lymph nodes, there is no lymphatic
input to PP; instead antigen uptake occurs via specialised epithelial cells, Microfold
or M-cells, in the follicle-associated epithelium (red in Figure 1.1). This antigen is
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transferred to local dendritic cells in the FRC (orange area in Figure 1.1), (Owen and
Bhalla, 1974) and these dendritic cells then migrate into the T-cell zone for antigen
presentation to lymphocytes. Pre-natal studies show that an average of sixty PP
develop in the human foetal gut (Cornes, 1965), and seven to eleven in the mouse
(Figure 1.2), distributed along the length of the small intestine, with a large variation
in the location, number, and size of PP between diﬀerent genetically identical mice.
Figure 1.1: Schematic representation of Peyer’s Patch in the small intestine. (a) Anti-
gen enters the Peyer’s Patch through the Microfold, or M-Cells in the follicle-associated
epithelium. The antigen is transferred to local dendritic cells in the subepithelial dome
(the orange area); (b) The antigen is then presented by the dendritic cell to T-Cells
(green cells) in the T-Cell zone (blue), triggering an adaptive immune response. Al-
ternatively, the antigen-loaded dendritic cell may migrate to mesenteric lymph nodes
via draining lymph, and a response triggered in the lymph node. Image adapted from
Figure 3 in Mowat (2003).
1.3 Peyer’s Patch Development
1.3.1 Basic Model of Development in Mice
The use of genetic tools, imaging technologies and ex vivo culture systems has provided
signiﬁcant insights into the cellular components and associated signalling pathways
that are involved in the formation of gut-associated secondary lymphoid tissue in mice
(Mebius, 2003; van de Pavert and Mebius, 2010; Randall et al., 2008; Veiga-Fernandes
et al., 2007). One example of such an investigation is demonstrated in Figure 1.3,
showing the use of imaging of both adult and foetal mice intestines to determine the
location of PP in the small intestine and the behaviour of cells that lead to organ
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Figure 1.2: Peyer’s Patch size, location, and number in six adult human-CD2-GFP
mice. Position on the length of the small intestine has been normalised to a percentage
to counter variance in small intestine length between mice. These data indicate that the
development process is highly stochastic. Graph taken from Alden et al (2012b).
development. The combination of a number of experimental studies has led to the
generation of an accepted model of pre-natal secondary lymphoid tissue development.
The understanding of the mechanisms involved in human PP development is limited,
mainly due to the diﬃculty of performing research using human foetal organs, and thus
studies attempt to align observations made in humans with data from murine studies
(Hoorweg and Cupedo, 2008). This section details the current understanding gleamed
from explorations using mouse models, summarised diagrammatically in Figure 1.4.
In the mouse, the migration of hematopoietic cells from the foetal liver into the
small intestine has been detected from Embryonic Day 14.5 (E14.5) (Mebius et al.,
2001). These hematopoietic cells can be divided into two populations, CD4−CD3−IL-
7Rα−c-kit+CD11b+CD11c+ cells termed Lymphoid Tissue Initiator Cells (LTin), and
CD4+CD3−IL-7Rα+c-kit+ termed Lymphoid Tissue Inducer Cells (LTi) (Fukuyama
and Kiyono, 2007; Veiga-Fernandes et al., 2007). Aggregations of these hematopoietic
cells in the small intestine can be observed by E17.5, with the completion of the ﬁrst
processes in compartmentalising the organ and formation of follicles detectable via
whole-mount immunostaining at E18.5 (Hashi et al., 2001). It is thought that the
process of organ formation between E14.5 and E18.5 occurs in three distinct phases
(Adachi et al., 1997). The ﬁrst is the appearance on the epithelium of VCAM-1+
stromal cells, termed Lymphoid Tissue Organiser Cells (LTo) (Adachi et al., 1997;
Fukuyama and Kiyono, 2007). This is followed by the identiﬁcation of clusters of
hematopoietic cells around VCAM-1+ expressing stromal cells from E14.5. As previous
imaging investigations have shown that hematopoietic cells (LTin and LTi) are evenly
distributed across the gut by E15.5 (Randall et al., 2008), it is assumed that this cell
aggregation phase must occur after this point, yet before E18.5, deemed to be the
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ﬁnal phase of development where lymphocytes are recruited and the follicle structure
developed.
The basic model of PP development in Figure 1.4 captures the current understand-
ing of the second of Adachi et al’s (1997) phases of PP development, the aggrega-
tion of hematopoietic cells. LTin cells express the tyrosine kinase receptor RET and
initiate the process of PP induction upon surface contact with an LTo cell express-
ing Artemin (ARTN), a known ligand for RET, leading to LTo cell diﬀerentiation
(Fukuyama and Kiyono, 2007; Patel et al., 2012; Veiga-Fernandes et al., 2007). This
diﬀerentiation leads to the upregulation of adhesion factors Vascular Cell Adhesion
Molecule (VCAM), Intercellular Adhesion Molecule (ICAM) and Mucosal Addressin
Cellular Adhesion Molecule (MAdCAM). LTi cells interact with VCAM-positive LTo
cells through the expression of LTαβ, that stimulates the LTβ receptor expressed on
the LTo cell. This induces the production of IL-7, and chemokines CXCL13, CCL19,
and CCL21 by the LTo cell (Adachi et al., 1997; Honda et al., 2001; Luther et al.,
2003). These in turn stimulate the IL-7R and chemokine receptors CXCR5 and CCR7
expressed by the LTi cell, thus a self-sustaining process is created where each cell type
has the ability to mutually stimulate its corresponding component (Nishikawa et al.,
2003). This attracts LTi cells to a forming aggregation through chemotaxis, and ad-
hesion factor expression retains them within the primordial patch. Cell aggregation
continues through to E18.5 where, for reasons not currently understood, further aggre-
gation of hematopoietic cells ceases to occur (Randall et al., 2008).
Figure 1.3: Peyer’s Patches in the mouse small intestine. Left: Diagram representing
a cross section of the intestine tract, large green patch represents where Peyer’s Patches
can be found in the small intestine. Source: Mark Coles, University of York, unpub-
lished; Centre: GFP Stain of Peyer’s Patches from a human-CD2-GFP adult mouse.
Source: Mark Coles, University of York, unpublished; Right: in vivo confocal image of
LTi cells at E17.5 in a human-CD2-GFP mouse foetal intestine. Source: Veiga-Fernandes
et al (2007).
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Figure 1.4: Steps involved in Peyer’s Patch development, adapted from Figure 3 in
van de Pavert et al (2010). 1: LTin and LTi cells migrate from the foetal liver into
the gut; 2: LTin cells express RET, the receptor for ARTN, which is expressed by the
LTo cell. RET/ARTN binding upregulates LTαβ expression on LTin cells; 3: LTαβ
on LTin cells binds to LTβR expressed by LTo cells, causing LTo cell diﬀerentiation; 4:
LTαβ expressed by LTi cells binds to LTβR expressed by LTo cells, causing further LTo
cell diﬀerentiation and expression of chemokines and adhesion factors; 5: Expression of
chemokines causes LTi cell chemotaxis, and adhesion factors retain these cells around
a primordial patch. This process continues until E18.5 where no further aggregation
occurs.
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1.3.2 Key Factors in Development
A number of studies have taken a reductionist approach and focused solely on the
inﬂuence of individual biological components in PP organogenesis (such as particular
chemokines and adhesion factors) to attempt to give some insight into the role each
has in this process.
RET
Experimental work by Veiga-Fernandes et al (2007) suggests that the tyrosine kinase
receptor RET, expressed by LTin cells, has a key role in PP organogenesis. LTo cells
are thought to express ARTN, a known ligand for RET (Randall et al., 2008; Veiga-
Fernandes et al., 2007). Flow cytometry reveals that genetic mutants that lack RET
have a full repertoire of hematopoietic cells (LTin/LTi), yet these fail to aggregate,
resulting in a lack of PP. This suggests that the RET/ARTN signalling pathway is
vital in orchestrating secondary lymphoid organ development. Stimulation of RET has
been suggested as the factor that then upregulates LTαβ expression on LTin cells.
IL-7R and Lymphotoxin
LTαβ expressing LTin and LTi cells bind to the LTβR expressed on the surface of LTo
cells, leading to LTo cell diﬀerentiation and the expresion of chemokines and adhesion
factors (described in the following sections). Mice that are deﬁcient for either LTαβ or
LTβR do not form PP, suggesting this interaction is key in PP development (Banks
et al., 1995; De Togni et al., 1994; Futterer et al., 1998; Honda et al., 2001; Pasparakis
et al., 1997).
LTαβ is expressed by LTin cells through stimulation of RET (Veiga-Fernandes
et al., 2007). It is thought that stimulation of Interleukin 7 receptor α (IL-7Rα)
induces the expression of LTαβ on LTi cells. Initially it was shown that mice deﬁcient
for IL-7Rα fail to form PP (Adachi et al., 1997, 1998). A further study that utilised
a monoclonal antibody to block IL-7Rα signal at diﬀerent time-points supported this
result, showing that no PP formed when IL-7R was blocked before E16.5 (Yoshida
et al., 1999). However, where IL-7R signalling was blocked after E16.5, the authors
still detected PP formation, suggesting that the inﬂuence of IL-7R is time-dependent,
and is involved in the initiation of tissue development. The stimulant for IL-7Rα
triggering remains an open question, with some suggesting this occurs through IL-7
expression by an LTo cell (Yoshida et al., 2002), yet others have to date failed to detect
IL-7 in the embryonic intestine (Honda et al., 2001), and detected normal PP anlagen
in IL-7 deﬁcient mice (Nishikawa et al., 2003). An experimental overexpression of
IL-7 leads to an abnormal number of LTi cells and thus a higher number of patches,
suggesting a potential role if present, although this is unlikely (Meier et al., 2007).
Whereas RANKL signalling triggers IL-7Rα expression in developing lymph nodes and
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was thus suggested as a potential regulator of IL-7Rα, PP organogenesis still occurs in
RANKL deﬁcient mice (Yoshida et al., 2002).
Chemokines
Stimulation of the LTβ receptor on LTo cells upregulates the expression of chemokines
CXCL13, CCL19, and CCL21 into the localised environment around a site of patch gen-
esis (Cupedo et al., 2004; Dejardin et al., 2002). These chemokines bind to chemokine
receptors CXCR5 and CCR7 expressed on the surface of LTi cells, the ﬁrst stimulated
by CXCR13 and the latter by CCL19 and CCL21 (Luther et al., 2003; Ohl et al., 2003).
Expression of homeostatic chemokines by an LTo cell causes LTi cell chemotaxis to-
wards sites of patch genesis through CXCR5 and CCR7 signalling, which are retained
by adhesion factors expressed in the primordial patch (expanded in next subsection).
The attraction of cells to a site of patch genesis through chemotaxis promotes cellular
interactions through LTαβ/LTβR signalling, and a further upregulation in chemokine
expression, thus expanding the area around a primordial patch that is aﬀected by
chemokine expression.
PP and lymph node formation has been found to be signiﬁcantly reduced in CXCR5-
deﬁcient mice, and where PP do form, these are typically smaller and lack the structural
characteristics observed in wild-type mice (Ansel et al., 2000). The existence of a second
chemokine pathway, through CCR7 signalling, may explain why some hematopoietic
cells still aggregate. Interestingly, studies suggest there is no signiﬁcant diﬀerence in
lymph node formation for CCR7 deﬁcient mice, suggesting that the CXCL13 pathway
could have a more dominant role in the recruitment and clustering of LTi cells (Luther
et al., 2003).
Adhesion Factors
The above details the interactions that promote LTo cell diﬀerentiation, cause the ex-
pression of chemokines and adhesion molecules, and ensure LTi cell chemotaxis towards
a site of PP organogenesis. However none of the above would result in the formation
of a PP if the aggregation was not held together by adhesion factors. LTin and LTi
cells are retained by LTo expression of adhesion molecules VCAM-1 and MAdCAM,
which bind to α4β1 and α4β7 receptors expressed on the surface of LTin and LTi cells
(Yoshida et al., 2001) respectively. A blockage in VCAM-1 expression has been found
to show a profound reduction in cell aggregation (Finke et al., 2002; Patel et al., 2012)
yet some aggregations do still form. This result could suggest that adhesion remains
possible through the MAdCAM pathway, yet VCAM-1 is a more dominant factor.
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1.3.3 Role and Dynamics of Hematopoietic Cells
Previous investigations have found that an absence of LTi cells results in a failure
to form PP (Sun, 2000; Yokota et al., 1999). The role and behaviour of the second
population of hematopoietic cells, LTin cells, is not fully understood, although it has
been suggested that this population is involved in an early phase of PP development
(Fukuyama and Kiyono, 2007; Veiga-Fernandes et al., 2007).
Early events in PP organogenesis have been explored through use of an ex vivo
culture system (Patel et al., 2012), in an attempt to further understand the role of LTin
cells. In this study, explant cultures of developing intestines from human-CD2-GFP
transgenic mice were incubated with beads soaked with ARTN, a known ligand for RET
expressed by LTin cells (Figure 1.5). Immuno-staining after a 12 hour period revealed
an accumulation of LTin cells in the vicinity of the bead and a strong upregulation of
adhesion factor VCAM-1 in the vicinity of the bead. The detection of LTi cells in the
vicinity of a bead however was rare. The same aggregation was also found to occur in
LTi deﬁcient mice , suggesting no role for LTi cells at an early stage of development.
This ﬁnding supports the role of RET and RET ligand signalling as the initiator in PP
development (Veiga-Fernandes et al., 2007).
As LTin and LTi cells in CD2-GFP mice both express green ﬂuorescent protein
(GFP), it was possible to capture images of cell movement over the period of one
hour at this early time-point in development. These images were processed using the
Volocity software tool (PerkinElmer) that provides the capability of creating a sequence
from time-lapse images and tracking cell motility over time, producing a distribution
of cell behaviour statistics. The tracked cells were categorised into two groups, those
<50µm from the ARTN-soaked bead and those further away (Patel et al., 2012). A
statistical analysis of cell track length, velocity, and displacement using the Volocity
software tool reveals that there is a statistically signiﬁcant diﬀerence between each
behaviour response between cells close to the bead and cells further away (Figure 1.5).
This alteration in cell motility is suggested to be mediated by the expression of adhesion
factors, supported by the ﬁnding that VCAM-1 expression is strongly upregulated.
1.3.4 Open Questions
Section 1.3.2 above details how several reductionist studies have been used to determine
the role of each factor in PP organogenesis. However, such an approach leaves inter-
esting questions that cannot be addressed using this technique. This section suggests
a few such explorations that have yet to be performed.
Figure 1.2 demonstrates that the formation of PP in mice is highly stochastic, in
terms of location, size, and number of PP that form. Indeed Cornes (1965) suggests
that no two observations will be identical. What causes such variance is yet to be
understood. One could suggest that this is caused by a variation in the availability
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Figure 1.5: Use of an ex vivo culture system to explore cell behaviour. Left: Repre-
sentative image of confocal microscopic analysis of an explant culture of a developing
intestine from a human-CD2-GFP transgenic mouse incubated with an ARTN soaked
bead. Immunoﬂuorescence staining: green - LTin/LTi cells; red - VCAM-1 cells. Scale:
100 µm. Top right: 60-minute time-lapse cell tracks at the twelve hour time-point, pro-
duced using Volocity. Green - cells <50µm from the bead; Yellow - cells >50µm from
the bead. Scale: 100 µm. Bottom right: Cell behaviour analysis of the cell tracks shown
top-right. White - cells >50µm from the bead (n=27 cells); Grey - cells <50µm from the
bead (n=17 cells). Length is the distance covered by the cell in that hour. Displacement
is the distance between the cell location at the start of the hour and the cell position
when tracking was ceased. P-Values calculated using Mann-Whitney U-Test. Image
adapted from Figures 1 and 2 published in Patel et al (2012)
of key cell types and factors between each observation, by the physical geometry of
the intestine, or simply that the process relies on the location and timing of contact
between an LTin and LTo cell, and thus is inherently stochastic in nature. However
current approaches do little to support any such conclusions.
The role of chemokines and adhesion factors has been elucidated from both gene
knockout experiments and ex vivo culture systems as detailed previously. However, it
has not yet been possible to quantify the expression of chemokine and adhesion factors
during development. The existence of such data may go some way towards explaining
the variance detailed above, while also suggesting if there is a limitation in the ex-
pression of these factors, and thus a limitation on the size of PP. Though techniques
exist that could make this possible (ELISA, bioassys, RNA extraction (Mahajan et al.,
2003)), it is currently believed that no such quantitative data exists.
Finally, the majority of the investigations detailed in Section 1.3.2 all examine the
end result: the formation of PP at E17.5. As noted previously in Section 1.3.1, studies
have suggested that PP development does occur in three distinct phases (Adachi et al.,
1997). However, the authors do not fully specify the time-points these phases occur
in the seventy-two hour period. The more recent ex vivo study does go some way to
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addressing this by examining the initial period of development (Patel et al., 2012), but
does not identify changes in system dynamics after that point. If such distinct phases
exist, diﬀerent biological factors may be more inﬂuential at diﬀerent time-points; an
interesting result that cannot be elucidated using gene-knockout experiments.
1.4 Advancing Biological Understanding Through Modelling
and Simulation
The use of models in advancing the understanding of biological systems is common
place and has been used for generations, the famous example being Watson and Crick’s
model that deﬁned the structure of DNA (Watson and Crick, 1953). Modelling provides
a means of exploring a concept or available biological data with the aim of generat-
ing hypotheses in advance or in place of further experimental investigation. Such an
approach has provided some of our fundamental understanding of immunology, an ex-
ample being the Nobel Prize shared by Burnet and Medawar for their combination of
modelling and experimentation to explore how the immune system discriminates be-
tween self and non-self (Chakraborty et al., 2003). The use of computational modelling
and simulation is a continuation of this approach. An underlying biological system is
examined with the intent of generating a model that details the current understanding
of the system, or an abstraction of it. This may then be instantiated as a simulation
that can be executed on a computer. (Polack et al., 2008; Read, 2011).
The integration of computational modelling with current experimental techniques
is an important step in moving biological explorations from a reductionist, descrip-
tive state to one that is predictive (Kumar et al., 2006). Section 1.3.2 described how
previously published investigations have determined the role of each factor in PP anal-
ysis by examining each factor individually. The adoption of computational modelling
shifts the focus from an examination of each individual component part to that of the
higher order behaviour, and how this emerges from components that lack the capabil-
ity to do this alone (Germain et al., 2011). This is known as the particular system’s
emergent property. The application of this approach has previously permitted the ex-
ploration of a range of complex biological systems, including T-cell signalling cascades
(Chakraborty and Das, 2010), autoimmune disease pathology (Read et al., 2009), in-
vestigating cell migration within germinal centers (Figge et al., 2008), emergence of
immune memory (Jacob et al., 2004; Lagreca et al., 2001), and system dynamics under
HIV-1 infection (Sieburg et al., 1990; Staﬀord et al., 2000). However, the approach has
yet to be adopted in exploring the formation of the immune system, and could have
the potential to examine the open questions detailed above in Section 1.3.4.
As the use of computational modelling becomes more prevalent, the potential bene-
ﬁts of adopting the approach in immunology are becoming increasingly apparent. Sig-
niﬁcant advances in laboratory experimental techniques has coincided with advances in
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and availability of computational power, making it possible to generate models and sim-
ulations that can explain large datasets generated using high throughput techniques.
Such datasets may be derived locally through experimentation, or be a consolidation
of datasets gathered from a variety of laboratories and techniques (Chakraborty et al.,
2003; Kirschner and Linderman, 2009). Computer simulations of a biological pro-
cess may also be more amenable to experimentation than that of the natural system
(Forrest and Beauchemin, 2007; Guo and Tay, 2005). Investigations that can be con-
ducted on a computer do not have the physical or ethical constraints that may apply
to investigations in the wet-lab. Such computer experimentation can aid the forma-
tion of hypotheses that explain the derived biological data and be used to evaluate
these hypotheses by comparing simulation results to those in the established litera-
ture (Chakraborty and Das, 2010; Chakraborty et al., 2003; Kirschner and Linderman,
2009). However, alongside its use as a tool supporting such analysis of biological data,
a robust simulator can be used as a predictive tool for informing future wet-lab inves-
tigations, through performing novel in silico experimentation prior to or in place of
laboratory work. Such investigations may reveal areas of the system where the current
understanding is incomplete and areas where further wet-lab experimentation is not
required. A focus on the higher-order behaviour and interactions between factors in
the captured system also makes it possible to understand how quantitative alterations
in individual components aﬀects overall system behaviour.
This thesis continues by examining this technique and how it is applied in the
modelling of biological systems. This includes a summary of methodologies, tools and
frameworks that have found application in the creation of such simulations.
1.4.1 Modelling Methodologies
There are broadly two categories of modelling approaches, although some hybrid ver-
sions combining elements of the two are beginning to emerge. These are introduced
below.
Mathematical Approaches
Mathematical models that summarise a biological system as a set of Ordinary Diﬀer-
ential Equations (ODE) have frequently been used to provide biological insight. These
capture populations of factors rather than individual instances, with each assigned a
real-number variable. A set of equations is compiled that specify the impact each factor
has on the size of the population of its complementary factors. Using these equations,
system behaviour that emerges from interations between large populations of factors
can be explored. Use of this approach has found application in explorations of innate
immune responses (Hu et al., 2007), immune system memory (Antia et al., 2005), pan-
creatic cancer treatments (Haeno et al., 2012), and in furthering the understanding
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of inﬂuenza A infection (Baccam et al., 2006; Beauchemin et al., 2008; Sidorenko and
Reichl, 2004; Smith et al., 2011; Smith and Perelson, 2012).
A substantial amount of ODE modelling work has also been undertaken to explore
the dynamics of human immunodeﬁciency virus 1, or HIV-1. (Perelson, 2002; Perelson
et al., 1996; Vaidya et al., 2010), and is thus a good example to use in exploring this
technique. The basic model of infection by Perelson and colleagues (2002) maintains
counts of three populations: host cells free of infection (T ), host cells that are infected
(I ), and circulating virions in the blood (V ). The model describes the change in the
sizes of these populations over a period of time (dt). The number of target cells in
the model is dependent on parameters that specify the rate at which new cells are
generated (λ), the death rate per cell (δ), and the rate at which cells become infected.
The latter occurs when target cells upon interact with viral particles at a rate stated
by κVT, with κ representing an infection rate constant. The population of infected
cells changes at the rate stated by κVT and the rate at which infected cells die, set by
parameter µ. The ﬁnal population, the virions, changes at a rate at which the infected
cells generate new virus particles, set by parameter p, and the rate at which virions
are cleared from the blood, captured by parameter c. All of this behaviour is captured
in equations 1.1-1.3 below:
dT
dt
= λ− δT − κV T (1.1)
dI
dt
= κV T − µI (1.2)
dV
dt
= pI − cV (1.3)
These equations capture the basics of HIV-1 dynamics. This model can be extended
to include potential interventions that change these dynamics: the work of Perelson
and colleagues (1996) and Vaidya and colleagues (2010) that capture the inhibition of
the virus replication by a anti-retroviral drug and the resistance to such drugs being
good examples. Once the model is generated, a parameter ﬁtting stage is conducted
where output from the calculation is set to match data that has been derived through
wet-lab experimentation, often through use of least sum of squares regression analysis
to minimise the squared diﬀerence between the laboratory data and that from the
model (Read, 2011). With this assured, a wide variety of analytical techniques can be
used to explore the captured process. The use of ODE’s lends itself to such analyses as
they are computationally eﬃcient, and thus a large parameter space can be explored
(Bauer et al., 2009).
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As may have been apparent in the above description, there is no mention of spatial
considerations in the HIV-1 model. Space is assumed to be one continuous compart-
ment, assuming a well-mixed space of elements. Thus traditional ODE’s do not have
the capability to represent the eﬀect an environment may have on the populations: the
focus is purely on examining the parameter values that capture interactions between
the populations. This can be countered through the use of Partial Diﬀerential Equa-
tions (PDE’s) that can capture changes in time and space, yet increase the complexity
of a model such that the advantages of using an ODE-based approach are mitigated
(Bauer et al., 2009).
Agent-Based Approaches
The above technique examines how interactions between biological factors inﬂuence a
population, such as how the level of viral production aﬀects the population of target
cells in HIV-1 infection. The assumption is made that each entity within the population
is identical. An agent-based modelling (ABM) approach diﬀers as each biological entity,
such as a cell, is represented explicitly, and can thus maintain its own attributes and
cell state (An, 2006; Bauer et al., 2009). Agent behaviour is speciﬁed as rules that
determine the set of states an agent, such as a cell, may exist within, and the event that
must occur for an agent to change state. This event could be an interaction between
another agent or the environment. Taking the HIV-1 study above as an example, if an
ABM approach was taken, each target cell would thus be its own individual entity, and
rules speciﬁed on how the cell would change into an infected state upon interaction
with a ’viral’ agent.
Modelling at an individual level rather than population level opens up an array of
investigations that are not possible with ODE modelling (Bauer et al., 2009). With the
increased use of two-photon imaging it has become possible to visualise the interactions
between individual cells and their environment: one example of this being an obser-
vation of the primary immune response for ﬁfty hours after an antigen is encountered
(Catron et al., 2004). The ex vivo culture system described in section 1.3.3 has also
utilised this technique to observe individual cells rather than a population (Patel et al.,
2012). Studies such as these reveal that it may not be correct to model all cells as one
population, and inherent stochasticity in the biological system may be an important
part of the system dynamics. As each cell would be represented explicitly using ABM,
such stochasticity can be captured, making this a suitable approach if this is an im-
portant consideration (Germain, 2001; Milanesi et al., 2009). This methodology has
found application in modelling cancer vaccination (Motta et al., 2005), experimental
autoimmune encephalomyelitis (Read, 2011), vaccine design (Kohler et al., 2000), and
tumour growth (Alarcon et al., 2005; Jiang et al., 2005). It has also been applied in
simulating clinical trials, linking explorations through modelling with ongoing work in
the clinic (An, 2001, 2006).
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The other signiﬁcant diﬀerence between an ABM and traditional ODE approach
is the ability to explicitly represent the environment in which the cellular interactions
are taking place. This is a vital consideration for biological systems such as those
taking place in foetal development where the environment has an inﬂuence over cell
behaviour yet is also constantly developing, or those where cell behaviour is constrained
by the environment. Efroni and colleagues’ (2007) model of the cell structure within a
lymphoid organ is a good example of the latter.
Choosing the Correct Approach
The choice of modelling approach is dependent on the scope of the problem being
investigated, and thus there is no correct or incorrect choice of strategy. The following
considerations tend to guide the decision of which approach should be adopted.
One of the advantages of using an ODE is that these tend to be more simplistic
than applying an ABM (Bauer et al., 2009). The equation or set of equations that
are generated tend to be formulated from a lower number of parameters than required
using an ABM approach, capturing less but recreating patterns observed in the domain
of interest. In both cases these parameters can be set through a process of calibration,
to ensure that the model correctly captures expected behaviour. Where an ABM
implementation may lead to a large number of parameters, an ODE approach may
be more viable (Bauer et al., 2009). The set of equations generated using an ODE
approach may be complicated but are unambiguous: it is these which capture the
system being modelled. With an ABM approach however, the implementation of the
model is much more complex, and the detail hidden within the implementation can
aﬀect the overall result. However, there are frameworks that are being utilised to
make the design of ABMs more transparent and easier to interact with, which will be
examined later in this chapter.
A modeller needs to consider whether the scope of the problem is to investigate
organism wide cell population dynamics or whether each individual in the system
needs to be examined as its own distinct entity (Germain et al., 2011). As described
previously in the HIV-1 model, ODE’s lend themselves well to a study of host-pathogen
interactions within a population, yet make the assumption that each entity within the
population is identical. However if characteristics of each individual target cell were to
be examined, an ABM approach is required.
The inclusion of spatial aspects is diﬃcult to achieve with an ODE model. Where
this is an important consideration, an agent-based model can be more appropriate
(Germain et al., 2011), and in some cases can contribute to the accuracy and meaning
of the result. Strain et al (2002) compared their ABM of HIV infection with that
developed using an ODE approach (Perelson et al., 1997) and found that the viral
infectiousness was overestimated by more than an order of magnitude in the ODEmodel
(Bauer et al., 2009), suggesting a consideration of space is important. Beauchemin and
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colleagues (2006) have also utilised an ABM model to capture HIV-1 dynamics, and
determined that representation of space is indeed an issue, reporting more reliable
results from an ABM when compared to real-world experimental data. For studies
that focus on the formation of cellular structures or tissue rather than host-pathogen
interactions, for instance the formation of germinal centres (Figge et al., 2008), the
modelling of space, and how this aﬀects the formation could be a key consideration.
Where choice is not constrained by either of the above, it may be necessary to
consider the availability of computing resources when determining whether to use an
ODE or ABM. In an ABM implementation, each individual entity is captured as an
agent, with each possessing a set of properties. In the majority of computational imple-
mentations this will require each individual entity to be represented as an individual
process. For systems with a large number of agents this will require a substantial
computational resource. However as the availability of powerful computing resources
such as computer clusters and cloud computing services increase, this drawback could
be negated. Additionally, it could be possible to consider a combination of aspects
from both ODE and ABM techniques, and implement a stage-structured model. This
approach has been demonstrated in a model of the cytotoxic T lymphocyte response to
antigen (Chao et al., 2003). In this implementation, each agent’s life cycle was divided
into stages and deemed to be identical to all other agents currently in that stage. As
this is the case, an integer value can be used to represent the population of agents in
that stage, removing the need to represent each agent explicitly, thus improving the
eﬃciency of the model by a number of orders of magnitude. Where the purpose of a
model is to capture an emergent population-level phenomenon while considering the
global behaviour of each agent involved in producing that phenomenon, this case study
is a good example of a methodology to adopt where it is necessary to capture a very
large number of agents.
1.4.2 Modelling Tools and Frameworks
As the integration of modelling and simulation with conventional wet-lab research has
become more popular and prevalent, a number of frameworks and toolkits have been
made available to aid simulation creation. This section summarises currently available
techniques and tools that are available and that have previously been used in the
modelling of biological systems, after which a brief evaluation is provided on the tool
suitability.
The CoSMoS Process
Although not designed speciﬁcally for biological systems, the Complex Systems Mod-
elling and Simulation Infrastructure (CoSMoS) Project was an EPSRC funded study
that established generic tools and techniques to support the modelling, simulation,
and analysis of complex systems (Andrews et al., 2010), and has found application in
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modelling biological systems (Garnett et al., 2008; Read, 2011) as well as ecological
and sociological systems (Polack et al., 2010). Collaboration between an investigator
constructing the model and an expert(s) in the system being modelled is encouraged,
and processes developed that aid interaction between the two. A set of rigorous activ-
ities is proposed that leads to the generation of a series of models, a process that is
detailed in Figure 1.6. These models underpin the understanding of the system that is
to be simulated, providing a level of transparency in the manner in which a simulation
has been implemented, an agreed speciﬁcation of the scope of the work, and a means
in which results can be interpreted in relation to the captured real-world system. This
section examines each of these models generated by utilising this process.
Figure 1.6: The CoSMoS Process for modelling complex systems, detailing the stages
of the process and ﬂow of information. This image of the process was taken from Read
et al (2011)
The system of interest that is being modelled, for example the foetal development
of PP, is termed as the Domain. The current scientiﬁc understanding of the system
dynamics, such as that detailed in section 1.3.1 for PP development, is captured in a
Domain Model. This process sets the scope of the exploration in collaboration with an
expert in that system, and can reveal areas to be captured where current understanding
is incomplete. Where this occurs, suitable assumptions are made and justiﬁed for sake
of scientiﬁc transparency. All the entities that have a role in system dynamics, and
the behaviours that produce an observed phenomenon, are included within the domain
model. At this point no consideration is given into how this will be implemented as a
simulation.
With this speciﬁcation agreed, a Platform Model is generated that speciﬁes how the
domain model can be implemented as a simulation platform. This speciﬁcally details
how each entity and its relevant behaviour described in the domain model will be imple-
mented in a computer simulation. Critical to the process, emergent behaviour speciﬁed
in the domain model, such as a statistically signiﬁcant change in a cells behaviour, is
removed. Such observed behaviour must emerge through interactions between entities
and not be directly encoded into the model, as this invalidates the simulator as a pre-
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dictive experimental tool. If this behaviour does not emerge through interactions, the
platform model does not capture the domain model appropriately, or the speciﬁcation
of the system under study in the domain model is incorrect. In the process of gen-
erating this model, further simpliﬁcations and assumptions may be necessary and are
documented accordingly for scrutiny alongside simulation results. Alongside the detail
of the system being captured, this model also speciﬁes user interfaces and data capture
mechanisms that are required in order to interact with the simulator.
The speciﬁcation that comprises the platform model is then implemented as a
Simulation Platform, adopting one of the modelling approaches described in detail
in section 1.4.1. The process places no constraints on modelling methodology or choice
of programming language. Completion of this phase leads to the generation of an in
silico tool through which experimentation can be performed.
The Results Model summarises the understanding generated from experimentation
conducted using the simulator. At this point, results from the simulator can be con-
trasted with real-world results in the domain model to determine a level of conﬁdence in
the simulator as a suitable representation of the system being captured. Such compar-
isons under diﬀerent simulation conditions may also generate predictions that inform
future investigations.
It can be noted from Figure 1.6 that the process has no deﬁned end point. A
comparison between results generated by the simulator and those with the domain
model may lead to a reﬁnement of the domain model, upon which the process starts
again. This is a process that will continue until the domain has been adequately
captured. Where this is the case, further iterations could also occur if the model is
extended further.
Immune System Simulation Platforms
Whereas the above provides a toolkit to aid the speciﬁcation of a model, it does not
specify how that model is implemented. A number of platforms have been developed
that enable an investigator to specify the events that occur on an interaction between
cells, to simulate a response. The objective behind their creation was to enable biol-
ogists who may lack the mathematical and computer coding skills to construct either
ODE or ABM simulations (Meier-Schellersheim et al., 2006). This section considers two
such tools, IMMSIM (Puzone et al., 2002) and Simmune (Meier-Schellersheim et al.,
2006), although it is noted that similar packages (Reactive Animation (Efroni et al.,
2005), SIS (Mata and Cohn, 2007)) are available.
IMMSIM is based on use of a cellular automator approach (Celada and Selden,
1992), and was constructed to examine discrete interactions within a set lattice grid
environment (Puzone et al., 2002). The platform has found application in exploring
the generation of immunological memory (Celada and Selden, 1992), hypermutation
(Celada and Seiden, 1996), and autoimmune responses (Celada and Seiden, 1998). The
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modeller speciﬁes the entities that have a role in the interaction, and the events that
should occur on interaction. Each individual entity in the system being captured is
represented as a data structure to store relevant properties, thus following an ABM
implementation as described previously. Each entity is then associated with a receptor,
with interactions between entities modelled as an interaction between these receptors.
Simulation execution is performed in steps, with an event triggered if an interaction is
detected in that time-step. This allows for a representation of time in the simulation.
Results are generated that detail the impact that interactions during a simulation run
has had on particular measures, which could include number of cells in a particular
state, or antibody maturation.
Simmune has been developed to allow the modelling of molecular interactions with-
out involvement in any underlying mathematics (Meier-Schellersheim et al., 2006).
These reactions are deﬁned using a graphical representation where the molecules in
the system are detailed and the complexes that comprise their respective binding sites
stated. The modeller connects binding sites via arrows, and speciﬁes conditions that
must be met for the interaction to occur. These interactions may aﬀect molecules both
within a cell and on the membrane, and Simmune allows for the inclusion of both,
thus making it possible to model the eﬀect of that interaction on the underlying cell
chemistry. Once population sizes are speciﬁed, Simmune calculates the time-course in
which changes occur to the molecular makeup of the model once an event is applied,
producing a quantitative measure of the binding states of all molecular mechanisms
in the model. The use of the platform has been exempliﬁed in examining the role of
chemosensing in Dictyostelium (Meier-Schellersheim et al., 2006).
Both packages are publicly available and in a process of ongoing development. Ex-
ploration of the reactions that are captured are performed by changing the interaction
rules that are speciﬁed in the design of the model.
Simulation Toolkits
Platforms such as Simmune and IMMSIM have been constructed to aid the modelling
of biological interactions that lead to an immune response. For applications that are
not host-pathogen based, the platforms may not provide the required functionality. In
these cases, it may be more appropriate to implement the simulation using one of many
simulation toolkits that are available.
Two examples of publicly available simulation toolkits are MASON (Luke, 2005)
and BREVE (Klein, 2002). Both provide a suite of background functionality upon
which a simulation can be built, including tools to create an environment, create agents,
perform collision detection between agents, and tools for visualising and capturing the
simulated environment. The modeller speciﬁes the agent types, the states the agents
could reside within, and the actions that agent performs both in that state and on
interaction with another agent. Simulations are then executed in discrete time-steps
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where each agents performs the respective behaviour dictated by its current state.
This allows for the inclusion of both space and time in the simulation, important for
scenarios such as Peyer’s Patch development where tissue formation is occurring in a set
environment for a set time-period. MASON is open source and has been implemented in
the Java programming language, whereas BREVE simulations are written in a bespoke
programming language, steve. The former focuses on the modelling of multi-agent
simulations, and has thus been optimised to ensure it can eﬀectively handle a large
number of agents. The latter focuses more on the environment that the interactions
take place, and captures this as a continuous 3D space. The appeal of both is that
these are open source and extendable, and can thus be more ﬂexible than the immune
simulators in the previous section. MASON has recently found application in the
modelling of experimental autoimmune encephalomyelitis (Read, 2011), a model for
multiple sclerosis, and BREVE in the modelling of global immune responses to primary
and secondary exposure to antigen (Jacob et al., 2004).
Toolkits and Frameworks: A Discussion
The objective behind the creation of the IMMSIM and Simmune packages is under-
standable: construct a package that makes simulation creation accessible to biologists
who may not have the skills to implement a simulator using other methods. Using in-
tuitive graphical interfaces, the process is straightforward, and quickly leads to results
that could be used to back an hypothesis or inform future work. Although this is ap-
pealing, there are aspects that need to be taken into consideration with this approach.
It is unlikely that a simulation will be created where all the underlying biologi-
cal detail is understood. This can be countered by making suitable assumptions and
abstractions, although it may not be known as to the eﬀect these have on system
dynamics and behaviour. One drawback in the use of immune system simulation pack-
ages is that these do not allow for the documentation of assumptions and abstractions
that have been made. It is noted that for Meier-Schellersheim et al’s (2006) model of
chemosensing that exempliﬁes the use of Simmune, these assumptions were released
as supplementary material that accompanies their results. However it has to be ques-
tioned as to whether all investigators will do this with packages being promoted as
drag-and-drop simulation creation tools. A lack of transparency on what has been in-
cluded in the model, and what has been left out, will lead to some justiﬁable scepticism
when judging results.
This could however be countered by using such packages alongside the CoSMoS
Process (Andrews et al., 2010). This could address any lack of transparency that us-
ing the platforms alone may create, through the creation of a model that speciﬁcally
details the underlying biology that has been captured and any assumptions and ab-
stractions made, and a further model that acts as a speciﬁcation of how this could be
implemented in IMMSIM or Simmune. This implementation would then take the role
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of the Simulation Platform within the CoSMoS Process.
If this were to be the case, the modeller would have to decide whether IMMSIM
and Simmune have the functionality to capture the biological system being studied.
Both IMMSIM and Simmune have been constructed with the aim of examining re-
sponses to interactions, and can detail how the response aﬀects system dynamics. For
applications that examine host-pathogen or cell receptor binding aﬃnity, such as the
many examples where IMMSIM and Simmune have been applied, this is suﬃcient, and
where the speciﬁcation is robust, signiﬁcant biological insight can be gained. However
if the emergent behaviour under examination is not based on how these interactions
aﬀect cell chemistry or properties, the use of IMMSIM and Simmune may not be ap-
propriate. These may also not be suitable for modelling biological systems where the
environment these interactions take place within inﬂuences the behaviour that is ob-
served. Tissue development could be an example of both, where aggregations of cells
emerge from interactions between cells in the system, mediated through interactions
with the environment. Where this is the case, it may be more appropriate to use one
of the simulation packages available to implement the simulation. Again, for the sake
of transparency, this could be paired with use of the CoSMoS process, with simulation
packages acting as an aid in the creation of the simulation platform.
Whereas IMMSIM and Simmune have sought to develop tools for biologists that
may lack the mathematical and computing skills to implement a simulation, the CoS-
MoS process takes a diﬀerent stance, suggesting that simulation creation is aided by
a collaboration between an expert in the ﬁeld being simulated and those creating the
model (Andrews et al., 2010). A successful collaboration can raise important questions
that the ﬁeld expert may not have yet considered, while ensuring that all involved un-
derstand the strengths and limitations of the tool that has been created (Polack et al.,
2010). This is an important step in understanding what the results mean in terms of
the system being modelled.
1.5 Conﬁdence in Simulation as a Representation of the Bio-
logical System
Any exploration of a biological system, whether this uses current laboratory or com-
putational techniques, can be treated with a degree of scepticism as the understanding
of each underlying aspect is incomplete. In both types of exploration, this is addressed
through the making of well justiﬁed assumptions. Thus the exploration is examining
an abstraction of the real system rather than the full detail. Implementing a computer
simulation of a biological system adds a further level of abstraction, as it is intractable
to capture all aspects of the biological system in the model. However as the aim is to
understand how interactions between factors lead to an observed, emergent behaviour,
the simulator does not need to be a complete representation of the system (Germain
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et al., 2011). For example, an interaction between two cells may lead to a higher-order
eﬀect on system dynamics and trigger pathways within each cell. With the interest
being on the former and not the latter, an assumption can be made that the particular
pathway is always triggered. It is critical that the assumptions and abstractions that
are made are taken into consideration when scrutinising simulation results to determine
their relevance to the biological system being explored.
Computational methods are ﬁnding increased application in the investigation of
a variety of biological systems, and explorations using a computational immunology
approach are increasingly being applied alongside current experimental techniques (Co-
hen, 2007; Germain et al., 2011; Kleinstein, 2008). In Section 1.3.4 above, it was noted
that although a reductionist approach to immune system development has provided
some key insight, questions do remain that such methods cannot address. Computa-
tional methods are not introduced to replace such investigations, rather to complement
them. For conﬁdence to be retained in the use of simulation as a tool for understanding
biological systems, it is important that the relationship between the simulation and the
system it captures is appreciated. However, it has been noted that there are few cases
where the adequacy of a simulation, in terms of representing the system it captures, is
discussed alongside results generated from it (Read, 2011).
This section examines a number of methods that aim to establish conﬁdence that
a result from a simulation developed using one of the techniques described in previ-
ous sections is representative of the biological system it captures. This issue has been
the topic of a recent study by Read (2011) that has examined current practices in
generating conﬁdence in simulation, alongside the development of a simulation of Ex-
perimental Autoimmune Encephalomyelitis (EAE). Read’s work is discussed alongside
other methods that were not included in his study. For this examination, the same def-
inition of conﬁdence is used as that proposed by Read: that conﬁdence is not absolute,
yet related to the simulation purpose and scope of experimentation, and established
through ensuring simulation results are representative of the abstraction of the system
it captures (Read, 2011).
1.5.1 Simulator Calibration
As was noted previously in this chapter, it is highly unlikely that a model will be
generated where values can be assigned to all parameters identiﬁed in its creation.
This may be as the underlying biological understanding is incomplete, or the method
of implementing that factor does not translate back to laboratory derived values (for
example the use of a probability function to capture binding aﬃnity). Calibration is
a process by which values are assigned to parameters such that simulation responses
are generated that are representative of those in the system being modelled. Through
this process the simulation is deemed an adequate representation of the higher-order
behaviour observed in the real-system, although a number of assumptions and abstrac-
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tions will have been made. Although such a process is therefore a vital stage in the
parameterisation of a model, it is rare to ﬁnd the process of calibration documented
alongside simulation results (Read, 2011). A limited number of studies do mention that
a procedure has been performed (Ray et al (2009) being one example) but not noted
how this was performed or the data that was used in the process. However, procedures
to ﬁt simulation results to biologically-derived responses have been described in simu-
lations of lymphocyte migration (Figge et al., 2008) and the life cycle of Mycoplasma
genitalium (Karr et al., 2012).
It may however be diﬃcult to access a suitable set of biological results upon which a
simulation can be calibrated. Even where one exists, there may be signiﬁcant variance
both in the result set and in comparison to results generated elsewhere, using identical
or other techniques, and it is thus questionable as to whether this is a representation
of the system being captured. It is cases such as this where a collaboration between
an expert in that biological system and a modeller is advantageous, as encouraged
by the CoSMoS Process (Andrews et al., 2010) detailed previously (Section 1.4.2). A
good example of this is the calibration process applied to Read et al’s (2012) model
of Experimental Autoimmune Encephalomyelitis (EAE). Initial parameter values were
established using a set of parameter values arrived at through informed estimation, and
simulation responses generated. An iterative process was then conducted where the
biological system expert, in this case a collaborator with expertise in EAE, examined
the simulation dynamics and identiﬁed areas that did not ﬁt with their understanding
and experience of the biological system. This led to further parameter alterations and
further discussions. Through a combination of the collaborators expertise and the mod-
ellers understanding of how the simulator captures system dynamics, a set of parameter
values were identiﬁed that adequately captures the collaborators understanding of the
system dynamics.
Calibration is an important process as it establishes the behaviour of the simulation
under circumstances deemed as normal. This acts as the baseline, to which the results
of future in silico investigations are compared. Without this link from the start, it is
not possible to use the simulator in experimentation that aims to provide biological
insight.
1.5.2 Validation Tools
Calibration may establish behaviour that produces an expected result, but producing
evidence that shows a simulator generates a result representative of the biological
system is not alone enough to provide conﬁdence in the use of the simulator as an
experimental tool. Simulations have previously been criticised as being opaque tools
(Di Paulo et al., 2000), where a result is generated yet it is not obvious why this is
the case. Full transparency in the implementation is key in understanding why such a
result is produced and verifying that there are no errors within the implementation that
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have aﬀected that result. A process of validation can be used to determine how ﬁt a
simulation is for its purpose (Polack et al., 2011). Such a process exposes the decisions
made in its design and implementation for scientiﬁc scrutiny. Where simulation is to be
used as a scientiﬁc instrument for furthering the understanding of a captured system,
this is critical, as these decisions and the evidence behind them may impact the result
generated.
Previous studies concerning the validation of simulations of complex systems have
taken inspiration from that used in the ﬁeld of safety critical systems (Ghetiu et al.,
2009, 2010; Polack et al., 2011). Computational tools used in this ﬁeld are subjected
to a stringent analysis of their compliance to a set of requirements before being in-
troduced, as an error within or failure of the implementation could lead to potentially
life-threatening circumstances (for example where this software was used in an aircraft).
Such an analysis utilises an Argument-Based Validation (ABV) technique where the re-
quirement is matched to evidence detailing how it has been met in the implementation,
and where applicable, how relevant parameters where derived. Visual notations such
as Goal-Structuring Notation (Kelly, 1999) have been developed to provide a method
of structuring such an analysis, ensuring each step in the implementation is validated,
the reasoning behind the inclusion or exclusion of a feature or assumption is provided,
and evidence given as to why this conclusion has been drawn (Ghetiu et al., 2010).
For GSN, this process is conducted through the production of a ﬂowchart, comprised
of the notation in Figure 1.7a. A basic example of the structure of a Goal Structuring
Notation (GSN) argument can be seen in Figure 1.7b.
It is proposed that ABV techniques can be used prior to, during, and after the
design and implementation of a computer simulation (Ghetiu et al., 2010). A set of
requirements, or goals, are identiﬁed. The strategy used to ensure this requirement is
met is clearly stated. Evidence that supports a claim that this requirement is met is
speciﬁcally noted alongside that goal, with any assumptions that were required. The
use of the technique was recently exempliﬁed by Polack et al (2011) to explore the suit-
ability of a simulation of cell division and diﬀerentiation in the prostate. The authors
detail how the process revealed important biological areas that had been overlooked or
inadequately addressed in the simulation and areas that could act as a starting point
for future experimental or simulation work (Polack et al., 2011). The former is an
important consideration in scrutinising results produced by the simulator. For cases
in some applications, there may not be the evidence to support a particular require-
ment. This may be due to incomplete biological knowledge. However, it is in these
such cases where the use of this technique is advantageous, as a structure is provided
that highlights these areas, showing where assumptions have had to be made, where
further biological exploration is necessary, and where results could be aﬀected by these
factors. Thus, not only is a tool for providing a structured assessment of an ongoing
simulation development, but it may potentially feed future explorations that verify a
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simulation result.
Excluding the work cited previously (Ghetiu et al., 2009; Polack et al., 2011), the
use and release of an argumentation strategy to support both a simulation and results
from it, to build conﬁdence in the simulation as a scientiﬁc instrument, is rare. The
justiﬁcation of each part of the simulator opens the design and parameterisation deci-
sions up for scientiﬁc scrutiny and should be encouraged. However it should be noted
that there is not currently a tool available to support such systematic documentation
of simulation-based research (Polack et al., 2011).
1.5.3 Ensuring a Simulation Result is Representative
For simulations that are implemented using an agent-based approach, the eﬀect inher-
ent stochasticity introduced by the implementation has on simulation response must be
appreciated. Agent-based approaches are suitable for capturing inherent stochasticity
in the biological system as each agent is its own entity, possessing a state and charac-
teristics (Forrest and Beauchemin, 2007), as would a biological factor such as a cell.
Behaviour of simulated biological factors may be dictated by the use of pseudo-random
number generation. For example, the simulator may randomly choose a probability that
a stable bind occurs when two cells come into contact. As behaviour is implemented in
this manner, the simulation will generate diﬀerent sets of responses for the same input
parameter set. This implementation issue introduces uncertainty, termed aleatory un-
certainty, that must be considered when establishing conﬁdence in simulation response
(Helton, 2008). If the simulation is to be used to perform in silico experimentation,
it is critical to ensure that the result is representative of the condition on which the
simulation was run, and not an eﬀect of stochasticity in the implementation.
Previously published studies that utilise an agent-based approach have addressed
this by performing a number of replicate simulation executions and taking a mean or
median of the set of results produced. A recent model of lymphocyte priming in the
lymph node utilised 10 executions (Linderman et al., 2011), while conclusions have been
drawn from a simulation of tuberculosis by performing either 4, 10, or 15 executions
dependent on the analysis being performed (Ray et al., 2009). However no statistical
measure is provided that suggests this number of runs provides a suﬃcient level of
accuracy.
Recent studies have established a statistical technique that can be used to miti-
gate the eﬀect of aleatory uncertainty on simulation results (Read et al., 2012). This
establishes the number of simulation executions required to achieve a desired level of
experimental accuracy while considering the computational resources available. The
analysis operates by contrasting distributions of simulation responses, all generated us-
ing one ﬁxed set of parameter values and containing an identical number of simulation
samples. The number of samples required to obtain statistically consistent distribu-
tions is established by varying the number of samples within each distribution. As
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(a) Goal-Structuring Notation. Figure taken from Ghetiu
et al (2010)
(b) A basic example of the construction of an ABV ﬂowchart, taken from Polack
et al’s (2011) study on validating a model of prostate cancer cell behaviour.
Figure 1.7: Use of argument-based validation techniques to evidence how a requirement
of a system has been met. Top: Goal Structuring notation used to develop the ﬂowchart.
Bottom: A basic example of the use of ABV from Polack et al (2011). Note that ﬁlled
diamonds denote that the argument has been continued on a further diagram.
the sample size increases, the likelihood of producing identical distributions increases,
reducing the eﬀect of implementation speciﬁc stochasticity.
This technique was developed alongside and exempliﬁed with the authors agent-
based simulation of EAE (Read, 2011). In their case study that exempliﬁes the tech-
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nique, 20 such distributions are generated, and the eﬀect of stochasticity on sample sizes
of 5, 10, 50, 100, 200, 350, 500, and 1000 simulation runs examined. The contrast be-
tween distributions is assessed using the Vargha-Delaney A-Test (Vargha and Delaney,
2000), a non-parametric eﬀect magnitude test that establishes scientiﬁc signiﬁcance
by examining the probability that a randomly selected sample from one distribution
will be larger than a randomly selected sample from the other. A result above 0.71 or
below 0.29 indicates a scientiﬁcally signiﬁcant diﬀerence between the populations, with
0.5 indicating no diﬀerence (Vargha and Delaney, 2000). The objective is to establish
the number of samples required to reduce the eﬀect to that deemed less than small by
the Vargha-Delaney A-Test. In the case of the stated case study, this was achieved for
a sample size of 500, and thus 500 simulation executions were performed for each in
silico exploration that was performed.
The contrast between the number of executions performed in the lymphocyte prim-
ing and tuberculosis studies (Linderman et al., 2011; Ray et al., 2009) with that in the
EAE simulation (Read, 2011) is huge, and goes someway to showing why this technique
is necessary. The implementation of this technique reduces the inherent stochasticity
in the simulation to a level near that observed in the biological system. Possessing a
statistical measure detailing why a particular number of samples was chosen provides
a strong argument that the measure generated from the distribution of results (mean
or median, dependent on application) is a representation of the condition on which the
simulation was run.
1.5.4 Sensitivity Analysis Techniques
A sensitivity analysis (SA) is the application of statistical techniques to examine how a
system responds to an alteration in input parameter values. Through varying param-
eter values and analysing the resultant eﬀect on simulation response, the parameters
that have an inﬂuential eﬀect on the simulations high-level behaviour can be identiﬁed
and, for some techniques, quantiﬁed. Application of SA techniques provides a powerful
tool for understanding simulation behaviour and how this aﬀects results, aiding the
scrutiny of results that are produced. Possessing this understanding helps establish
the relationship between the simulation and the real-world system, to determine if a
result is an aﬀect of simulation parameterisation or a true reﬂection of the underlying
biology.
One of the attractions of using simulation is to produce results that can further the
understanding of a biological system. Sensitivity analysis techniques provide a means
of performing this exploration: where a parameter is found to be highly inﬂuential,
this could suggest that the biological mechanism(s) it captures are important in the
behaviour of that system. Such results could then be veriﬁed using current laboratory
techniques where possible.
However to retain conﬁdence in such conclusions, uncertainty in the value of simu-
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lation parameters, termed epistemic uncertainty (Helton, 2008), must be appreciated.
Section 1.5.1 detailed how a process of calibration can be used to determine a set of
parameters for which the simulation produces the expected result, but gives no measure
of how the value assigned to each parameter inﬂuences simulation result. This measure
can be provided through use of SA techniques. Where SA reveals a parameter value
alteration has no inﬂuential eﬀect on simulation response, the accuracy of the simula-
tion is not impacted by the value set to that parameter (Read et al., 2012). However
if the analysis reveals that the parameter is inﬂuential, where changes in parameter
value do cause a signiﬁcant change in simulation response, the analysis is highlighting
both the inﬂuence of and uncertainty in the value of that parameter, which must be
taken into account when results are scrutinised. If uncertainty in these values were to
be addressed, the simulation would produce much stronger predictions (Marino et al.,
2008; Read, 2011).
This section continues by examining two types of sensitivity analysis technique
that provide an understanding of simulation behaviour, in the context of establishing
conﬁdence in simulation results. The ﬁrst examines how robust the simulation is to
a perturbation of an individual input, and are termed one-at-a-time SA techniques,
whereas the second set of techniques perturb the values of two or more parameters
simultaneously, to identify any compound eﬀects between parameters.
Simulation Robustness to Parameter Perturbation
A simulators robustness to a perturbation in parameter value can be determined using
a one-at-a-time approach (Read et al., 2012). This technique alters the value of a single
parameter at a time, with the complementary parameter set remaining at their baseline
values. The simulation response under that condition is contrasted with responses
generated using baseline parameter values. Where a simulation response is found to
be sensitive to that parameter value, caution should be exercised when results are
interpreted, as these may be artefacts of parametrisation rather than representations
of the biology (Helton, 2008). Where no eﬀect is observed, the analysis suggests that
the parameter value change has little impact on simulation response. Studies that
examine T-cell motility in lymphoid tissue have applied this technique with that in
mind: to suggest that the simulation is robust to changes in parameter value (Zheng
et al., 2008). However, studies of inﬂuenza utilise the technique for the opposite eﬀect,
to examine parameter values either side of baseline values and suggest the inﬂuential
parameters (Beauchemin et al., 2005).
Neither of the examples stated follow a formal procedure for quantifying the eﬀect
a change in parameter value has had on simulation response. This has been addressed
through the development of a technique that determines if changing a parameter value
leads to a scientiﬁcally signiﬁcant behavioural alteration in contrast to the baseline
simulation (Read et al., 2012). For each simulation parameter being explored, a range
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of potential values it could take is established, and simulations performed where that
parameter is assigned a value within that range. Simulation responses under those
conditions are contrasted with results generated under baseline conditions using the
Vargha-Delaney A-Test (Vargha and Delaney, 2000) described in the previous section.
This provides a statistical measure of the eﬀect that the change in parameter value has
caused, and identiﬁes the points in the range of values explored at which the parameter
perturbation results in signiﬁcant changes in simulation behaviour. Where suﬃcient
data is available, conﬁdence in the validity of these results can be gauged by contrasting
this information with biologically accepted ranges of values. Where this is not the case,
the sensitive parameters are identiﬁed, aiding the understanding of the behaviour of
the simulator and potentially the underlying biological system (Read et al., 2012).
Gaining Insight using Global Sensitivity Analysis Techniques
Although robustness analysis suggests the eﬀect of perturbing single parameters, it
cannot reveal compound eﬀects that occur when two or more are adjusted simultane-
ously. The eﬀect one parameter has may rely on the value assigned to another. Global
sensitivity analyses perturb all parameters of interest simultaneously, to reveal whether
there is a correlation between simulation response and the value assigned to a particu-
lar parameter (Saltelli et al., 2000). Where this is the case, parameters that could be
coupled and that have the greatest inﬂuence on simulation responses are highlighted.
If the relationship between the simulation results and underlying biological foundation
is strong, such conclusions can then be used to suggest the inﬂuential biological factors.
Such an analysis has been applied to determine the contribution of cytokine TNF-α
to an immune response against tuberculosis (Ray et al., 2009), where the inﬂuential
biological mechanisms have been suggested by establishing the simulation parameters
which reverse the immune response.
The aforementioned tuberculosis study varies the value of a range of parameters
of interest and calculates a Partial Rank Correlation Coeﬃcient (PRCC), a statistical
measure of correlation between parameter input value and response (Ray et al., 2009).
The result produced therefore has some link to the parameter value sampling procedure
used. Recent work has taken this a stage further and considered the importance of
parameter value sampling in the application of global sensitivity analysis methods
(Read et al., 2012). The authors technique utilises a latin-hypercube design (McKay
et al., 1979) that aims to select sets of parameter values that cover the entire parameter
space, while ensuring no correlation is formed between the value sets that are generated
(Saltelli et al., 2000). This rigid approach to the selection of parameter values ensures
that there is no sampling bias that could aﬀect the PRCC that is calculated from
simulation results generated from the parameter sets.
Additional studies have also examined the use of a diﬀerent sampling and analy-
sis technique, the extended Fourier Amplitude Sampling Test (eFAST) (Marino et al.,
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2008; Saltelli, 2004; Saltelli and Bollardo, 1998), which uses fourier frequencies to gener-
ate parameter value samples. For each parameter of interest, values are chosen through
use of a sinusoidal curve of a particular frequency through the parameter space, with a
number of values chosen from points on the curve. The chosen frequency can then be
utilised in calculation of a statistical measure revealing the proportion of variance that
can be explained by perturbing the value of each factor, which suggests how sensitive
the simulation and biological system is to that parameter. This technique has been
applied for a number of ODE based models (King and Perera, 2007; Marino et al., 2008;
Zhao and Tiede, 2011), yet has not found application in statistical analysis of agent-
based implementations. The combination between the inherent stochasticity of such
models and the complexity of this technique may make such an analysis intractable,
as the analysis requires a large number of parameter value sets. For stochastic sys-
tems, where uncertainty is addressed by performing replicate runs, this may lead to an
intractable number of simulation runs, especially if the number of parameters is high
(Tarantola et al., 2006). There is a balance between the insight this technique provides
and the computational resources available. Where the number of parameters is high,
the latin-hypercube technique described in the previous paragraph is more appropriate
(Read et al., 2012).
Application of Sensitivity Analysis Techniques
The use of sensitivity analysis techniques may be well established in other ﬁelds (Saltelli
et al., 2000) but it is only recently that these techniques have found application in
simulations of biological systems (Marino et al., 2008; Ray et al., 2009; Read, 2011;
Read et al., 2012). Where examples do exist, these tend to detail an application
of the techniques to ODE rather than stochastic agent-based models (Read et al.,
2012). Although the added complexity of agent-based models means any analysis
would require considerable computational resources (for reasons discussed in section
1.5.3), the insight that can be gained using the techniques, in terms of conﬁdence in
simulation result, makes the analysis worthwhile.
It was noted in section 1.4.2 that an increase in the potential and use of computa-
tional models has coincided with the development of a number of packages that aim
to assist with simulation development. Although a number of sensitivity analysis tech-
niques have been described, there currently exists no generic package for determining
how representative a simulation is of its biological system and understanding how in
silico results can be interpreted in the context of the biological domain. It could be sug-
gested that if a package incorporating a number of techniques such as those described
above was developed, a full sensitivity analysis of a simulation would be eased and thus
encouraged. Increased use and exposure may then make this analysis an essential part
of any study that uses simulation, for both ODE and agent-based implementations.
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1.5.5 Verifying in silico Experimentation Results
It could be suggested that a straightforward comparison between a simulation result
and a result from published literature or laboratory experiment provides a strong in-
dication of the simulators reliability as an experimental tool. It is understandable to
think that if the simulator replicates the expected result, the system dynamics have
been captured. In his analysis, Read (2011) has a negative opinion of this technique,
applied in work by Linderman (2011) among others, suggesting that such comparisons
are open to accusations of being ’cherry-picked’ to support the intended result, unless
such experimentation was detailed prior to the simulators implementation. However,
this is open to interpretation. For example, in a model that captures cell behaviour
leading to an observed physical property, such as an aggregation of cells, the focus is on
correctly capturing cell behaviour rather than the emergent property. Thus it would
be sensible to compare this emergent behaviour to a number of previously observed
examples. The argument is also dependent on whether the comparison is quantitative
or qualitative, especially in cases where the comparison is visual rather than statistical.
It is therefore diﬃcult to rule this out as a method of veriﬁcation: it is dependent on
the model and the type of results being used in the comparison.
Instead Read (2011) supports a stronger approach noted as best practice, where sim-
ulation predictions are veriﬁed in the laboratory (Bauer et al., 2009). Although this is
deﬁnitely a strong method and one which closes the loop in terms of simulation-derived
laboratory experimentation, it requires a high level of conﬁdence in that simulation re-
sult. However the author does note that this has drawbacks: laboratory investigations
are expensive, time-consuming, require specialist staﬀ, and may require the use of
animals and thus ethical certiﬁcation, and thus should be performed as a ﬁnal step
once conﬁdence in the simulation result is assured. However, there are successful ex-
amples where simulation predictions have been supported by laboratory investigations
(Efroni et al (2007) being one), suggesting there is scope if computational modelling is
integrated with laboratory experimentation from the initial design stages.
1.5.6 Simulation Availability
Performing all the steps above may make a convincing argument that a good level
of conﬁdence in the simulator as a representative tool is established. However, one
additional and elementary step may aid the development of conﬁdence in simulation
as an experimental tool. Although the use of modelling and simulation is becom-
ing increasingly popular, and results published alongside biological experimentation in
high-impact journals (Kleinstein, 2008), it is rare to have access to the simulators that
have been generated. Granting access to the ﬁeld would provide experimental immu-
nologists with the opportunity to examine the tool themselves, to both provide input
into future iterations of the simulator and use the simulator to inform their future
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investigations. This is an important consideration if this approach is to become widely
accepted and conﬁdence grow in the use of computational modelling as a technique.
1.6 Thesis Overview
This thesis details the development and use of statistical and simulation tools that
enable a computational exploration of lymphoid organ development. This is driven by
the following aims:
1. Development of a robust computational model that replicates emergent behaviour
observed ex vivo and in vivo.
2. Development of a statistical toolkit to help determine the relationship between
simulation results and the biological system.
3. An exploration of the biological factors inﬂuencing behaviours that emerge through
interactions between biological factors.
4. Application of the simulation and statistical toolkit to perform novel in silico
experimentation.
Aim 1: Development of a robust computational model that replicates emer-
gent behaviour observed ex vivo and in vivo
Previously described examples demonstrate that computational models can provide
useful insight in the continued exploration of biological systems. To date, this tech-
nique has not been utilised in furthering the understanding of immune system develop-
ment. Previously published investigations have led to the generation of a basic model
of secondary lymphoid formation (Section 1.3.2). This model will be used in the devel-
opment on a computer simulation of Peyer’s Patch development. Available biological
data and published results will then be utilised to ascertain if the simulation is an
adequate representation of the development of these lymphoid organs. Transparency
in the design and implementation of this simulation will be a key aspect of this study,
ensuring that the strengths and limitations of the simulator are understood.
Aim 2: Development of a statistical toolkit to help determine the relation-
ship between simulation results and the biological system
This chapter has detailed the availability of a number of simulation tools and frame-
works that can aid simulation development. However the simulation is developed, it
is important to establish the link between the results and the real world system, to
indicate whether the result is providing biological insight. Although a number of un-
certainty and sensitivity analysis techniques that can help establish this link have been
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described (Read et al., 2012; Saltelli et al., 2000), a comprehensive statistical package
for the analysis of simulation results does not yet exist. This may explain why some
investigators make little attempt to elucidate how representative a simulation result is
(Read et al., 2012). The development of a package of statistical techniques that can be
applied to any simulation has the potential to address this, and thus increase overall
conﬁdence in the use of simulation as an exploratory tool.
Aim 3: An exploration of the biological factors inﬂuencing behaviours that
emerge through interactions between biological factors
Using the developed simulation and statistical toolkit, a quantitative analysis of the
inﬂuence of each biological factor in the behaviour that is observed can be undertaken.
This provides insight that can not currently be revealed using current laboratory ap-
proaches. This analysis focuses on two emergent aspects of the system: the formation
of aggregations of cells that become Peyer’s Patches and hematopoietic cell behaviour
observed ex vivo (Patel et al., 2012). This furthers the understanding of the role of
each biological factor in inﬂuencing that emergent behaviour.
Aim 4: Application of the simulation and statistical toolkit to perform novel
in silico experimentation
Whereas the above aims to explore the contribution of biological factors in behaviours
that are observed, computer simulation can be used to perform in silico experimenta-
tion. Such experimentation may be used to either support or inform current laboratory
investigations where possible, or to support the generation of hypotheses which are dif-
ﬁcult to examine in a laboratory. Two sets of in silico experiments are conducted:
an in silico replication of previously published laboratory investigations, and novel in
silico investigations that aim to address areas of biological understanding that remain
incomplete.
1.6.1 Thesis Structure
This thesis addresses these aims in six chapters, organised as follows:
Chapter 2 describes the methodologies used and the creation of the tools required
to perform an in silico analysis of lymphoid tissue formation. The chapter describes
the creation of a simulation of lymphoid tissue formation, including how conﬁdence is
gained in the use of simulation as an experimental tool through calibration and val-
idation. Next, a package of statistical tools created to analyse simulation results, to
establish their relationship to the biological system, is described. Methods used to
generate in silico experimentation results from the simulator are also detailed.
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Chapter 3 utilises the simulation and statistical tools developed in Chapter 2 to
examine key factors that inﬂuence hematopoietic cell behaviour during hour 12 and 72
of PP development, in conjunction with on-going ex vivo culture system investigations.
Chapter 4 examines the use of simulation as a tool for performing in silico experi-
mentation, replicating previously performed laboratory experimentation and perform-
ing novel investigations. The latter half of the chapter utilises the statistical toolkit
created in Chapter 2 to suggest the key factors that inﬂuence Peyer’s Patch character-
istics (e.g. size).
Chapter 5 utilises the simulator to perform a time-lapse analysis of the develop-
ment process, identifying the stages of development when diﬀerent biological factors
may be inﬂuential. This aims to determine if PP development occurs in distinct phases.
Chapter 6 provides a critical review of the work that has been conducted in rela-
tion to the project aims identiﬁed above.
Chapter 2
Methods and Tool Development
2.1 Introduction
This chapter details the methods used in addressing the thesis objectives speciﬁed
in the previous chapter. For the thesis objectives to be met, suitable tools needed
to be developed. This chapter not only describes the methods that have been used
in the explorations of lymphoid tissue formation that follow, but also describe the
development of the tools needed to perform these explorations.
The chapter begins by describing the development of a model and simulation that
replicates Peyer’s Patch development. In some respects this can be thought of as an
application of the CoSMoS process (Andrews et al., 2010) that was described in Chap-
ter 1. A series of models were created that describe gut-associated lymphoid tissue
development in the mouse. Developed in close collaboration with experimental immu-
nologists, these models detail the biological information that has been encapsulated, a
justiﬁcation on any abstractions and assumptions that were made, and a speciﬁcation
of how this information was encoded within a computer implementation. From these
models, a simulation of the process has been implemented that captures the abstrac-
tion of the biological system speciﬁed, creating a tool through which the explorations
in the following chapters can be performed. This chapter details the techniques used
to develop, calibrate, and validate this tool, ensuring it is ﬁt for the purpose of this
study.
One of the motivations for implementing a computer simulation of a biological pro-
cess is that is enables in silico experimentation to be performed. Using a well designed
simulator, this has the potential to explain any underlying data on which a simulation
has been constructed (Guo and Tay, 2005) and provide novel biological insight by fa-
cilitating experimentation that is impractical or impossible to perform using current
laboratory methods (Andrews et al., 2010; Efroni et al., 2003). Many statistical meth-
ods to aid analysis of simulation results have been described (Marino et al., 2008; Read
et al., 2012; Saltelli, 2004; Saltelli et al., 2000), yet there is currently no comprehensive
statistical package available that aids the analysis of simulation results. Thus a statis-
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tical toolkit, spartan, has been developed to provide a comprehensive set of tools for
understanding both uncertainty in simulation results and the relationship between the
simulation and the real-world system. Each technique included within this toolkit is
detailed in this chapter. The analysis tool developed has been utilised in explorations
of lymphoid tissue formation in the chapters that follow.
With these tools in place, explorations that address the objectives in this thesis can
be performed. The ﬁnal sections of this chapter detail the methods used to perform
the investigations in the following chapters.
2.2 Pairing Current Experimental Techniques with Modelling
and Simulation
2.2.1 Methodology
The methodology involved in modelling and simulating lymphoid tissue development
utilised the principled approach speciﬁed in the CoSMoS Framework (Andrews et al.,
2010), described in section 1.4.2. In this process, the biological system being explored
is termed the domain of interest. Understanding of the functional process is captured
in a series of models: domain, platform, simulation, and results. Each of these models
is considered in turn below:
2.2.2 Domain Model
Overview
The initial stage is the creation of a domain model that encapsulates the current
scientiﬁc understanding of the biological system, scoping both what is to be modelled
and the research question the model is to address. This is a model of the biological
model, one completely isolated from any thoughts on how the biological system could
be translated into computer code (a simulation). This is important as at this point
the details of how the simulation is to be implemented are not of concern, and may
distract from the speciﬁc modelling of the biological system. The domain model may be
a diagrammatic representation, detailing biological factors including cell types, factors
that inﬂuence cell behaviour (e.g. chemokines, adhesion factors) and a description of
the environment in which interactions between these factors take place (e.g. the foetal
intestinal tract). The model will also detail any emergent properties that are observed
through interactions between biological factors. Such behaviours could include the
formation of cell aggregations or changes in cell behaviour.
The CoSMoS Framework (Andrews et al., 2010) stresses the importance of collab-
oration with an expert in that biological system when generating the domain model.
This aids interpreting results in the literature, with a view to including these in the
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model, and potentially permits the inclusion of results from any ongoing laboratory
investigations the collaborator may be involved in. In the scoping of the biological
features that are to be included, many areas will be revealed where the current bio-
logical understanding is incomplete. Collaboration in domain model generation allows
for suitable assumptions and abstractions to be made that have biological justiﬁcation.
These are documented for sake of scientiﬁc transparency.
This section presents a domain model of Peyer’s Patch development that has been
developed based on the literature described in Chapter 1 and in collaboration with
experimental immunologists, a ﬁrst stage in the development of a tool for exploring
lymphoid tissue development. Through undertaking this process, a full exploration of
the domain (foetal PP development) has been performed and captured using a number
of diagrammatical techniques. Areas where the underlying biological understanding is
incomplete have been identiﬁed and suitable assumptions made and documented where
necessary.
A System-Level Overview
Figure 2.1 captures a delineation of both cell behaviour observed in ex vivo culture
results described in section 1.3.3 and results from published literature, using a dia-
grammatical technique exempliﬁed by Read et al (2009). Although this diagram has
no formal schematic, it is useful in identifying the factors in the biological domain that
are to be included in the domain model, the behaviours that become apparent upon
interaction between them, and how these behaviours lead to the system behaviour
observed.
The top of Figure 2.1 details the high level phenomena that has been observed in the
system, either experimentally or detailed in the literature. The dotted line separates
the observed phenomena from hypotheses that are believed to be responsible for their
occurrence. It is these behaviours that will be captured in the series of models that
follow. Where these hypotheses could explain an observed phenomenon, a connection
is made between the two. Where there is still uncertainty in what causes the observed
phenomenon, no hypothesis is included on the diagram. Connected to these hypotheses
are the entities in the biological domain that are believed to be responsible for the
behaviour that emerges, and are thus included in the domain model. Each is in turn
connected to other entities that it may interact with to produce that hypothesis.
Observations from the ex vivo culture system and experimental results in the litera-
ture has led to the formation of three high level observable phenomena that are detailed
on the top of Figure 2.1. The ﬁrst, a small clustering of hematopoietic cells around a
stromal cell after thirteen hours, can be observed in cell tracking images taken in the
preceding hour, as seen in Figure 1.3.3. There is no expected behaviour linked to this
observation due to the uncertainty in the factors causing this to occur. The second, an
alteration in cell velocity and displacement, has become apparent through a statistical
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analysis of the cell tracking data over that hour, presented by Patel et al (2012). The
authors suggest that this is caused by interactions between the cells leading to an ex-
pression of adhesion factors. Thus this hypothesis is linked to LTin and LTi cells. The
ﬁnal observable phenomenon are the large clusters of hematopoietic cells around LTo
cells that are visible along the length of the foetal mouse gut at E17.5. It is widely
accepted in the literature that this emerges through LTi cell response to chemokine
expression (Cyster, 1999; Luther et al., 2003; van de Pavert and Mebius, 2010; Randall
et al., 2008). This hypothesis is in turn linked to the LTi cell, which both triggers
LTo cell diﬀerentiation that upregulates expression of chemokines and expresses the
receptors to respond to this expression (Luther et al., 2003; Randall et al., 2008).
Through a process of delineating the system, it is possible to make simpliﬁcations
to make the generation of a model tractable, while ensuring the expected behaviours
are reproduced. It is intractable to represent all aspects of the biological system in a
model, and thus a subset are included that are suﬃcient to produce the phenomenon
that is observed (Read, 2011). In this instance, Figure 2.1 denotes the involvement
of three chemokines (CXCL13, CCL19, CCL21) and three adhesion factors (VCAM-1,
ICAM-1, MAdCAM). A full quantiﬁcation of the expression levels of each of these
molecules has not yet been possible. As this is the case, a simpliﬁcation has been
made in the initial model where these are considered as one adhesion factor and one
chemoattractant factor respectively. It can also be noted that IL-7R signalling is not
included on the diagram. It was noted in section 1.3.2 that IL-7R signalling is thought
to be responsible for causing the expression of LTαβ by LTi cells, through a process
that is not currently understood. The abstraction in Figure 2.1 makes the assumption
that IL-7R triggering occurs and hematopoietic cells express LTαβ, and thus have the
capability to interact with stromal cells as observed ex vivo and in vivo . The focus is on
capturing the interactions that lead to the higher-order behaviour, and thus explicitly
modelling the upregulation of LTαβ is not necessary. The documentation of cell level
assumptions and abstractions such as this is detailed in the following section.
Capturing Cell-Level Dynamics
Each of the key cell types identiﬁed in the domain is represented explicitly in the domain
model. For each cell type, states (observed behaviours or gene expression proﬁle) that
the cell might exist in and the interaction(s) that must take place for that cell to
change state are examined. Such descriptions are documented through the use of State
Diagrams, a documentation method closely related to that included within Uniﬁed
Modelling Language (UML) (Rumbaugh et al., 2005). UML is a notation widely used
in software engineering that has also found application in the speciﬁcation of models of
biological systems (Bersini and Carneiro, 2006; Read et al., 2009). Through creating
the domain model, biological parameters are identiﬁed and recorded. Some of these
parameters have known values that have been determined experimentally or noted in
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the literature, whereas the values of others are currently unknown. Where this is the
case, suitable assumptions have to be made and clearly justiﬁed. This section details
the dynamics for each cell type identiﬁed in the system delineation step and in the
literature at an individual level.
1. Hematopoietic Cells (LTin/LTi Cells)
Figure 2.2 depicts the domain model state machine diagrams for the hematopoi-
etic cell populations CD4−CD3−IL-7Rα−CD11b+CD11c+, or LTin cells, and
CD4+CD3−IL-7Rα+c-kit+, or LTi cells, involved in Peyer’s Patch development.
Although two distinct populations, both cell types are believed to migrate from
the foetal liver and can be detected in the foetal mouse intestine from E14.5
(Mebius et al., 2001). Experimental work by Veiga-Fernandes et al (2007) has
revealed that cell movement initially follows that of a random walk. Thus after
migration, cells exist within the ﬁrst state, moving randomly across the intestinal
tract. This movement is at a speed within a range also determined by the authors.
Transition out of this state diﬀers dependent on cell type:
(a) Lymphoid Tissue Initiator (LTin) Cells
Investigations by Veiga-Fernandes et al (2007) also revealed the importance
of RET in triggering lymphoid tissue formation, a receptor expressed by
LTin cells. Upon contact with an LTo cell, RET binds to an appropriate
ligand expressed by the LTo cell, thought to be ARTN, stimulating LTαβ
expression on the LTin cell. Cell contact has led to changes in the cell char-
acteristics, thus the change in state as noted in Figure 2.2a. Cell movement
from this point is then inﬂuenced by the level of localised expression of ad-
hesion factors. Should the level of expression of these factors be suﬃcient,
it is assumed that LTin cell movement is localised around the LTo cell, as
revealed in ex vivo observations by Patel et al (2012) described in section
1.3.3. Where the level is insuﬃcient, the cell moves away, returning to a
state where its movement is random.
(b) Lymphoid Tissue Inducer (LTi) Cells
In contrast, LTi cells are thought to express receptors for chemoattractants
expressed by diﬀerentiated LTo cells. An LTi cell will reside in a state mim-
icking a random walk until chemotaxis is triggered through localised levels
of chemoattractant expression. Where this occurs, LTαβ receptor expres-
sion is upregulated and the cell begins to move towards a primordial patch,
thus a change in state is noted in Figure 2.2b. With chemotaxis mediating
LTi recruitment, contact between an LTo and LTi cell is promoted. Such
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contact leads to LTo cell diﬀerentiation through lymphotoxin receptor sig-
nalling, and the upregulation of chemokine and adhesion factor expression
as detailed in section 1.3.1. A third state has been noted on Figure 2.2b to
denote that this contact has occurred. Similarly to LTin cell motility after
contact with an LTo cell, cell movement from this point is then inﬂuenced
by the level of localised expression of adhesion factors. Should the level
of expression of these factors be suﬃcient, cell movement remains localised
around an LTo cell. Where the level is in suﬃcient, an LTi cell may migrate
away from a a primordial patch, either returning to a state where the move-
ment is random or being inﬂuenced by expression level of chemoattractants
in its vicinity.
Through collaboration with experimental immunologists, hypotheses can
also be included in the model that have yet to be published or widely ac-
cepted, with the aim of judging the aﬀect that hypothesis has on observed
emergent behaviour. In this case, collaborators assisting with the design of
the model have added such a hypothesis: that LTi cells could potentially
cause the diﬀerentiation of non-RET ligand expressing LTo cells within the
gut surface. Such diﬀerentiation occurs through a number of contacts be-
tween these cells, deemed immature LTo cells, and LTi cells. Thus an addi-
tional state is added to the LTi state diagram in Figure 2.2b, where the LTi
cell is in contact with an immature LTo. This contact is assumed to be for
a brief period, after which the LTi cell returns to a state where movement
is either random or being inﬂuenced by chemoattractant expression.
A series of assumptions have been made concerning LTin and LTi cell behaviour,
listed in Tables 2.1 and 2.2. For LTin/LTi contact with an LTo cell, the assump-
tion has been made that a stable contact which leads to LTo cell diﬀerentiation
does not deﬁnitely occur when two cells come into contact. This introduces the
need to capture binding aﬃnity within the model. It is also assumed that the
response to adhesion factor receptor signalling increases as adhesion factor ex-
pression in the vicinity is increased, thus making the LTin/LTi cell more likely to
remain within a forming PP. However, some stochasticity in cell behaviour must
remain, and thus there is a chance that a cell may not respond to adhesion factor
expression. With regards to chemokine expression, it has not yet been possible
to quantify expression level over development time. The assumption has thus
been made that chemokine expression diﬀuses over distance, getting stronger as
distance from the LTo decreases. It is also assumed that the expression does not
decrease.
The process of creating a domain model of LTin and LTi cell states and interac-
tions has led to the identiﬁcation of a number of parameters that capture aspects
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of these described characteristics. These parameters, and the value determined
from the literature, are detailed in Figure 2.2.
2. Lymphoid Tissue Organiser (LTo) Cells
As detailed in section 1.3.1, LTin and LTi cells aggregate around non-hematopoietic
VCAM-1+ICAM-1+ stromal cells, termed LTo cells. An analysis of foetal mice
intestines taken at E15.5, using ﬂow cytometry, determined that 20% of cells were
stromal. The way these cells are distributed in the epithelium remains unknown.
With the agreement of the collaborating immunologists, a normal distribution
has been assumed, and initial explorations will assume that 20% of the epithe-
lium is comprised of stromal cells. This observation raised interesting questions
prior to creation of the domain model, concerning how the number of aggrega-
tions (patches) that form is limited if this were the case. If this is correct, and
there were no limiting factor, it would be expected that a large number of PP
would form, rather than the 8-12 previously observed (Figure 1.2). Thus a further
assumption is made that only a subset of these stromal cells have the capability
to diﬀerentiate into VCAM-1+ LTo cells that have the capability to mediate PP
development.
Figure 2.4 depicts the domain model state machine diagram for this cell type.
In contrast to the hematopoietic cells in the previous section, it can be noted
that there are four potential initial states (black circles). Working from left to
right, the ﬁrst two are states that LTo cells may exist within at E14.5, when PP
development is thought to commence (Mebius et al., 2001): the ﬁrst for stromal
LTo cells that have the capability to mediate PP development and the second
for stromal LTo cells that do not. LTo cells that do have the capability express
a ligand for RET. Ligation of the RET ligand upregulates LTαβ expression on
LTin cells and causes LTo cell diﬀerentiation, thought to trigger the process of
PP development (Veiga-Fernandes et al., 2007). As the RET pathway has this
key role in development, it has been assumed that LTo cells that do not have the
capability to mediate PP development do not express RET ligand. At present
the ratio between the two subsets of LTo cells remains unknown, yet could be
established through experimentation using the simulator at a later stage. Should
the cell be in the second initial state, where RET ligand is not expressed, there
is a theory that these cells could also diﬀerentiate under certain environmental
conditions, namely a large number of contacts with LTi cells and being located
within a set distance from another diﬀerentiated LTo cell. The second initial state
on the diagram is included to allow this theory to be considered if necessary. The
third and fourth initial states in Figure 2.4 are triggered upon LTo cell mitosis.
The assumption has been made that LTo cells divide every 12 hours, and the
resulting cells have the same attributes as the parent cell. Thus these initial
states are required to capture that process.
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Once LTo cell diﬀerentiation has occurred through the RET signalling pathway,
further diﬀerentiation and thus a change in state occurs on stable contact with
an LTi cell, upregulating the expression of chemokines CXCL13, CCL19, and
CCL21. In this state, the cell will also continue to upregulate the expression of
adhesion factors on each stable contact with an LTin or LTi cell. The assump-
tion has been made that this continues up to a point where expression of both
chemokine and adhesion factors is saturated, at which point the cell enters a ﬁnal
state that has been deemed as mature.
Biological parameters that have been identiﬁed in the generation of this model
are documented in Figure 2.4, and again assigned values from the literature
where possible. Similarly to the LTin and LTi domain models, a number of
assumptions have been made concerning LTo cell behaviour and documented in
Table 2.3. These mainly concern chemokine and adhesion factor expression by an
LTo cell, both of which have yet to be quantiﬁed experimentally and thus need
to be assumed.
Capturing Cell-Level Interactions
Within the domain model a further UML diagram, an Activity Diagram, is utilised
to specify how the cells detailed in the state diagrams interact. It is through these
interactions that the observed system dynamics are expected to emerge. This dia-
gram documents the order in which cellular events and interactions take place for this
emergent behaviour to be observed. Boxes represent an event that the cell may be un-
dertaking during the process, with arrows representing a ﬂow of actions after the event,
that become possible if the condition on the arrow is met. Diamonds represent two or
more actions that may be possible, with the resultant ﬂow dependent on meeting the
condition on one of the arrows.
Behaviour that has been observed both in in vivo imaging (Veiga-Fernandes et al.,
2007) and ex vivo culture systems (Patel et al., 2012) emerges through interactions
between three cell types speciﬁed in the state machine diagrams, mediated by the
expression of adhesion and chemoattractant factors. The Activity Diagram for this
model can be seen in Figure 2.5. This activity diagram captures two forms of emergent
behaviour that is observed. The ﬁrst of these is the statistically signiﬁcant change in
cell motility around a forming patch, as observed in the ex vivo culture system (Patel
et al., 2012) described in section 1.3.3. The second is the aggregation of cells that is
characterised at the end of hour 72 as an primordial Peyer’s Patch. Whereas current
experimental techniques have provided a quantiﬁcation of a change in cell behaviour,
no current investigations have provided quantitative data on what should be considered
as a Peyer’s Patch at the end of hour 72, in terms of number of cells or area occupied
by such an aggregation. Although this is problematic, the development of such a model
can be used to help address this prior to such data becoming available.
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Development Period and Spatial Dynamics
This section of the domain model is a speciﬁcation of the environment in which the
interactions described above are taking place, and the time-period over which this
occurs. This ensures that the model considers any restrictions that are imposed by
environmental eﬀects. Having this speciﬁcation aids the decision on which modelling
methodology to adopt (i.e. ODE or agent-based) when this is considered in the platform
model.
From the activity diagram in Figure 2.5, two forms of emergent behaviour were
noted: an alteration in cellular behaviour when in the vicinity of an LTo cell and
the identiﬁcation of aggregations of hematopoietic cells along the gut. The process
is known to commence at E14.5 with the migration of hematopoietic cells into the
intestine (Mebius et al., 2001), with aggregations of hematopoietic cells being visible
at E17.5 (Randall et al., 2008). Thus this model captures this 72 hour period. The
maturation of LTin and LTi cells that occurs prior to E14.5 (van de Pavert and Mebius,
2010), and PP compartmentalisation that occurs after E17.5 (Hashi et al., 2001) is
outside of the scope of this model.
The emergent behaviour has been observed in one of two settings: either in vivo
imaging of the developing gut (Veiga-Fernandes et al., 2007) or in ex vivo culture (Patel
et al., 2012). The domain model generated here will focus on capturing the emergent
behaviour as it would occur in the developing gut. To accurately represent the foetal
intestine in which the cells interact, and capture the dynamic nature of the developing
tract, images were taken of the developing mid-gut from twelve mouse embryos, six at
E14.5 and six at E15.5, using stereomicroscopy (Zeiss). Measurements of the length
and circumference of each were taken using ImageJ (Fiji). Flow cytometry has been
used to determine the percentage of cells that are LTin, LTi, and LTo cells, at E15.5.
These ﬁgures can be used to calculate a representative number of cells present in the
gut at that time-point.
A representative size for each cell type has been gathered from the literature (Veiga-
Fernandes et al., 2007). A value range within which a cells velocity will exist has been
determined by examining the behaviour characteristics of cells in Patel et al’s (2012) ex
vivo culture system that are further than 50µm from a ligand, and thus are less likely
to be inﬂuenced by adhesion and chemoattractant expression. The velocities of these
individual cells can be seen in Figure 2.3, revealing cell velocities can be considered to
be normally distributed.
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Figure 2.1: Expected Behaviours diagram, detailing the phenomena observed in the
domain being modelled, and the behaviours which emerge from interactions thought to
be responsible for them
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(b) LTi Cell State Diagram: Domain Model
Parameter Name in Model Domain Value
τ LTin/LTi Cell Size HCellDiameter 8µm
σ LTo Cell Size LToDiameter 24µm
ω LTin/LTi Cell Speed Lower Bound cellSpeedLowBound 3.8µm/min
ξ LTin/LTi Cell Speed Upper Bound cellSpeedUpBound 8.8µm/min
� LTin Input Time lTinInputTime 72 Hours
γ LTi Input Delay Time lTiInputDelayTime 0 Hours
η LTi Input Time lTiInputTime 72 Hours
Figure 2.2: Domain Model UML State Machine diagrams for hematopoietic LTin and
LTi cells, and biological parameters identiﬁed in the creation of the model. All parameter
values have been derived from laboratory explorations detailed in Veiga-Fernandes et al
(2007) and Patel et al (2012).
54 CHAPTER 2. METHODS AND TOOL DEVELOPMENT
Distribution of Cell Velocities Observed in ex vivo Culture System
N
um
be
r o
f C
el
ls
0
1
2
3
4
5
6
7
3.
5 
− 
4.
0
4.
0 
− 
4.
5
4.
5 
− 
5.
0
5.
0 
− 
5.
5
5.
5 
− 
6.
0
6.
0 
− 
6.
5
6.
5 
− 
7.
0
7.
0 
− 
7.
5
7.
5 
− 
8.
0
8.
0 
− 
8.
5
8.
5 
− 
9.
0
ex vivo Cell Speed Ranges (microns/min)
Figure 2.3: A breakdown of the cell velocities that were observed for cells in the ex vivo
culture system. This has been calculated from tracking cells > 50µm from the ARTN-
soaked bead (see Section 1.3.3), where no chemokine or attractants are inﬂuencing cell
behaviour. Such individual variation is an important aspect to capture in the domain
model.
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If cell within percentage θ of LTo
cells that express RET Ligand
Adhesion Molecule Levels at peak
AND
Chemokine Expression at peak
If distance to LTin Cell σ/2 + τ/2 (cell in contact)
AND
Bind between cells is suﬃcient
If distance to LTi Cell σ/2 + τ/2 (cell in contact)
AND
Bind between cells is suﬃcient
Expression of RET-Ligand
Upregulation of Adhesion Molecules
Upregulation of Chemokines
Mature LTo
LTo
(Domain) Immature LTo cell
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OR
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*
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Where a cell is in a state denoted by a star, this cell will divide after a set period of time. The two resultant cells will be in the same state as the cell prior to division
Parameter Name in Model Domain Value
θ Percentage of LTo cells expressing RET
Ligand
percentStromaRETLigands Unknown
D Cell Division Time lToDivisionTime 12 Hours
τ LTin/LTi Cell Size HCellDiameter 8µm
σ LTo Cell Size LToDiameter 24µm
Figure 2.4: Domain Model UML State Machine diagrams for stromal LTo cell, and
biological parameters identiﬁed in the creation of this model. All parameter values have
been derived from laboratory explorations detailed in Veiga-Fernandes et al (2007) and
Patel et al (2012).
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Figure 2.5: Domain Model Activity Diagram detailing the order in which interactions
are thought to occur to produce the the emergent behaviour observed. Where parameters
are noted on the interactions, these can be found in the parameter tables in Figures 2.2
and 2.4
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2.2.3 Platform Model
Overview
The platform model acts as a speciﬁcation of how the domain model could be encoded
as a computer simulation. Individual cells, the environment, and interactions that
lead to biological state changes are examined and translated into a form that can be
captured in computer code. For example, capturing cell receptor binding aﬃnity could
be achieved through use of a probability function. Such translation therefore leads to
the identiﬁcation of platform speciﬁc parameters, of which the numerical value may
again be unknown. Thus further assumptions are made, based on known biology or
collaborator insight where possible, and documented for scrutiny alongside simulation
results. Critical to the modelling process, emergent behaviour speciﬁed in the domain
model is entirely removed from the platform model. Biologically observed behaviour
must emerge through interactions between components and not be encoded into the
model, as this invalidates the simulator as a predictive experimental tool.
Section 1.4.1 detailed a number of potential techniques available that can be applied
in modelling a biological system, including use of ODE’s or agent-based approaches.
The detail in the domain model can now be utilised to determine which methodology
is best suited to addressing the research problem identiﬁed. This section details the
generation of the platform model specifying how the domain model described in section
2.2.2 could be encoded as a computer simulation.
Choosing the Modelling Methodology
Potential methodologies that can be applied in the modelling of biological systems were
discussed in detail in section 1.4.1. In the Peyer’s Patch domain model, one of the key
emergent behaviours under examination is the change in individual cell behaviour on
interaction with other cells or biological factors in the environment. Thus the scope is
an individual rather than population level, focusing on the importance of interactions
in mediating this change in behaviour. As this is the case, the application of an
agent-based model is appropriate. Each cell type (LTin/LTi/LTo in this case) will
be created as an agent within the system, with each agent possessing its own state
and characteristics. This ensures it is possible to explore how quantitative changes in
biological factors aﬀect the behaviour of each cell individually.
Capturing Cell-Level Dynamics
This section details how the dynamics for each cell type identiﬁed in the domain model
has been translated into a platform model description. Aspects of the detail already
covered in the domain model has not been repeated here, rather this is a detail of how
the aspects in the domain model will be implemented.
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1. Hematopoietic Cells (LTin/LTi Cells)
Although two diﬀerent cell types, thus two diﬀerent agent types, the implemen-
tation of the LTin and LTi cell shares some common features. The ﬁrst of these
is the assignment of speed at which the cell moves. Experimental work by Veiga-
Fernandes et al (2007) has established a range within which LTin/LTi cell speed
resides, as was noted in Figure 2.2. Further to this work, an analysis of the cells
that were tracked in the ex vivo culture system described in section 1.3.3 suggests
cell velocities can be considered to be normally distributed (Figure 2.3). In this
model, cells are assigned a random set speed within the established range using a
Gaussian random number generator, and it is assumed that the cell always moves
at this velocity unless aﬀected by the adhesion or chemoattractant expression.
The second common attribute is the calculation of a respective cell input rate.
The domain model contains the results of ﬂow cytometry analyses that suggests
the percentage of cells that are LTin and LTi cells at E15.5. Similarly to the
assumptions made for LTo cell number (section 2.2.2), the assumption is made
that these cells are normally distributed in the gut at E15.5. Using gut dimensions
measured from stereomicroscopy images and these percentages, an estimation of
the number of LTin and LTi cells in the gut at E15.5 has been calculated (Figure
2.10). As the model captures the time from initial migration of LTin/LTi cells
into the gut, respective input rates can be calculated such that a set number
of cells enter the simulated gut per time-step, ensuring the correct number is
reached at the time-point that represents E15.5. In this model, it is assumed
that this input rate is linear. As no cell counts have been determined at time-
points after E15.5, the assumption has been made that cell input remains at that
rate through to E17.5, the time-point at which this model ends.
Finally, both cells express LTαβ on the cell surface, that binds to LTβR expressed
on the surface of LTo cells. Section 1.3.2 detailed how lymphotoxin signalling has
a key role in LTo cell diﬀerentiation, and thus the upregulation of adhesion and
chemoattractant expression. For the purposes of this model, the assumption is
made that lymphotoxin signalling always occurs if a stable bind is formed between
an LTo cell and hematopoietic (LTin/LTi) cell. The occurrence of a stable bind is
controlled through use of a probability function to mimic binding aﬃnity. To date
the value of this parameter is unknown, and thus needs to be established through
a process of model calibration. For LTin cells, RET signalling is modelled the
same way, with RET binding to an LTo cell expressing the required ligand if a
stable bind is formed.
Similarly to the domain model, cell level behaviours are expressed as UML state
machine diagrams that form a speciﬁcation to be implemented in the simulation
platform. Figures 2.6a and 2.6b detail LTin and LTi cell level behaviour at the
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platform model level respectively. In the majority of cases, a change in LTin and
LTi state is mediated through interaction with adhesion or chemoattractant fac-
tors. As the implementation of these factors is covered in detail in the latter part
of this section, this has not been covered here. Additional cell level parameters
that have been identiﬁed in the generation of the platform model, and will thus
be included in the simulation platform, are listed in the table at the bottom of
Figure 2.6. Any further assumptions that have been made are also documented
in Tables 2.1 and 2.2 respectively.
2. Lymphoid Tissue Organiser (LTo) Cells
Figure 2.7 depicts the platform model UML state machine diagram for the LTo
cell, capturing an implementation of the LTo domain model in Figure 2.4. Simi-
larly to the domain model diagram, there are a number of potential initial states.
Again the ﬁrst two (reading from left to right) captures the hypothesis that LTo
cells detected in the early stages of development may be in one of two subsets:
one where cells express RET ligand and can mediate PP development, and one
where RET ligand is not expressed. Where RET-ligand is expressed, a change in
state is triggered through stable contact with a RET expressing LTin cell agent.
A stable contact is determined through the use of a probability function. For the
alternative subset, the hypothesis generated by the collaborating experimental
immunologists, that the cell could diﬀerentiate after suﬃcient contacts with LTi
cells, has also been captured. Once in this diﬀerentiated state, adhesion factors
are expressed, implemented as detailed in Figure 2.9 and described later in this
section.
The remaining three initial states all capture the process of LTo cell mitosis. In
this model, LTo cell division occurs once the cell has been active for 12 hours.
Rather than divide, a new LTo cell agent is added to the model, inheriting the
same attributes as the dividing cell. These three initial states capture that in-
heritance.
Further change in LTo state is triggered through stable contact between the cell
and an LTi cell. In this state, the cell will also express chemoattractant molecules,
as well as adhesion factors. A speciﬁcation of how chemokine expression can
be implemented is detailed in Figure 2.8. As chemokine and adhesion factor
expression increase, the number of stable contacts between the LTo cell and LTi
cell increases, further upregulating chemokine and adhesion factor expression.
This continues to a point where expression is deemed to be saturated, controlled
by two parameters. Where this occurs, the cell changes into a further state where
it is deemed to be mature.
It can be noted that it is possible to transition from diﬀerentiated LTo states to a
state where RET-ligand is down-regulated. This is an experimental feature that
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has been included in the model in consultation with the experimental immunol-
ogists, which has the potential to investigate the eﬀect on patch development if
RET-ligands were inhibited at certain time-points in development.
Capturing Spatial Dynamics
Figure 2.10 speciﬁes how the environmental measurements captured from stereomi-
croscopy images of the developing gut have been translated into measures that can
be used to create a representative in silico environment. Parameters identiﬁed in the
creation of this speciﬁcation are listed in the table at the bottom of Figure 2.10. A
scale has been set such that 1 pixel represents 4µm. The platform model makes the
additional assumption that the emergent behaviour dynamics can be recreated using
a 2D environment, where all interactions and cell movement is occurring on the gut
surface. This 2D plain will be considered semi-toroidal in that the top and bottom are
connected, forming a continuous plain across the intestine width. In reality, Peyer’s
Patches are 3D structures and cell aggregations form on a 3D scaﬀold. However, form-
ing the aggregation on a 2D plain is a suitable abstraction in this case due to the lack
of quantitative data to deﬁne a Peyer’s Patch. Later results in this chapter will detail
a calibration process that will form a measure of what a ’patch’ is in terms of the
simulation, and it is this measure that can be used as a baseline when performing in
silico experimentation to explore the process of cell aggregation.
With a scale set that translates the biological measurements to pixels, cell sizes
and speeds have also be translated accordingly, ensuring a direct mapping between the
real and simulated system. To capture the cell velocity distribution observed in Figure
2.3, a cell speed will be derived using a Gaussian random number generator. With
this being the case, a continuous coordinate grid is preferable, allowing for greater
accuracy in capturing cell movement dynamics. Thus there will be no set grid-space
in the simulation.
However a grid is used to manage LTo cell location in the model. The grid over-
lays the 2D environment, with each grid square the size of an LTo cell agent. Section
2.2.2 noted how calculations from ﬂow cytometry data have been used to estimate the
number of stromal cells present at E15.5. This is used to calculate the number of LTo
cells that should be placed in the grid at start of any simulation. A percentage of these
are then set to express RET ligand, with the remaining LTo cell agents remaining in
the second subset where no ligand is expressed. The value of this percentage param-
eter remains unknown. For LTo cell division, assumed to occur every twelve hours, a
replicate of the ’dividing’ LTo cell agent is created in the nearest free location on the
grid.
As noted previously, cellular interactions are occurring while the intestine environ-
ment is still developing. As such, the environment starts at pixel dimensions translated
from measurements taken from stereomicroscopy images taken at E14.5, and expands
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at the same rate each simulation time-step until it reaches the dimensions observed
from imaging at E15.5. With no further measurements available, the assumption is
made that the gut continues to grow at the same rate for the remaining 24 hours of
development.
Although it would be preferable, available computational resources may make it
intractable to model the entire length of the intestine. Such an implementation would
capture a representative number of LTin, LTi, and LTo cells. With the implementation
being agent-based, and each of these existing as an individual process, this would
be computationally expensive. The need to perform a replicate number of such runs
(as detailed in section 1.5.3) to reduce aleatory uncertainty inherent in agent-based
simulations does not make this viable. Instead, a 10% section of the length will be
captured, with the number of patches that would be expected to emerge scaled down
respectively.
Modelling Chemokine Expression
The domain model speciﬁes the existence of three chemokines expressed by the LTo
cell: CXCL13, CCL19 and CCL21, that in turn bind to receptors CXCR5 and CCR7
expressed by LTi cells. Expression of chemokines by an LTo cell causes LTi cell chemo-
taxis towards sites of patch genesis, promoting cellular interactions and further upreg-
ulation in chemokine expression, thus expanding the area around a primordial patch
where LTi motility is aﬀected. It was noted in the domain model description that a
full quantitative analysis of chemokine expression levels in the mid-gut during foetal
development has yet to be performed, thus it is diﬃcult to assign a set role to each of
the three chemokines involved. However, PP formation in CXCR5-deﬁcient mice, the
receptor for CXCL13, is signiﬁcantly reduced (Ansel et al., 2000). Although not exam-
ined in PP formation, mice deﬁcient for CCR7, the receptor for CCL19 and CCL21,
did form a normal number of lymph nodes (Luther et al., 2003). This generates the
hypothesis that CXCL13 expression could have a dominant role in the clustering of
LTi cells.
Taking this into consideration, a simpliﬁcation has been introduced in the platform
model where CXCL13, CCL19, and CCL21 will be modelled as a single chemokine,
that binds to one single receptor on LTi cells. This will be modelled as an attractant
where level of expression by an LTo cell is directly related to the number of stable
contacts that occur between the LTo cell and LTi cells. As expression increases, the
distance over which this chemoattractant inﬂuences cell motility also increases, with
level of expression getting greater as distance to the LTo cell reduces.
This diﬀusion pattern can be modelled using an inverse sigmoidal curve, as de-
scribed in Figure 2.8. On initial LTo cell diﬀerentiation, chemokine expression is low,
and thus only aﬀects a relatively short area around an LTo cell. Thus the equation
of the curve can be set such that the curve is tight. As cellular contacts increase,
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expression increases and the curve can be relaxed by changing the respective input
variable, modelling an increase in the distance that the chemokine is being diﬀused.
Figure 2.8 then describes how this function is used to calculate chemoattractant level
in the vicinity of an LTi cell, to determine if chemotaxis is induced. This calculation
produces a result between 0 (no expression) and 1 (strong expression). It can be noted
from the description that a threshold is used within this calculation to ensure that a
suﬃcient level of chemokine expression is in the vicinity of an LTi cell for chemotaxis
to occur. The value for this threshold is currently unknown.
This method of chemokine expression modelling introduces the parameters listed
in the table at the bottom of Figure 2.8. With the current biological understand-
ing incomplete, values for these parameters need to be determined using a process of
calibration once the model is implemented as a simulation.
Modelling Adhesion Factor Expression
A study of the literature reveals the involvement of three adhesion factors in PP devel-
opment: VCAM-1, ICAM-1, and MAdCAM (Yoshida et al., 2001). However as noted
in the domain model description, there is no quantitative data detailing the expression
levels of these three factors. As this is the case, a simpliﬁcation has been introduced
where the eﬀect of these three adhesion factors will be modelled as just one factor. This
section details the method that will be used to encapsulate adhesion factor expression
and response in the model.
Adhesion factors are expressed upon stable interaction between a hematopoietic
cell and an LTo cell. This model makes the assumption that the increase in expression
is identical with each cell contact, thus the level of expression is directly related to
the number of cellular interactions. Figure 2.9 details this relationship and LTin/LTi
response to expression. An increase in the level of adhesion factor expression inﬂuences
the probability that an LTin or LTi cell will remain in the vicinity of the LTo cell
for a prolonged period. This probability increases linearly up to a threshold, set to
ensure some stochasticity remains in cell behaviour, capturing the small likelihood
that adhesion factors may not bind to receptors and thus not inﬂuence cell motility.
This model of adhesion identiﬁes two parameters for which a value remains un-
known. These are the slope of the linear equation that captures the relationship
between probability of prolonged adhesion and number of cellular contacts, and the
maximum probability that an LTin/LTi cell responds to adhesion factor expression
(see image in Figure 2.9). Values for these parameters would therefore need to be
established through a process of calibration once this model is implemented.
User Interaction and Data Collection
Within the platform model, consideration is also given into how user interaction and
data collection will be added to the simulator. Table 2.4 speciﬁes the considerations
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that have been given to user interaction and data collection in the case of the lymphoid
tissue development tool being developed here. This acts as a speciﬁcation of the tooling
that is necessary to include in implementation.
An implementation of the Platform Model will have two interfaces. The ﬁrst is a
graphical user interface that provides a visual representation of the simulated intestine
tract. This aids the use of any simulator as a visual experimental tool. The second
captures this behaviour without any graphical interface, with the aim of generating
datasets that can be used in statistical analyses. This aids the performance of in silico
experimentation where a high number of replicate runs may be necessary. In both
cases, parameter values are speciﬁed prior to simulation run in an Extensible Markup
Language (XML) ﬁle. This ensures that the parameters can be adjusted without the
need to access the simulation implementation.
A speciﬁcation of simulation results and how these should be output is also stated
in Table 2.4. These are discussed in more detail in the Results Model section of this
chapter (Section 2.2.5).
64 CHAPTER 2. METHODS AND TOOL DEVELOPMENT
If contact cell is an LTo Cell AND
Probability of escape <
Probability adhesion factors
prolong contact 2
If contact cell
is not a RET Ligand
Expressing LTo Cell
OR
If distance between cell
and stromal cell < σ/2 + τ/2
(cell is in contact)
AND
Strength of LTi/LTo
bind suﬃcient 3
Entry to tract between start of simulation
and endpoint set by ε 1
Probability of escape >
Probability adhesion factors
prolong contact 2
Random movement on tract surface
LTin
(Platform)
1: Each cell is assigned a speed using a gaussian random number generator. The cell speed limits in the domain model
(parameters ω and ξ ) are translated into platform model values (1 pixel = 4 microns, see Figure 2.10). This creates limits
for the random number generation that are in pixels/min. As each timestep may not necessarily represent one minute
(number of seconds per time-step is set in parameter Λ ), the lower and upper bounds are recalculated based on the
number of seconds represented per time-step, and stored as parameters Π and Θ respectively
2: Probability adhesion prolongs contact is calculated as described in Figure 2.9
3: Strength of Bind: Result of Probability Calculation where bind occurs if generated random number (0-1) < χ
Localised movement around LTo mediated by adhesion
Stable Contact with RET Ligand expressing Cell
Probability of escape <
Probability adhesion
factors prolong
contact 2
*
Cells that are in a state denoted by a star are deemed to take no further part in the simulation if they leave the right or left
side of the simulated environment
(a) LTin Cell State Diagram: Platform Model
Entry to tract between timepoints
set by γ and η 1
Local Chemokine Level < Φ 4
Random movement on tract surface
Response to Chemokine Level in Local EnvironmentContact with Immature LTo Cell
Contact with Cell Expressing RET Ligand
Prolonged Surface Contact (Adhesion Eﬀect)
Distance between
cell and inactive stromal
cell > σ/2 + τ/2
LTi
(Platform)
If distance between cell
and stromal cell < σ/2 + τ/2
(cell is in contact)
AND
Strength of LTi/LTo
bind suﬃcient 3
Probability of escape >
Probability adhesion factors
prolong contact 2
If distance between cell
and stromal cell < σ/2 + τ/2
(cell is in contact)
If contact cell is an LTo Cell
AND
Probability of escape <
Probability adhesion
factors prolong contact 2
1: Each cell is assigned a speed using the gaussian random number generator, as described for LTin cells above
2: Probability adhesion prolongs contact is calculated as described in Figure 2.9
3: Strength of Bind: Result of Probability Calculation where bind occurs if generated random number (0-1) < χ
4: Response to chemokine in the vicinity is calculated as described in Figure 2.8
Cells that are in a state denoted by a star are deemed to take no further part in the simulation if they leave the right or left
side of the simulated environment
Local Chemokine Level > Φ 4
*
*
(b) LTi Cell State Diagram: Platform Model
Parameter Name in Model Platform Value
τ LTin / LTi cell size HCellDiameter 2 pixels
σ LTo cell size lToDiameter 6 pixels
Λ Seconds per simulation step secondsPerStep 60 seconds
Π Simulation run cell speed lower bound cellSpeedSimLowBound Calculated
Θ Simulation Run Cell Speed Upper Bound cellSpeedSimUpBound Calculated
χ Probability stable bind occurs on contact stableBindProbability Calibrated
φ Threshold Value that triggers chemotaxis chemoThreshold Calibrated
Figure 2.6: Platform Model UML State Machine diagrams for hematopoietic LTin
and LTi cells, and additional LTin/LTi cell parameters identiﬁed in the creation of the
Platform Model
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If cell within percentage θ of
cells that express RET Ligand
and within Υ circumference range
Expression of RET-Ligand
If cell not within percentage θ of
cells that express RET Ligand
No Expression of RET-Ligand
Upregulation of Adhesion Molecules
Upregulation of Chemokines 2
Mature LTo
RET Ligand Down-Regulated
Inactive LToContact Count =β
If Distance to LTi Cell < σ/2 + τ/2
AND
Strength of LTi/LTo bind suﬃcient 1
If Adhesion Probability (Calculated) = ν 3
AND κ = Z
if time elapsed >ρ
if time elapsed >ρ
if time elapsed >ρ
If distance to LTin Cell < σ/2 + τ/2
(cell in contact) AND
Strength of bind with LTin/LTi suﬃcient 1
1: Strength of Bind: Result of Probability Calculation where bind occurs if generated random number (0-1) < χ
2: Chemokine Expression Calculation is detailed in Figure 2.8
3: The limit of adhesion factor expression is calculated as detailed in Figure 2.9
Where a cell is in a state denoted by a star, this cell will divide after a set period of time. The two resultant cells will be in the same state as the cell prior to division
LTo
(Platform)
Cell exists as a
result of cell
division
Cell exists as a
result of cell
division Cell exists as a
result of cell
division*
*
*
Parameter Name in Model Platform
Value
I Initial Chemokine Curve Value initialChemokineExpressionValue Calibrated
Z Maximum Chemokine Curve
Value
maxChemokineExpressionValue Calibrated
κ Chemokine Expression Level chemoExpressionLevel Calculated
A Adhesion Factor Expression Level adhesionExpression 0
π Hours immature LTo cell remains
active
imLToActiveTime Unknown
ρ Hours RET Ligand Expressed numHoursRETLigandActive 72 Hours
χ Probability stable bind occurs on
contact
stableBindProbability Calibrated
β Number of Stable Contacts
required to activate immature cell
immatureContacts Unknown
Figure 2.7: Platform Model UML State Machine diagrams for stromal LTo cell, and
parameters identiﬁed in the creation of this model. It can be noted that there are
ﬁve starting points on this diagram, and only four on the LTo Domain Model diagram
(Figure 2.4). This captures the abstraction made in the Platform Model that only a
percentage of LTo cells in the simulator will express a ligand for RET (expressed by
the LTin cell). Reasons behind the need for an abstraction are detailed in the domain
model, section 2.2.2.
.
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Modelling Chemokine Expression and Response
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 initialChemokineExpressionLevel
Curve continues to relax until at level set by 
 parameter maxChemokineExpressionLevel
Blue − Threshold level at which chemokine expression
 level enough to induce chemotaxis, set
 by parameter chemokineExpressionThreshold
The chemokine expression eﬀect has been mod-
elled using an inverse sigmoid curve, adjusted
such that the top of the curve meets the top of
the y axis (at 1), by setting a constant within
the sigmoid function to 3.
The initial curve is tight, calculated through
using the initial chemokine expression level as-
signed to parameter initialChemokineExpres-
sionLevel. This models expression over a limited
distance, but one which strengthens as distance
to the LTo reduces. With each stable contact be-
tween an LTo and LTi cell, the curve is relaxed
by adjusting the parameter increaseChemoEx-
pression, representing an increase in expression.
With this increase, diﬀusion aﬀects LTi cells
over a greater distance. This expression in-
creases until a maximum level of expression is
reached, set by parameter maxChemokineEx-
pressionLevel.
With each time-step, an LTi cell performs a move. To determine whether chemotaxis is triggered
during this move, a virtual grid is drawn around the cell, with the centre of each grid space being
placed at the distance the cell is to move (denoted by that particular cells speed). The simulator
then evaluates the chemokine level in each square using the formula:
1
1 + e−(−LToChemokineExpressionLevel+distanceToLTo+sigmoidCurveAdjust)
(2.1)
where the sigmoid curve adjustment is 3, the constant used to make the curve meet the y
axis. Should the level be over a threshold level at which chemotaxis is induced (parameter
chemokineExpressionThreshold), the chemokine level has an eﬀect on that cells behaviour.
The calculated level of expression becomes the probability that the cell will move in
that direction. Therefore it is most likely the cell will follow the level of chemokine expression as
it gets closer to the LTo cell, but there remains some possibility that the cell may not respond
to the level of expression at a greater distance.
Parameter Name in Model Simulator Value
φ Chemokine Expression
Threshold
chemoExpressionThreshold Range: 0-1, Calibrated
B Sigmoid Curve Adjustment chemoCurveAdjust 3
I Initial Curve Value initialChemokineExpressionValue Calibrated
Z Maximum Curve Value maxChemokineExpressionValue Calibrated
ι Increase in expression on
contact
increaseChemoExpression Calibrated
Figure 2.8: Description of how the chemokine factors are included in the Platform
Model. This details how the LTo cell increases chemokine expression with each stable
contact and how the probability that LTi chemotaxis is induced is calculated. The table
details the simulation parameters that have been identiﬁed in this process. This ﬁgure
has been adapted from that included in Alden et al (2012b)
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Modelling Adhesion Factor Expression and Response
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Slope set by parameter
 adhesionFactorExpressionSlope
Probability threshold set by parameter
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The probability of prolonged cellular contact
mediated by adhesion factors is modelled using
a linear equation, with a slope parameter value
set through a process of calibration (parameter:
adhesionSlope)
Each LTo cell has the same initial adhesion fac-
tor expression level (set by parameter initialAd-
hesion). With each stable contact, the level of
adhesion factor expression increases (parameter:
adhesionIncrement). This increases the proba-
bility that a cell remains in the vicinity of the
LTo cell for a prolonged period. This probability
increases until a threshold is reached (parame-
ter: maxProbabilityOfAdheison). This thresh-
old exists to ensure some stochasticity remains,
and although adhesion factor expression may be
high, there is a chance that an LTin/LTi cell
may move away from the forming primordial
patch
Upon stable contact between an LTo and LTin/LTi cell, the probability of prolonged adhesion is
calculated using the formula:
adhesionSlope ∗ LToAdhesionExpressionLevel (2.2)
where adhesion slope is set during a process of calibration. Should this probability be higher
than the maximum probability threshold (also set during calibration), the probability is set to
the threshold value.
Parameter Name in Model Simulator Value
M Initial Expression of
Adhesion Factors
initialAdhesion 0
Ξ Linear Equation Slope adhesionSlope Calibrated
E Increase in Expression on
Contact
adhesionIncrement Calibrated
ν Maximum Probability of LTi
Response
maxProbabilityOfAdhesion Range 0-1
Figure 2.9: Description of how the adhesion factors are included in the Platform
Model. This details how the LTo cell increases adhesion factor expression with each
stable contact and how the probability that an LTin or LTi cell remains in the vicinity
of an LTo cell is calculated. The table details the simulation parameters that have been
identiﬁed in this process. This ﬁgure has been adapted from that included in Alden et
al (2012b)
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Modelling the Intestine Environment
Biology: Stereomicroscopy (Zeiss) and ImageJ (Fiji) used to measure length and
circumference of small intestines from twelve mice, six at E14.5 and six at E15.5. Top:
One mouse intestine sample at E15.5. Average intestine length and circumference at
E14.5 and E15.5 were calculated from these measurements. Intestine dimensions at
E17.5 were estimated from the diﬀerence in these values.
Simulation: The biological measures inform the generation of the simulation
environment: a 2D representation of the small intestine (represented by the graph
above). 1 pixel = 4µm. X axis: small intestine length; Y axis: small intestine
circumference. Dots represent LTin and LTi cells. Cells that leave the top/bottom
appear on opposite side. Cells that leave right/ left are removed from the simulation
Cell Counts: Estimations of LTin and LTi numbers at E15.5 have been deter-
mined using ﬂow cytometry. To ensure the correct number of cells are created, a linear
input rate is used to create the required number of cells per time-step. This cell input
rate that continues through until the end of the simulation run.
ς = (((Γ/τ) ∗ (Δ/τ))/100) ∗ δ
Υ = (((Γ/τ) ∗ (Δ/τ))/100) ∗ ψ (2.3)
Parameter Name in Model Domain Value Simulator Value
Γ Initial Circumference initialGridHeight 0.966mm 244 pixels
Δ Initial Length initialGridLength 28.80mm 7203 pixels
K Maximum Circumference upperGridHeight 1.016mm 254 pixels
P Maximum Length upperGridLength 29.22mm 7303 pixels
ζ LTo Cell Density stromalCellDensity 20% 20%
Υ Intestine Growth Time growthTime 72 Hours 72 Hours
δ Percentage of cells that are
LTin at E15.5
percentLTinfromFC 0.45% 0.45%
ψ Percentage of cells that are
LTi at E15.5
percentLTifromFC 0.37% 0.37%
ς LTin Input Rate lTinInputRate Calculated
λ LTin Input Rate Function lTinInputRateFunction linear
Ξ LTin Input Rate Constant lTinInputRateConstant Not Used
Ψ LTi Input Rate lTiInputRate Calculated
Υ LTi Input Rate Function lTiInputRateFunction linear
Σ LTi Input Rate Constant lTiInputRateConstant Not Used
Figure 2.10: A description of how the simulation environment relates back to the
developing mid gut, and parameters identiﬁed in the creation of this representation
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State Model Assumption
Random Movement
on Tract Surface
Domain There is no attractive inﬂuence on an LTin cell any contact
with RET ligand-expressing cells will occur randomly.
Platform Each cell is assigned a speed between the lower limit set by
parameter Π and upper limit set by parameter Θ. This is
chosen randomly from a Gaussian random number genera-
tor.
Contact with RET
ligand-expressing
cell
Domain For lymphotoxin signalling to occur, the bind between the
two cells must be of suﬃcient strength. If the bind aﬃnity
is suﬃcient, we assume that cell signalling always occurs.
If contact is with a cell expressing RET ligand yet not an
LTo, and a stable bind occurs, the cells will bind brieﬂy but
no signalling occurs.
Platform Whether LTin and LTo cells bind will be determined by a
probability function. If a chosen probability is > parameter
χ then a stable bind is formed.
Localised
movement around
LTo mediated by
adhesion
Domain An LTin cell will remain in contact with an LTo cell if there
is a suﬃcient expression level of adhesion factors.
As expression level increases, the LTin cell is more likely to
remain in contact
Though there may be suﬃcient expression level of adhesion
factors, there is still a possibility that the LTin cell may
move away from the LTo.
Though the cell remains in contact with the LTo, LT
signalling and up-regulation of adhesion factors and
chemokines only occurs on initial contact.
Platform LTin cell will remain in close contact with the LTo cell
making small movements around it.
Prolonged adhesion is decided through use of a probability
function, detailed in Figure 2.9.
Other Assumptions Domain LTin cells migrate into the tract throughout the whole pe-
riod being modelled. All LTin cells are the same size, 8
µm.
Platform Flow cytometry has helped estimate the number of LTin
cells that should be present at E15.5 in development. A
linear input rate is used to ensure this is reached. This rate
remains constant throughout the simulated period.
The environment is modelled as a 2D plane on which all
movement and interactions occur (Figure 2.10). Should an
LTin leave the left/right of the screen, this cell is removed
from the simulation.
Table 2.1: List of assumptions made at both domain and platform model level con-
cerning the behaviour of and interactions with an LTin cell.
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State Model Assumption
Random Movement
on Tract Surface
Domain Cells move randomly until the level of chemokine expression
in the vicinity is above a threshold.
Platform To ascertain chemokine level, the expression level in each
gridsquare around the LTi is calculated (Figure 2.8). If
none of these values is above φ, the cell moves randomly.
Response to
chemokine level in
local environment
Domain Three chemokines are known to play a part in the process
CXCL13, CCL19, and CCL21. However as an abstraction
we will assume these can be modelled as a single chemokine.
IL-7, which could stimulate IL-7 receptor signalling and
regulate chemokine receptor expression levels of LTi cells,
has not been included in the model. The assumption will
be made that there is always suﬃcient IL-7 present for
chemokine receptor expression to be upregulated.
There is always a small chance that the cell may not re-
spond to the level of chemokine.
Platform Chemokine expression is modelled using an inverse sigmoid
curve (see Figure 2.8). As some stochasticity must remain,
the chance that the cell will move in the direction of the
strongest level is determined by probability function.
Contact with RET
ligand-expressing
cell
Domain For lymphotoxin signalling to occur, the bind between the
two cells must be of suﬃcient strength. If the bind aﬃnity
is suﬃcient, we assume that cell signalling always occurs.
Platform Whether LTi and LTo cells bind will be determined by a
probability function. If a chosen probability is > parameter
χ then a stable bind is formed.
Prolonged surface
contact (adhesion
eﬀect)
Domain An LTi cell will remain in contact with an LTo cell if there
is a suﬃcient expression level of adhesion factors.
As expression level increases, the LTi cell is more likely to
remain in contact. Although there may be suﬃcient ex-
pression level of adhesion factors, there is still a possibility
that the LTi cell may move away from the LTo
Although the cell remains in contact with the LTo,
LT signalling and upregulation of adhesion factors and
chemokines only occurs on initial contact.
Platform The LTi cell would remain in close contact with the LTo
cell making movements around it. Prolonged adhesion is
decided through use of a probability function (Figure 2.9)
Other assumptions Domain LTi cells migrate into the tract throughout the whole sim-
ulated period. All LTi cells are the same size 8 µm.
Platform Flow cytometry has helped estimate the number of LTi cells
that should be present at E15.5. A linear input rate is
used to ensure this is reached. This rate remains constant
throughout the simulated period. The environment is a
2D plane where all movement and interactions occur (see
Figure 2.10). A cell is removed should it leave the left/right
of the screen.
Table 2.2: List of assumptions made at both domain and platform model level con-
cerning the behaviour of and interactions with an LTi cell.
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State Model Assumption
No expression of
RET ligand
Domain Although we are aware that 20% of the intestine tract con-
tains stromal cells, we assume only a percentage of these
have the potential to become patches.
Platform Where only a percentage of LTo cells are active, all are still
placed on the intestine tract, but interactions only occur
with LTo cells which have the potential to become patches
(that express RET ligand).
Expression of RET
Ligand
Domain Cell will remain active throughout the time period, irre-
spective of whether the cell changes state or not.
Platform All LTo cells which express RET ligand have the poten-
tial to express adhesion factors and chemokines (thus form
patches).
Upregulation of
adhesion molecules
Domain Adhesion molecules are upregulated with every contact
where the strength of the bind is suﬃcient (Figure 2.9).
Upregulation only occurs on initial contact with the cell;
prolonged contact due to adhesion does not lead to further
upregulation.
Cells in this state will divide after a set number of hours.
Platform Expression of adhesion factors does not degrade over time.
With each stable contact, a counter representing adhesion
factor expression is increased. This determines the strength
of adhesion and probability the cell will remain in contact
(see Figure 2.9).
Upregulation of
chemokines
Domain Chemokines are up-regulated with each LTi/LTo contact
where the strength of the bind is suﬃcient (see Figure 2.8).
Upregulation only occurs on initial contact with the cell;
prolonged contact due to adhesion does not lead to further
upregulation.
Cells in this state will divide after a set number of hours.
Platform Chemokine expression does not degrade over time.
With each stable contact, a constant that is used to calcu-
late chemokine expression in the sigmoidal curve function
is adjusted (Figure 2.8). This determines the distance over
which the chemokine has an eﬀect.
Mature LTo Domain
Platform Both adhesion molecules and chemokines must have
reached their peak of expression to reach this state.
Other Assumptions Domain LTo cells in all bar the top two states will divide after 12
hours. On division, the cells will possess the same attributes
as the original cell prior to division. It is assumed that
other pathways, such as the NF-κB pathway, are always
activated.
Table 2.3: List of assumptions made at both domain and platform model level con-
cerning the behaviour of and interactions with an LTo cell.
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Consideration Platform Speciﬁcation
Simulation
Interface
Graphical User Interface:
• Enabled with use of MASON Toolkit
• Environment and cell movement displayed in MASON window,
settings can be varied on simulation control console
Non-GUI Simulator:
• Interaction via XML parameter ﬁle read by simulator when
started
Instrumentation Simulation results output as CSV ﬁles:
• Tracking results: cells in vicinity of LTo cell between two stated
time-points
• Tracking results: cells >50µm from LTo cell between two stated
time-points
• Cell Positions: X and Y positions of all LTin and LTi cells at a
stated time-point
• LTo Statistics: Value of Chemokine and Adhesion Factor expres-
sion parameters for all LTo cells, at a stated time-point
Images:
• Screenshots every timestep during tracking (for time-lapse movie
generation)
• Screenshots at every 12 hour time-point
• Screenshot at end of simulation
Quantifying Data Stored by Simulation:
• Cell Position (x,y)
• Position when cell tracking commenced
• Position when cell tracking period elapsed
• Distance covered by cell in tracking period
Calculated by simulation:
• Cell track length covered in tracking period
• Cell velocity in tracking period
• Cell displacement in tracking period
Calculated from simulation CSV ﬁle output:
• Number of aggregations of LTin/LTi cells formed (patches)
• 2D area of the patches that form
Table 2.4: List of simulation design considerations included within the platform model.
These detail how interaction with the simulation will occur, the instrumentation that is
required, and the quantifying data that will be produced, detailed further in the Results
Model. Whereas the previous ﬁgures detail how the biological system is captured, this
is the ﬁrst time the use of the simulation as a software tool is considered
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2.2.4 Simulator
A computer simulation is created from the speciﬁcation in the platform model. In this
case, the platform model has been implemented as a computer simulation using the
Java programming language and MASON simulation environment, a cross-platform
toolkit for the creation of multi-agent simulations (Luke, 2005). Each of the cell types
detailed in section 2.2.2 have been implemented as a Java class and methods created
that match the transition events detailed in the state machine diagrams. Expression
of chemoattractants and adhesion factors has been captured as speciﬁed in Figures
2.8 and 2.9. A virtual environment has been created that matches the speciﬁcation
in Figure 2.10. As MASON simulations are executed in steps where each active agent
performs a behaviour set by its current state, developmental time is incorporated by
setting each timestep to represent one minute. This however is a default ﬁgure and can
be changed if an exploration requires it. Where an alteration is made, the simulator
adjusts relevant parameters, such as cell speeds accordingly.
2.2.5 Results Model
The results model provides a structure to interpret the results that arise from in silico
experiments performed using the simulator. Having a structure with which to contrast
simulation results with the domain model provides a level of conﬁdence that the sim-
ulator is a fair representation of the system being modelled. A speciﬁcation is created
that documents the output obtained from the simulation, what domain knowledge this
is compared to, and the statistical methods used to generate this result. Simulator
output is in the form of simulation responses that are deemed to be of biological in-
terest. They may include cell movement properties, factor expression levels, or space
measurements.
For the PP simulation platform, output captured falls into three categories:
Cell Behaviour Responses
The domain model speciﬁes two forms of emergent behaviour, the ﬁrst of these con-
cerning a change in cell behaviour around the site of a forming Peyer’s Patch. For a
judgement to be made on whether the simulation correctly captures this behaviour,
cell responses need to be captured and contrasted with cell distributions observed ex
vivo (Patel et al., 2012), where cell behaviour was tracked for a period of one hour,
and three responses calculated: path length, velocity, displacement. In the platform
model, a scale was set such that environmental measurements and cell speeds can be
translated back into a form that can be directly compared with the biological mea-
sures. Thus, the simulation platform contains the functionality to track cells for a set
period and produce these three statistical responses for each cell tracked (Figure 2.11).
These responses are output as a comma separated value (CSV) ﬁle at the end of the
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tracking period. This produces a distribution of cell behaviour responses that can then
be directly compared to those captured ex vivo .
Although the ex vivo investigation only considered one time-point, for a length of
one hour, functionality has been included in the results model for cell tracking to be
completed at multiple time-points in simulation, for any length of time required.
Patch Characteristic Responses
As has been noted previously in this chapter, characterisation of a PP in simulation is
diﬃcult for two reasons. Firstly, little biological data exists that can be used to classify
what a patch is, in terms of size or area, and the existence of patches tends to be noted
visually rather than through use of any statistical measure. Secondly, PP can form as
3D cell aggregations rather than the 2D aggregations that this model generates. Thus,
even if quantitative data did exist, the two structures are not directly comparable.
However, though these form in 2D, conclusions can still be drawn on how biological
factors are inﬂuencing the formation of these aggregations.
The simulator produces four responses that are deemed ’Patch Characteristics’ in
future experimentation in this thesis. The ﬁrst two are the 2D area of the aggregation of
LTin/LTi cells, and the number of such aggregations that form. These are calculated
using the R statistical package once the simulation run is complete, using X and Y
coordinates of LTin and LTi cells that are output from the simulator as a CSV ﬁle.
Potential patches are identiﬁed and counted using k-means hierarchical clustering, and
agents that are a greater distance than double the diameter of an LTi cell away from
another cell removed. Cluster size is generated by calculating the area within eight
coordinates selected from the perimeter of the cluster, as detailed in Figure 2.12. Being
in possession of these measures makes it possible to determine the eﬀect quantitative
changes in simulated biological factors has on cell aggregation. The other two measures
detail the level of adhesion and chemoattractant factors expressed by the LTo cell at
the end of the simulation. As these measures are directly related to cell interactions,
this gives an indication of how such quantitative changes in parameter value aﬀected
interactions between the LTo and LTin/LTi cells.
Similarly to the cell behaviour characteristics, cell X and Y coordinates can be
output from the simulation at any time-point, making it possible to examine inﬂuences
on cell aggregation over time.
Simulation Snapshots
Alongside the statistical measures generated above, conclusions can also be drawn
from visual simulation output. The simulation platform includes the functionality to
automatically produce snapshots of the simulated gut environment, either at twelve
hour intervals and at the end of simulation, or for each simulation time-step. The
latter enables movies to be generated from simulation runs, or cell tracking analysis to
2.2. PAIRING CURRENT EXPERIMENTAL TECHNIQUES WITH MODELLING
AND SIMULATION 75
be performed using the Volocity software package that is used for the performing the
same analysis for ex vivo and in vivo images.
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in silico Cell Tracking
Agents (LTin and LTi cells) can be tracked at any time-point in the simulation, for any duration of
simulation time-steps. In the ex vivo work, (Patel et al., 2012), three cell responses were calculated
using the software Volocity package and cell tracking images. These responses, cell path length,
displacement, and velocity, are also calculated for the simulator, using the equations below.
Agent position at the start of the tracking period is recorded in agent variable trackingStart-
Position. At the end of the period, the end position is recorded in agent variable trackingEndPosition.
Distance Between Two Coordinates:
The distance between two points, used in these calculations, would be calculated as follows:
diffX = new X location− original X location
diffY = new Y location− original Y location
distance =
�
diffX2 + diffY 2
(2.4)
However, using this formula does not allow for the fact that a cell may roll around the top and
bottom of the screen. To take this into account, an adjuster is introduced. Initially the calculation is
performed with an adjustment of 0. Should a distance be returned that is greater than half the width
of the simulated tract, a roll-around is detected. If the end Y coordinate is less than the original Y,
the calculation is performed again, with the height of the tract used as the adjuster in the calculation.
If the end Y coordinate is more than the original Y, the calculation is performed with the height of
the tract as the adjuster, but this time the adjustment is negative.
distance =
�
diffX2 + (diffY + adjuster)2 (2.5)
Cell Path Length:
Cell path length is calculated during each time-step that tracking is performed. This starts as 0, and
is incremented with each time-step as follows:
pathLength = pathLength+ distance from old to new coordinates (2.6)
Cell Displacement:
Cell displacement is simply the distance between the start and end coordinates:
diffX = trackingEndPosition X − trackingStartPosition X
diffY = trackingEndPosition Y − trackingStartPosition Y
displacement =
�
diffX2 + (diffY + adjuster)2
(2.7)
Cell Velocity:
Cell Velocity is calculated at the end of the tracking period:
cellV elocity = pathLength/tracking time steps completed (2.8)
Figure 2.11: Equations detailing how the simulated cell behaviour characteristics are
calculated in the Platform Model
.
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(a) Individual patches
(b) Approximating patch size
Figure 2.12: Identifying Peyer’s Patches and approximating the size. In (a), patches
are identiﬁed using k-means hierarchical clustering. Any patches that roll around the
top and bottom of the screen, as on the left hand side, are deemed one patch. In (b),
patch size is approximated by choosing eight points on the perimeter of the cluster.
The value returned for the patch size is the area of the shape formed by joining these
eight points (as shown by the red line in (b)). For patches that roll around the top and
bottom, the coordinates are normalised to join the patch as one, and the area calculated.
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2.2.6 Calibration to Establish Baseline Behaviours
The simulation platform is an implementation of the platform model speciﬁcation,
that is in turn a speciﬁcation of the biological system captured in the domain model.
However, the domain model does not capture every detail of the biological system,
rather it captures an abstracted view of it. There is no guarantee that the simulation
platform will produce the cell behaviours observed in in vivo imaging and ex vivo
culture. As can be seen in the domain and platform model descriptions above, there are
a number of parameters for which a biological value remains unknown, and parameters
introduced in the platform model which capture a biological process (and thus do not
translate back to the biological system) for which values are also unknown.
Calibration is the process by which values are obtained for any parameters for
which a numerical value is unknown, with the objective to ensure that the simula-
tor produces behaviour responses observed in previously published studies or ongoing
experimentation where available. Where biological data is available, a comparison be-
tween a simulation result and available data can be made using statistical tests such
as the Mann-Whitney U-Test, which will indicate statistical similarity between two
sets. Using a structured trial and error approach, values are assigned to parameters for
which a value is unknown, and altered until no statistical diﬀerence exists between the
available data being used for comparison and simulation result distributions. Where
there is more than one emergent behaviour observed, the simulation should be cali-
brated to ensure each emergent behaviour is reproduced. This section examines the
calibration of the Peyer’s Patch simulation developed in this chapter.
Cell Behaviour Baseline Simulation
Analysis of ex vivo cell tracking images (Patel et al., 2012) has provided distributions of
cell behaviour responses upon which simulation results can be compared. As described
in section 1.3.3, cell behaviour was tracked for an hour at the twelve hour time-point,
with results capturing two distributions: cells within 50µm of a RET ligand expressing
cell, and cells further away. With this data available, the simulation can be run and
cell responses for hour twelve of development captured, and the respective distributions
compared in order to judge how suitable the simulator has captured this behaviour.
In this case, there are six parameters for which a value remains uncertain:
(a) Probability at which an LTin/LTi cell will form a stable bind with an LTo cell upon
contact. A stable bind is deﬁned as contact that leads to LTo cell diﬀerentiation
and an increase in expression of adhesion and chemoattractant factors.
(b) Initial level of chemokine expression upon LTo diﬀerentiation.
(c) Saturation limit of chemokine diﬀusion.
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(d) Level of chemokine required in a cells local environment to induce LTi cell chemo-
taxis.
(e) Level at which surface adhesion factors are expressed with each stable contact
between an LTin/LTi and LTo cell.
(f) Probability that the level of adhesion factors expressed on the surface of an LTo
cell will restrict LTin/LTi cell movement.
The goal of the calibration process is to ﬁnd a potential set of values for these six
parameters where the simulation produces cell behaviour responses that are statistically
similar to those observed in the ex vivo culture system. The simulation has been run
and cell velocity and displacement responses captured for hour twelve of development.
With no guarantee the data is normally distributed, the Mann-Whitney U-Test has
been used to compare the in silico and ex vivo distributions, and dot-plots produced
to aid visual comparison of cell behaviour responses. This has been performed using
a structured trial and error approach, tweaking parameter values until behaviour is
produced that is statistically similar to that observed ex vivo. A selection of the dot-
plots produced in this process are included in Figure 2.13.
Figure 2.14, produced at the end of this process, is a visual comparison of cell
behaviour responses ex vivo against those from the calibrated simulator. It can be noted
that there is no statistical diﬀerence between the two sets of results. This provides a
level of conﬁdence in the simulators use in exploring the cell behaviour it has captures.
Cell Aggregation Baseline Simulation
Calibrating the simulator with respect to the second emergent behaviour, the forma-
tion of cell aggregations after 72 hours that mature to form PP, is however more com-
plex for two reasons previously noted in this chapter: the unavailability of biological
measurements, and relating the 2D abstraction used in simulation to the real-life 3D
structures. Explorations in Chapter 4 of this thesis seek to examine the inﬂuence that
the six parameters listed in the previous section have on patch characteristics, thus a
baseline result needs to be established. In this instance, a baseline behaviour has been
found using the simulation parameter values established above. This establishes the
patch characteristic responses of aggregations that form under parameter conditions
that replicate emergent cell behaviour observed ex vivo . This baseline can then be
used to examine the eﬀect an alteration in these parameters has on these simulation
patch characteristics.
Key factors in patch formation can be determined by examining the formation of
one patch. To do this, one RET-ligand expressing LTo cell agent is placed at the centre
coordinate of the simulation environment. The analysis is examining the parameters
inﬂuence on a patch rather than the eﬀect of LTo cell position, and thus this is not
important in the analysis. Restricting its position ensures there is no variability in
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result caused by the simulators choice of LTo cell position. The simulation can then
be run to produce the patch characteristic responses detailed in Section 2.2.5. A rep-
resentative baseline result can then be established by generating a number of replicate
results. The method by which this number is established is discussed later in this
chapter. This forms a distribution of responses under normal conditions for use as a
comparator when conditions are changed.
Calibration based on Number of Patches
It was shown in Figure 1.2 that between eight and twelve PP develop along the length
of the mouse intestine, variability that cannot currently be explained. Flow cytometry
results have been used to estimate the number of LTo cells to include in the model
(Section 2.2.2). However if patches formed around each of these cells, the number of
patches would be in three ﬁgures. Thus the assumption was made in the domain model
that only a certain number of these cells would have the capability to form PP.
As was noted in Section 2.2.3, the simulation captures 10% of the length of the
mouse intestine. Thus one would expect no more than 2-3 patches form in this short
section. The simulation randomly ﬁlls 20% of the environment with stromal cells. A
set percentage of these are then chosen at random to have the capability to form PP.
Calibration here has thus focused on establishing the percentage of cells that have the
capability to diﬀerentiate into LTo cells, and thus form PP.
A range of percentage values was set and 100 simulation runs performed for a set of
values in that range. Using a snapshot taken at the end of the simulation run, number
of patches that form was determined visually, by experts in the ﬁeld manually counting
what they determine to be a patch. Averages were then taken for each percentage used,
as shown in Figure 2.15. It was determined that the correct number of patches form
where only 0.25% of the 20% of cells express RET-ligand, having the potential to
mediate PP development. Thus, this is used as the value for that parameter in the
relevant analyses in the chapters that follow.
2.2.7 Argument-Driven Validation
Argument-Driven Validation is a technique that can be used to structure an assessment
of the model in such a way that each step in the construction process was validated, the
reasoning behind the inclusion or exclusion of a feature or assumption provided, and
evidence given as to why this conclusion has been drawn (Ghetiu et al., 2010; Polack
et al., 2011). Thus, in this case, features included from the domain and platform
models are both assessed and scrutinised. The overall objective is to go through the
model in steps, linked together by the available evidence to support that step, leading
to increased conﬁdence that certain parts of the model are correct, while identifying
areas open to further examination. This may identify features where assumptions have
been made which need further investigation, or identify clariﬁcations needed from the
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biological experts. The latter may then feed into wet-lab experimentation in order to
assess a feature, or lead to an assessment of the reliability of biological results gathered
from external sources such as published literature.
This process is captured in diagrammatical form using Goal-Structuring Notation
(Ghetiu et al., 2010; Kelly, 1999), the results of which can be seen in Figures 2.16-2.19.
The argumentation has been split into three ﬁgures for ease of reading. The ﬁrst,
Figure 2.16, is the top level of the argument. This states the main claim being argued,
in this case that the simulation is an adequate representation of the biology. This in
turn is broken down into four sub-claims which, if solved, provide a argument that
supports the main claim. This section considers each of these subclaims in turn.
For ease of comparison, claim 1.1.3 is considered ﬁrst, as this is detailed on the
same diagram as the main claim (Figure 2.16). The claim is made that the simulation
produces cell behaviour statistically similar to that observed ex vivo. The previous
section of this chapter examined the use of calibration to ensure that this is the case,
and these results are noted on the diagram as evidence that the claim can be veriﬁed.
Claim 1.1.1 is more complex, and examines whether there is adequate biological data
included in the model. The argument is detailed in Figure 2.17. In this case, the claim is
examined using four strategies, each of which concerning a subset of the parameters that
have been derived from biological data. The ﬁrst considers the representation of LTin
and LTi cells, in terms of number, size, and cell velocity; the second the representation
of stromal LTo cells; the third the representation of the biological environment; and
the ﬁnal strategy data related to Peyer’s Patch characteristics. Where relevant, sources
of the biological data are noted, and where necessary any assumptions that have been
made based on this data documented. This gives an overview of how the data has
been obtained and how this has then be utilised in the creation of the simulation.
This helps improve conﬁdence in the design of the model as parameter generation
from biological data is more transparent. One claim, under strategy 1.1.1.4, is noted
with a blank diamond. This concerns biological data that can be used to compare
PP generated in silico to that ex vivo. As has been noted previously in this chapter,
such quantitative data is not currently available, making it diﬃcult to support a claim
that PP are generated that are of a representative size. Thus the claim needs to be
developed further, noted by the presence of the diamond. This however should not be
viewed negatively: one of the objectives in performing ABV is to identify such areas
where current understanding is lacking.
The second claim made examines the abstractions made, and how these are justi-
ﬁed. This argument is detailed in Figure 2.18. It is vital that the use of abstraction
is transparent, as these may aﬀect the meaning of the results generated, thus in turn
aﬀecting any hypotheses developed from them. Again this claim is examined in four
strategies: the ﬁrst considers the implementation of chemokines, justifying why the
implementation of one chemokine rather than three is a suitable abstraction; the sec-
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ond the implementation of adhesion factors; the third the 2D implementation of a 3D
environment; and the ﬁnal strategy abstractions linked to cell signalling. In the ma-
jority of cases, subclaims generated from these strategies are supported by available
evidence or the insight provided by collaborating experimental immunologists. There
are three claims however that need to be developed further. The ﬁrst two claim that
simulation chemokine and adhesion factor expression levels are representative of that
in the biological system. No previous laboratory studies have generated quantitative
data on which simulation expression levels can be compared, and thus this is an area
where further experimental work is required. The third claim is that the physical shape
of the gut (e.g. the bends) has no impact on PP formation. As no previous study has
examined the role that the physical geometry of the environment, the assumption has
been made that this has no aﬀect on the process, mainly due to the diﬀerence in scales
between the individual cells and the environment.
Claim 1.1.3 examined the ﬁrst of the emergent behaviours observed, the change
in cellular behaviour in the vicinity of a forming PP. Claim 1.1.4 (Figure 2.19) ex-
amines the second, the development of aggregations of cells after 72 hours, that later
become PP. The claim is made that the simulation adequately captures this emergent
behaviour. This is justiﬁed using three strategies: determining whether a represen-
tative number of PP are formed along the intestine length; that previously published
experimental results that examine PP formation in diﬀerent physiological conditions
are replicated; and that the simulation correctly captures the characteristics of a PP
observed in vivo. The ﬁrst strategy uses evidence from the calibration process in sec-
tion 2.2.6, and results in Figure 2.15, to demonstrate that a representative number of
patches do form. It is noted that this is based on the assumption that only a certain
percentage of LTo cells can express RET ligand and thus mediate PP development.
The second strategy, replicating previously published results, is noted as needing to
be developed further. Experimentation using the simulator to examine this claim is
addressed in Chapter 4 of this thesis. Finally, the last strategy examines the size of
these emergent aggregations. As noted previously, there is no biological data on which
simulation PP size response can be contrasted. However, the method by which PP are
identiﬁed is justiﬁed alongside the claim.
When considered together, these diagrams provide a detailed ﬂow of the decisions
that have been made in the course of simulation development. In this case, the process
may come across as static: claims have been made and supported and areas of further
development identiﬁed, and a ﬁnal document produced. In practice however, the de-
velopment of these arguments would not end here, yet would continue as simulation
results are analysed and the simulation developed further.
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2.3 Making the Simulation Tool Publicly Accessible
Making the simulator freely available enables immunologists to engage with the tool
for their own research and provide critical feedback on any future iterations of the
simulator. The simulator and its underlying source code are freely available to run
online and for download (http://www.cs.york.ac.uk/immunesims/frontiers).
Figure 2.13: Two example dot-plots produced during the process of calibration. In
both cases, the right hand side of the plot shows the average cell velocity for a particular
simulation run, for cells tracked in during hour twelve of development. The left hand
side is the cell velocity distribution that was observed ex vivo . The statistical result
produced by the Mann-Whitney U-Test when the two distributions are compared is
noted in the graph header. For the scenario on the left, cell velocity is too fast, and thus
the parameters chosen have not correctly captured cell behaviour. For that on the right,
the parameters are much more suitable, and there is no statistical diﬀerence between
the two distributions.
Figure 2.14: A comparison of the behaviour of the calibrated simulation platform with
cell behaviour responses observed ex vivo . Top row: ex vivo cell responses; Bottom row:
in silico cell responses. The ﬁrst column contains cell tracking images for hour twelve
of development. Both were produced using Volocity (PerkinElmer), the ex vivo image
by producing an sequence from images captured each minute, and the in silico image
by producing a sequence from screenshots captured at each time-point representing one
minute. This ﬁgure has been adapted from that published in Patel et al (2012).
84 CHAPTER 2. METHODS AND TOOL DEVELOPMENT
0.1% 0.15% 0.20% 0.25% 0.5% 2.5% 5.0% 10.0%
Average Number of Peyer's Patches Observed in 
 Simulated 10% of Gut Length
Percentage of LTo Cells Capable of Forming Patches
A
ve
ra
ge
 N
um
be
r o
f P
at
ch
es
 Id
en
tif
ie
d 
(V
is
ua
lly
)
0
5
10
15
20
25
30
35
40
45
50
55
60
1.5 2
2.7
3.8
9.8
20.8
35.4
50.8
Figure 2.15: Average number of PP that form where the percentage of LTo cells that
express RET ligand, and thus have the capability to form PP, is adjusted. Averages are
taken from 100 runs of the simulation under each condition. Average number of patches
that form in the simulated 10% of the gut length is noted above each bar. Patches are
determined visually in conjunction with experts in lymphoid tissue development. As
10% of the gut has been captured, between 2-3 patches would be expected.
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CLAIM 1:
Model is an adequate
representation of the biology
Purpose:
- Recreate emergent observed in vivo and ex vivo
- creation of tool for exploration of hypotheses
Deﬁnition: 'Adequate'
Experimental work using model 
produces statistically comparable results 
to those seen biologically
STRATEGY 1.1
Argue over scientiﬁc content, the adequacy
of the abstraction, and experimental results
CLAIM 1.1.1:
Underlying biological data
is adequate/accurate
CLAIM 1.1.2:
The abstraction (platform model)
is adequate representation
CLAIM 1.1.3:
Simulated cell behaviour between
12 and 13 hours matches that
observed in ex vivo culture
CLAIM 1.1.4:
Simulation captures cell aggregation
emergent behaviour at 72 hours
STRATEGY 1.1.3.1:
Argue that simulated cell behaviour is
statistically similar to that ex vivo at 12 hours
CLAIM 1.1.3.1.1:
Simulated cells <50μm from a forming
patch behave as observed ex vivo
Justiﬁcations:
1. Mann-Whitney U-Test used as no
guarantee that the data is normally 
distributed
Mann-
Whitney test
reveals no statistical
diﬀerence
(Figure 2.15 )
CLAIM 1.1.3.1.2:
Simulated cells >50μm from a forming
patch behave as observed ex vivo
Mann-
Whitney test
reveals no statistical
diﬀerence
(Figure 2.15 )
J
Figure 2.16: Argument-Based Validation for the development of the Peyer’s Patch
Simulation. This is the top level. A claim is made that the simulation is an adequate
representation of the biology, and arguments put forward to support this where possible.
This is broken down into four subclaims. A black diamond shows that the claim has
been developed in another ﬁgure due to limitations on space. These follow on the next
pages. Claim 1.1.3 has been developed in this ﬁgure, noting the evidence that simulated
cell behaviour at the twelve hour time-point is statistically similar to that observed ex
vivo, and where this result can be found.
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Figure 2.17: Argument-Based Validation for the development of the Peyer’s Patch
Simulation - Claim 1.1.1. This claim argues that the biological data included within
the model and on which the simulation is judged is adequate. In the majority of cases
evidence is provided for subclaims of the main claim. Where data is unavailable, the
claim cannot be met and needs more development, and is noted with a blank diamond.
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Figure 2.18: Argument-Based Validation for the development of the Peyer’s Patch
Simulation - Claim 1.1.2. This claim examines the abstractions that have been made,
and whether these are suitable. Thus in this case the implementation of chemokines,
adhesion factors, the environment, and cell signalling is explored. In the majority of
cases evidence is provided for subclaims of the main claim. Where data is unavailable,
such as chemokine and adhesion factor expression levels, the claim cannot be met and
needs more development, and is noted with a blank diamond.
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Figure 2.19: Argument-Based Validation for the development of the Peyer’s Patch
Simulation - Claim 1.1.4. This claim states that the simulator correctly replicates the
second observed emergent behaviour, cell aggregations that become PP. It is noted that
one of the claims, that previously published results are replicated, will be examined
in this thesis. Where data is unavailable, the claim cannot be met and needs more
development, and is noted with a blank diamond.
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2.4 Developing the spartan Statistical Analysis Toolkit
Results generated through simulation may be aﬀected by uncertainty caused by as-
pects of the biological system that are currently unknown and need to be assumed,
and by uncertainty introduced in the implementation of the simulator (Helton, 2008).
Such uncertainty may be present in two forms: aleatory uncertainty that arises through
stochasticity inherent in both the biological and simulated system, and epistemic uncer-
tainty arising as the values of some simulation parameters cannot currently be deﬁned
(Helton, 2008). Although integrating computer simulation with current experimental
techniques has become a popular approach in furthering the understanding of biologi-
cal systems (Germain et al., 2011), in many cases where this approach is applied little
attempt is made to reveal how representative the simulation result is in terms of the
biological system it has captured (Read et al., 2012).
The increase in popularity of computer simulation as an tool for exploring the dy-
namics of biological systems has led to the development of a number of packages that
aid simulation development, as detailed in section 1.4.2. However there is no compre-
hensive statistical analysis package available to help determine how representative a
simulation is of the biological system it has been constructed to represent and under-
stand how results generated from the simulation can be interpreted in the context of
that biological system. Uncertainty and sensitivity analysis techniques have recently
found application in exploring results from biological simulations in order to appreciate
these factors and the eﬀect of uncertainty on simulation results (Marino et al., 2008;
Ray et al., 2009; Read et al., 2012). An application of these techniques provides the
means to understand the relationship between the simulation and the real system and
to provide some biological insight.
This section details the creation of a package of statistical techniques to aid the
understanding and analysis of results generated through simulation. This package
has been called spartan (Simulation Parameter Analysis R Toolkit ApplicatioN) and
provides implementations of previously described uncertainty and sensitivity analysis
techniques (Marino et al., 2008; Read et al., 2012; Saltelli et al., 2000) that when com-
piled as one package provide a comprehensive toolkit to explore the eﬀect of uncertainty
on simulation results. Spartan has been developed in the open-source R statistical en-
vironment and is freely available from the R package repository or for download from
http://www.cs.york.ac.uk/spartan. This should help encourage simulation developers
to perform such analyses to reveal how representative a simulation result is in terms
of the biological system being captured, results that can then be published alongside
their results for full scrutiny.
The spartan toolkit is utilised in conjunction with the simulator developed above in
the chapters that follow to further understand the development of secondary lymphoid
organs in the gut. The package contains four techniques, all of which are utilised in
this thesis, each providing a diﬀerent method of analysing results from the simulation
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with the aim to understand the eﬀect of uncertainty on results and provide some novel
biological insight. The remaining part of this section examines each of the techniques
that has been included.
2.4.1 Mitigating Aleatory Uncertainty
In agent-based simulations such as the lymphoid tissue formation simulation developed
in this chapter, agent behaviour is aﬀected by use of pseudo-random number generation.
Thus, diﬀerent results are produced, although input parameter values remain constant.
Prior to the simulators use as a predictive tool, it is critical that the eﬀect inherent
stochasticity has on results is understood (Helton, 2008). To mitigate the eﬀect of
this aleatory uncertainty and achieve a representative result, replicate simulation runs
are necessary. To determine the number of replicates required (n) that reduces the
uncertainty to level at which the result can be considered representative of the condition
on which the simulator is being run, while considering computational resources, the
technique described by Read et al (2012) has been included within spartan .
To establish n, a number of replicate run sizes (sample sizes) are chosen. Taking a
sample size of ﬁve as an example, twenty simulation result sets are obtained, with each
of the twenty sets containing the results from ﬁve simulation runs. From the results of
each simulation run, medians are calculated for each of the simulation responses. These
are collated to form a set of median responses for each of the twenty subsets. Thus, in
this case we have 20 sets of median responses, each of which contains the medians of
each response of ﬁve simulation runs. The eﬀect of uncertainty between the 20 sets of
results is quantiﬁed using the Vargha-Delaney A-Test (2000), a non-parametric eﬀect
magnitude test that establishes scientiﬁc signiﬁcance by contrasting two populations
of samples and returning the probability that a randomly selected sample from one
population will be larger than a randomly selected sample from the other. Results
above 0.71 or below 0.29 indicate a scientiﬁcally signiﬁcant diﬀerence between the
populations, and 0.5 indicates no diﬀerence (Table 2.5) (Vargha and Delaney, 2000).
The responses from the ﬁrst set are compared with the remaining response sets in turn.
Repeating this procedure for diﬀerent sample sizes determines how many simulation
samples should be compiled in generating averaged results to reduce the scientiﬁc eﬀect
of stochasticity to an acceptable level. To achieve a representative result, there should
be no statistical diﬀerence in all twenty comparisons. The spartan package produces a
plot for each sample size, detailing the A-Test result for each of the twenty comparisons.
A summary plot is then produced revealing the maximum A-Test result for each sample
size, helping determine the number of simulation runs required to mitigate aleatory
uncertainty.
2.4. DEVELOPING THE SPARTAN STATISTICAL ANALYSIS TOOLKIT 91
Eﬀect Size Large Medium Small None
A-Test Score <0.29 & >0.71 <0.36 & >0.64 <0.44 & >0.56 0.5
Table 2.5: A-Test magnitude eﬀect sizes as speciﬁed by Vargha and Delaney (2000).
An A-Test score is between 0 and 1, with 0.5 representing no diﬀerence between two
distributions. As this is a magnitude the result has a direction, and thus there are small,
medium, and large boundaries either side of 0.5
2.4.2 Parameter Robustness Analysis
The simulation features parameters for which values are unknown or cannot currently
be determined. This may be as currently available techniques cannot determine the
biological value, or caused through the translation of biological information into a
format that can be implemented within a simulation. Robustness analysis examines
the implications of biological uncertainty or parameter estimation on simulation results.
Where a simulation is found highly sensitive to the value of these parameters, caution
must be exercised in interpretation of results; they may be artefacts of parametrisation
rather than representations of the biology (Helton, 2008).
Robustness to parameter perturbation can be explored using a one at a time ap-
proach (Read et al., 2012). A set of simulation parameters of interest is determined.
Taking each in turn, the value of that parameter is adjusted, with all other parameters
remaining at their calibrated value. The Vargha-Delaney A-Test described previously
(Vargha and Delaney, 2000) is employed to determine if changing the parameter value
has led to scientiﬁcally signiﬁcant behavioural alteration in contrast to the baseline
simulation. This indicates how robust the simulator is to an alteration in the value
of each parameter, and can indicate the validity of results produced by the simulator
when considering results over a biologically accepted range of values.
For an agent-based implementation such as the simulator developed here, replicate
runs are required to mitigate the eﬀect of aleatory uncertainty. Spartan takes this into
account where this is the case and compares the distribution of simulation responses
from a number of replicate runs with that from the number of replicate runs of the
baseline simulation. The robustness to parameter change is thus being judged on a
result that is representative of the condition on which the simulator was run. For
each parameter examined, spartan produces a plot detailing the A-Test score for each
parameter value, in comparison to a result from the baseline. The plot thus reveals
the statistical change in simulation response caused by a change in parameter value,
and any statistical aﬀect that becomes apparent as the parameter value is increased or
decreased.
2.4.3 Global Sensitivity Analysis: Sampling-Based Approach
Though robustness analysis elucidates any aﬀects of perturbing single parameters, it
cannot reveal compound eﬀects that become apparent when two or more are adjusted
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simultaneously. Global sensitivity analyses reveal such eﬀects, and can indicate the
parameters that have the greatest inﬂuence on simulation response. To identify such
parameters, a sampling-based technique that perturbs the values of all parameters of
interest simultaneously has been included within spartan (Read et al., 2012; Saltelli
et al., 2000). A set of simulation parameters of interest is determined, and for each,
a range of parameter values to explore. A number of simulation parameter value sets
are then created through use of a latin-hypercube sampling approach (McKay et al.,
1979). This selects values for each parameter from the parameter space, aiming to
reduce any possible correlations while ensuring eﬃcient coverage of the space over a
minimal number of samples (demonstrated in Figure 2.20).
Simulations are then performed for each set of parameter values generated. Where
the simulation is agent-based, a number of replicate runs are performed for each set to
mitigate the eﬀect of aleatory uncertainty as described in section 2.4.1. The spartan
package includes functionality to process these replicates and calculate the median of
simulation responses observed for simulations run under the conditions speciﬁed by
that parameter set.
Each parameter is then taken in turn, and simulation responses ordered by the value
assigned to that parameter. A plot is produced for each simulation response detailing
the value of the response observed against the parameter value. This eases the iden-
tiﬁcation of any relationship between the value of that parameter and the simulation
response, although a number of parameters are being perturbed simultaneously. For
example, the trend of points on the graph may suggest that a simulation response, such
as velocity, decreases as the value of a particular parameter increases. The plot may
also reveal if such a trend only becomes apparent when that parameter is in a speciﬁc
value range. A statistical measure is also provided through calculation of a Partial
Rank Correlation Coeﬃcient (PRCC), a robust measure for quantifying non-linear re-
lationships between an input and output (Marino et al., 2008), and the calculated value
stated in the plot header. Correlations that become apparent can be attributed to the
value of the parameter, and the parameters that have signiﬁcant impact on simulation
behaviour determined by the size of the eﬀect identiﬁed.
2.4.4 Global Sensitivity Analysis: Variance-Based Approach
In this approach, simulation parameters are varied, and resultant variation in simula-
tion response partitioned between those parameters. The extended Fourier Amplitude
Sampling Test (eFAST), developed by Saltelli et al (Saltelli, 2004; Saltelli and Bol-
lardo, 1998) is also a global sensitivity analysis technique, and has proven one of the
most reliable methods among variance-based techniques (Marino et al., 2008). This
has been included in spartan to provide an alternative global analysis technique that
can be contrasted to results generated by the technique above. A set of simulation
parameters of interest is determined, and for each, a parameter value range to explore.
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Figure 2.20: Image taken from Read et al (2012), exemplifying use of a latin-hypercube
sampling approach for two parameters. The parameter space is split into subdomains,
indicated by dotted lines. Ten samples have been taken, with one coming from each
subdomain to ensure the parameter space is fully explored
Taking each in turn, values are chosen for all parameters through the use of sinusoidal
functions of a particular frequency through the parameter space, with the frequency
of the parameter of interest being much diﬀerent to that used for its complementary
set. This is demonstrated in Figure 2.21. A number of parameter values are selected
from points along each of these curves. This creates a set of simulation parameters for
each parameter of interest. Due to the symmetrical properties of sinusoidal functions,
it is probable that the same parameter value sets could be selected. To address this, a
resampling scheme is encouraged where a phase shift is introduced into each frequency,
and sampling repeated (Marino et al., 2008; Saltelli et al., 2000). Thus, a number of
parameter value sets are created for each parameter of interest. This process is re-
peated for an extra parameter, the dummy, which has an arbitrary value range but
no impact on simulation behaviour. This enables a comparison between the impact of
each parameter and one known to have no eﬀect on simulation response. As an exam-
ple of sampling using this approach, for 7 parameters, plus a dummy, three resample
curves, and 65 parameter values from points along the curves, 1,560 sets of parameters
would be produced. For analyses where a large number of parameters are explored,
this technique could be computationally expensive (Ratto et al., 2007; Tarantola et al.,
2006).
Simulations are performed for each set of parameter values generated. As described
with the latin-hypercube technique above, spartan includes functionality to process
replicate runs required to mitigate aleatory uncertainty in agent-based simulations,
through the calculation of medians for each simulation response under the conditions
set by that parameter set.
Results generated are analysed taking into account the frequencies that were used
to generate that parameter set. Through Fourier analysis using these frequencies,
variation in output can be partitioned between the parameters, giving an indication of
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the impact each has on simulation response. Using the equations given in Marino et
al (2008), two sensitivity indexes are calculated for each parameter: an eFAST First-
Order Sensitivity Index (Si) and eFAST Total-Order Sensitivity Index (STi). The ﬁrst
indicates the fraction of output variance that can be explained by the value assigned
to that parameter. The latter indicates the variance caused by higher-order non-linear
eﬀects between that parameter and the others explored. The spartan package produces
plots of these measures for each simulation response. To determine whether a parameter
has a signiﬁcant impact on simulation response, these sensitivity indexes are compared
to those calculated for the Dummy using a two-sample t-test.
Figure 2.21: Parameter sampling and analysis using the extended Fourier Amplitude
Sampling Test (eFAST). Left: Input parameter sampling - each parameter is varied
through use of a sinusoidal curve of a particular frequency, and values chosen from
points along the curve. The image shows sampling for two parameters. The parameter
of interest is assigned a signiﬁcantly diﬀerent frequency. Right: Chart detailing the
sensitivity indexes for each parameter. The ﬁrst-order sensitivity index Si, or the fraction
of output variance that can be explained by the value assigned to that parameter, is in
white; the higher order eﬀects between parameters STi is in grey; the remaining variance
SCi is explained as variance accounted for by the parameters complementary set. Image
taken from panels A and D from Figure 3 of Marino et al Marino et al. (2008).
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2.5 Use of the Simulator and spartan to Explore Lymphoid
Tissue Development
The simulation and spartan package provide the tools necessary to perform an in silico
exploration of lymphoid tissue development. The following chapters make use of these
tools to explore how changing the conditions under which the simulator is run can
provide additional biological insight that could inform future laboratory experimenta-
tion. This section details the methods that are used in producing these results and
hypotheses.
2.5.1 Analysing Changes in Cell Behaviour
Section 2.2.6 described how the simulation has been calibrated such that emergent cell
behaviour replicates that observed ex vivo (Patel et al., 2012). The simulation provides
the functionality to perform this analysis through tracking simulated cells for a period
of one hour at the twelve hour time-point, to produce output ﬁles that can be processed
by statistical tools. Thus it is possible to run the simulation under diﬀerent parameter
value conditions and utilise spartan to assess the impact this has on cell behaviour
responses. Additionally, the simulator provides functionality to produce this output
for any time point in the simulated 72 hour period. This makes it possible to examine
if cell behaviour at the end of the simulated period diﬀers from that at the twelve-hour
time-point, and note if the inﬂuence of simulated biological factors changes over time.
This is the focus of Chapter 3.
Chapter 5 takes this a stage further, and utilises a combination of the simulator
and spartan package as a tool to perform a time-lapse analysis of cell behaviour re-
sponses. This involves running the simulation under diﬀerent conditions and capturing
cell behaviour responses at twelve-hour intervals. Techniques in the spartan package
can then be utilised to determine if and when the inﬂuence of simulated biological
factors changes, providing biological insight diﬃcult to obtain in the laboratory.
2.5.2 Contrasting Simulator With Published Results
With regard to the second emergent behaviour captured by the simulation, the forma-
tion of PP, comparisons between a simulator result and published experimental results
have been made visually. It was noted in section 2.2.5 that X and Y coordinates of all
LTin and LTi cells are output from the simulation at the end of the run. These cell co-
ordinate ﬁles are processed in the R statistical environment to produce a plot showing
the formation of PP across the simulated gut length. In Chapter 4, these visual images
are contrasted with phenotypes in the relevant publications observed through use of
antibody staining of LTi and LTo cells, with the help of collaborating experimental
immunologists.
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2.5.3 Simulating Gene-Deﬁcient Mice Experiments
To simulate gene-knockout experiments, with the aim to replicate previously pub-
lished results in silico, boolean parameters have been included in the simulator. A
gene knockout is indicated by setting the relevant knockout parameter to true. Three
boolean parameters have been included that model a knockout of RET, chemokines,
and adhesion factors respectively.
2.5.4 Simulating Experiments that have Examined Reduced
and Over Expression of Biological Factors
To simulate changes to level of expression or cell numbers, values for relevant pa-
rameters in the platform model can be adjusted as required prior to simulation run.
Simulation parameter values are speciﬁed in an XML ﬁle, that is read by the simulator
when the run starts. A reduced or overexpression is modelled by changing the values
within that ﬁle. For example, experimentation in Chapter 4 examines the impact of
a change in LTin cell number on PP formation. This study is performed by simply
running the simulation with diﬀerent values for that parameter.
Chapter 3
Factors Inﬂuencing Hematopoietic
Cell Behaviour in Peyer’s Patch
Development
Laboratory explorations of hour 12 of Peyer’s Patch development have suggested there
is a statistically signiﬁcant diﬀerence between hematopoietic cell behaviour near a
forming Peyer’s Patch and cell behaviour further away. The previous chapter detailed
how a computer simulation has been implemented that replicates this emergent
behaviour, producing results that are statistically similar to cell behaviour observed ex
vivo. This chapter applies the techniques in the spartan toolkit developed in the course
of this study to analyse simulation results and suggest the biological factors that could
be causing this change in cell behaviour during hour 12. Furthermore, the same
analysis techniques are applied to examine simulated cell behaviour during the ﬁnal
hour of organ formation, to determine if the inﬂuence of biological factors changes
over the course of development.
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3.1 Introduction
The previous chapter describes the development of a set of tools that can be used
to perform an in silico exploration of lymphoid tissue formation. This detailed how,
through a process of calibration, it has been ensured cell behaviours that emerge at
an early time-point in simulation are statistically similar to that seen in ex vivo obser-
vations at the same time-point (Patel et al., 2012). The ex vivo cell tracking analysis
reveals a statistically signiﬁcant change in hematopoietic cell velocity and displacement
(LTin/LTi cells) when in the vicinity of an ARTN-soaked bead, placed to model cellu-
lar behaviour around a stromal (LTo) cell. Such behavioural alterations are thought to
occur through interactions between the cells, mediated by adhesion and chemoattrac-
tant factors expressed by LTo cells (van de Pavert and Mebius, 2010; Randall et al.,
2008; Veiga-Fernandes et al., 2007). As calibration and validation results have provided
conﬁdence that the simulator is a suitable representation of the development process,
explorations in this chapter use the simulator as a tool to suggest the factors that could
be inﬂuencing this change in cellular behaviour at the twelve hour time point.
The simulation is however an abstraction of the biological system that it captures,
and this separation must be appreciated when interpreting in silico explorations with
respect to the biological system under study. Such simulation results may be aﬀected
by uncertainty arising from aspects of the biological system that are currently unknown
and thus needed to be assumed, and by uncertainty introduced in the implementation
of the simulator (Helton, 2008). In Chapter 2, a set of statistical techniques to appre-
ciate the eﬀect of uncertainty in simulation results was described. In this chapter the
Simulation Parameter Analysis R Toolkit Application (spartan) package of statistical
techniques compiled in completion of this thesis (Alden et al., 2012a) is utilised to
appreciate the eﬀect of uncertainty on results generated from this simulation and to
explore the factors inﬂuencing cell behaviour in the vicinity of an LTo cell. Techniques
available within spartan can be used to determine how representative the simulation
is of its biological system and understand how in silico results can be interpreted in
the context of the biological domain. When brought together, these techniques provide
a comprehensive set of tools that work towards establishing the relationship between
the simulation and the biological system, enabling the use of the simulator as a tool
for providing such novel biological insights. Using spartan, the number of simulation
samples required to mitigate stochastic eﬀects and attain a desired level of experimen-
tal accuracy is determined, conﬁdence is built that results are representative of biology
as opposed to parameterisation artefacts resulting from epistemic uncertainty, and
valuable biological insight is gained through rigorous statistical analysis of simulation
results.
This chapter begins by examining the eﬀect of aleatory uncertainty on simulated
cell behaviour at the twelve hour time-point (Section 3.3). As the model has been
implemented using an agent-based approach, each cell is represented as an individual
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entity, and thus may behave diﬀerently to other agents of the same cell type. This
captures the stochasticity in cell velocity and displacement that was observed in the
ex vivo culture system (Patel et al., 2012) described in section 1.3.3, which tracked cell
behaviour for an hour at the twelve-hour time-point, data on which this simulator has
been calibrated (Section 2.2.6). It was noted in section 2.4.1 that such stochasticity does
however imply that diﬀerent simulation runs under the same parameter conditions will
produce diﬀering results. In that section a method by which this uncertainty, termed
aleatory uncertainty, could be mitigated was described. This is utilised in this chapter
to ensure results are produced that are representative of the condition on which the
simulation was run.
With the above technique ensuring the eﬀect of aleatory uncertainty is mitigated,
the parameters of the simulation can now be perturbed to examine the eﬀect each has
on simulated cell behaviour. As noted previously, the simulation is comprised of a
number of parameters for which a value is not yet known. Although suitable values
have been obtained through a process of calibration, there remains some uncertainty
in the true value of these parameters, termed epistemic uncertainty (Helton, 2008).
This chapter continues by using techniques within the spartan package to explore how
robust simulated cell behaviour during hour 12 is to an alteration in the values of
these unknown parameters (Section 3.5.1). Where cell behaviour at this time-point is
found to be highly sensitive to parameter value, it must be considered whether this
sensitivity is caused by parameterisation or whether this is a true representation of the
biology. Such parameters have been identiﬁed using a technique that perturbs their
value independently of all other parameters over a set range (Read et al., 2012), an
approach described in detail in section 2.4.2.
However, the eﬀect one parameter has may rely on the value that is assigned to
another. Further statistical techniques included within spartan and described in section
2.4 have been utilised to examine the eﬀect on simulated cell behaviour of changing
the value of all unknown parameters simultaneously (Sections 3.5.2 and 3.5.3). Such
statistical approaches are called global sensitivity analysis techniques, and can be used
to identify compound eﬀects that occur although the values of all parameters in a subset
are being perturbed. The identiﬁcation of compound eﬀects can indicate parameters
that are highly inﬂuential in aﬀecting simulated cell behaviour at this time-point, and
in identifying such relationships, this analysis can oﬀer unique biological insight.
Considering the results gained from each statistical technique together provides
a means of suggesting the biological factors inﬂuencing the change in cell behaviour
during hour twelve of development observed ex vivo (Patel et al., 2012). However, the
process of lymphoid tissue formation in the gut is known to continue for another 60
hours after that time-point (Mebius, 2003; Randall et al., 2008). Thus, it would be
interesting to reveal if the same conclusions concerning the impact of each factor are
to be drawn at hour 72 as drawn for hour 12, or whether diﬀerent biological factors
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become inﬂuential at diﬀerent time-points of development. The latter conclusion could
potentially extend Adachi et al’s (1997) hypothesis that PP formation can be split into
distinct phases. The authors determine these phases to be the appearance of VCAM-
1+ stromal cells in the gut, the identiﬁcation of clusters of LTi cells around VCAM-1+
expressing stromal cells, and the recruitment of lymphocytes from E18.5. However, an
exploration of the period between the appearance of LTo cells and clustering of LTi
cells up to E17.5 where this simulation stops, through an analysis of cell behaviour,
may suggest additional phases between Adachi et al’s ﬁrst and second phase, with
diﬀerent biological factors becoming inﬂuential at diﬀerent time-points.
This chapter continues by exploring this hypothesis, and examining simulated cell
behaviour after 72 hours of PP development, or E17.5. To do this, the simulation was
run, and as performed previously, cells that are within 50µm of a primordial PP tracked
for a period representing one hour, but this time during the 72nd hour of development.
The factors that inﬂuence simulated cell behaviour were then determined using the
same statistical techniques as those described above for the twelve hour time-point.
Conclusions from these results can be contrasted with those produced after twelve
hours of development, to determine if diﬀerent factors are inﬂuential at the end of the
PP development period. Should this be the case, the hypothesis that there could be
diﬀerent development phases within the 72 hour development window will hold.
3.2 Aims
Explorations in this chapter utilise the developed simulator and statistical techniques
within the spartan package to achieve the following aims:
1. To determine the number of simulation runs required per run condition that
attains a desired level of experimental accuracy, mitigating aleatory uncertainty.
2. To examine the implications of biological uncertainty or parameter estimation
on simulation results at both hour 12 and 72 of development, ensuring a result
is representative of the biology rather than parameterisation artefacts, and thus
biological insights can be drawn.
3. To identify any compound eﬀects present between two or more simulated bio-
logical factors at both hour 12 and 72 of development, indicating the pathways
and components that have a substantial eﬀect on simulation behaviour at that
particular time-point.
4. To partition the variance in results caused by perturbing the values of each factor,
and thus establish how sensitive the simulation and biological system is to the
value of each factor at both the 12 and 72 hour time-point.
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5. To contrast the results gathered in achieving the above aims, to determine whether
the impact of a biological factor changes over time.
3.3 Mitigating the eﬀect of Aleatory Uncertainty
The eﬀect of aleatory uncertainty can be mitigated by performing a number of sim-
ulation runs under identical conditions. To determine the number of simulation runs
required to obtain a representative result, sample sizes of 1, 5, 50, 100, 300, 500, and
800 simulation runs were analysed using the technique described by Read et al (2012)
detailed in section 2.4.1. The objective is to reduce the variance in simulation output
response measures, in this case the cell behaviour measures of Velocity and Displace-
ment between hours twelve and thirteen. Figures 3.1a, 3.1b, 3.1c show the A-Test
scores for these simulation output responses in each of the 20 result sets, for 5, 100,
and 500 samples respectively. Figure 3.1d shows the maximum A Test score for each
simulation response over the 20 result sets, for all sample sizes analysed. The latter
indicates that reducing the eﬀect magnitude of aleatory uncertainty on simulation re-
sults to less than small (the desired level, as deﬁned by Vargha-Delaney (2000) and
listed in Table 2.5) requires 500 simulation runs. Thus, 500 runs should be performed
for each investigation conducted using this simulator, where the focus is on examining
changes in cellular behaviour.
3.4 Investigating the Impact of Factors for Which No Value
is Currently Known
In this simulation there are six parameters for which the value is uncertain:
(a) Probability at which an LTin/LTi cell will form a stable bind with an LTo cell upon
contact. A stable bind is deﬁned as contact that leads to LTo cell diﬀerentiation
and an increase in expression of adhesion and chemoattractant factors.
(b) Initial level of chemokine expression upon LTo diﬀerentiation.
(c) Saturation limit of chemokine diﬀusion.
(d) Level of chemokine required in a cell’s local environment to induce LTi cell chemo-
taxis.
(e) Level at which surface adhesion factors are expressed with each stable contact
between an LTin/LTi and LTo cell.
(f) Probability that the level of adhesion factors expressed on the surface of an LTo
cell will restrict LTin/LTi cell movement.
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The remaining analyses in this chapter explore the eﬀect uncertainty in the value
of these parameters has on simulation response. A change in response is measured by
examining alterations in two simulation output responses: velocity and displacement
of cells within a 50µm distance of an LTo cell. These responses are captured for each
cell within that distance over a period representing one hour, at both the simulated 12
and 72 hour time-points. The range of values explored for each of these parameters is
speciﬁed in Table 3.1.
Parameter Baseline Value Lower Limit Upper Limit
stableBindProbability* 0.5 0.0 1.0
chemokineExpressionThreshold* 0.3 0.0 1.0
initialChemokineExpressionValue 0.20 0.10 0.50
maxChemokineExpressionValue 0.04 0.015 0.08
adhesionFactorExpressionSlope 1 0.25 5.0
maxProbabilityOfAdhesion* 0.65 0.1 1.0
Table 3.1: The six simulator parameters for which a value is not currently known,
the value each has been set in calibration, and the ranges explored using sensitivity
and uncertainty analysis techniques. * denotes the parameters for which a full range of
potential values has been explored.
3.5 Examining Hematopoietic Cell Behaviour During Hour
12 of Development
With the number of replicate runs required per condition established, the statistical
techniques available within the spartan package can be used to explore the impact
of each parameter in Table 3.1 on simulated cell behaviour during hour twelve of
development. This hour is considered ﬁrst as this is the time-point at which the
simulator has been calibrated, using ex vivo data from the same hour of development.
3.5.1 Simulation Robustness to Parameter Perturbation
One-a-time analysis (Read et al., 2012) was used to determine how sensitive the sim-
ulation behaviour during hour twelve is to the value of each parameter in Section 3.4.
Each parameter was examined in turn, and its values perturbed over the range of values
speciﬁed in Table 3.1. Five-hundred simulation executions were performed for each pa-
rameter value in accordance with the aleatory analysis in Section 3.3. The distribution
of response values obtained for each parameter value is contrasted with a distribution
obtained using baseline parameter values using the Vargha-Delaney A-Test (2000), as
detailed in section 2.4.1.
(i) Chemokine Related Parameters
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Figures 3.2a and 3.2b show the eﬀect of adjusting the initial level of chemokine
expression upon LTo cell diﬀerentiation and the saturation limit of chemokine
diﬀusion respectively. Ranges of values were chosen such that the sigmoidal curve
used to model the distance at which the chemokine is diﬀused (explained in
Figure 2.8) explores a signiﬁcant range either side of the calibrated value. For
both parameters, this analysis indicates that perturbing the expression level of
chemokines at this early time point has no statistical eﬀect on the behaviour of
cells in the vicinity of a forming patch.
Figure 3.2c shows the eﬀect of adjusting the probability that an LTi cell will not
respond to chemokine expression in its locality. All potential values for this pa-
rameter have been explored, and a similar conclusion to that above is drawn, that
altering this parameter has no statistical eﬀect on cell velocity at this time-point.
However there is a small eﬀect on cell displacement when set to the parameters
extreme upper value, where the cell will never respond to chemokine expression.
Thus early in PP formation the model predicts that chemokines are unlikely to
be the key force driving tissue formation and causing the statistically signiﬁcant
change in cellular behaviour.
(ii) Cell Binding Probability Parameters
Figure 3.2d reveals an alteration in the probability that a stable interaction occurs
when an LTin/LTi cell is in contact with an LTo cell has no eﬀect on cell behaviour
for all values except when set to the lower extreme. Again all possible values have
been explored for this parameter. As the lower extreme value is a probability of
zero, no stable binding would occur, meaning no LTo diﬀerentiation, and thus no
expression of adhesion or chemoattractant factors that inﬂuence cell behaviour.
As such this eﬀect is an expected result.
(iii) Adhesion Factor Related Parameters
In contrast to Figures 3.2a-d, Figure 3.2e reveals a trend in cell velocity A-Test
response when the maximum probability that adhesion factor expression aﬀects
cell motility is perturbed. This suggests that simulated cell behaviour is sensitive
to the value of this parameter, and its value may only lie in a small range either
side of its calibrated value, after which the simulation would produce results that
are, on the basis of data seen in calibration, biologically implausible. A change
in parameter value does however have no signiﬁcant eﬀect on displacement unless
set to the extreme upper value, where adhesion factors will always retain a cell
within a primordial patch.
An alteration in the level of adhesion factors expressed by an LTo cell upon
stable contact also reveals a signiﬁcant change in cell velocity response (Figure
3.2f). Although not classiﬁed as a large diﬀerence by the A-Test bounds set by
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Vargha and Delaney (2000), results either side of parameter values 0.5 and 2.25
do fall outside the category that the authors deem as a ’small’ diﬀerence and into
that deemed a ’medium’ diﬀerence. Again these results suggest that the value of
this parameter is restricted within a certain window of values, between 0.5 and
2. Surprisingly, there is little statistical diﬀerence between adhesion expression
values that are two, three, and four times the calibrated value, suggesting that
once an initial overexpression has occurred, increasing this further has no impact
on simulated cell behaviour. In contrast, the value of adhesion factor expression
parameters seems to have no statistically signiﬁcant eﬀect on cell displacement
at this time-point.
3.5.2 Identifying Compound Eﬀects at 12 Hours Through Si-
multaneously Perturbing all Unknown Parameter Val-
ues
Using the latin-hypercube sampling approach described in section 2.4.3, 500 sets of
simulation parameter values were generated, with each parameter being assigned a
value within the ranges speciﬁed in Table 3.1. For each set of values, 500 simulation
runs were performed to mitigate the eﬀect of aleatory uncertainty. Median cell velocity
and displacement measures were calculated for each run, thus generating a distribution
of 500 median cell behaviour responses at hour 12 for each parameter set. In contrast
to the above, where distributions of results were being compared using the A-Test,
in this case the median of this set of medians is calculated for both cell behaviour
measures, and assigned as the simulation behaviour response under the conditions
speciﬁed in that parameter set. Taking each of the six parameters speciﬁed in Table 3.1
in turn, simulation responses were ordered by the value assigned to that parameter, and
plots generated for each output response (Figures 3.3 and 3.4), detailing the responses
observed for all values assigned to that parameter. Compound eﬀects are noted by
the identiﬁcation of any trends on the plot, and value of the Partial Rank Correlation
Coeﬃcient (PRCC) speciﬁed in the plot header. Both the generated plot and the PRCC
value can be used to suggest the parameters that are highly inﬂuential on simulation
behaviour, and provided unique biological insight into the factors that are important
at this stage of tissue development.
(i) Chemoattractant Related Parameters
Both the plots in Figures 3.3a and 3.3b and the respective PRCC values reveal
no trend between simulation cell velocity responses and the value assigned to the
parameters that capture expression of chemoattractant molecules. For the cell
displacement measure, the same result is found for the initial level of chemokine
expression (Figure 3.4a), but a small trend does become apparent when altering
the parameter that limits chemoattractant expression (Figure 3.4b)
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Similarly, an alteration in the probability that an LTi cell does not respond to
chemokine expression in the environment (Figure 3.3c) reveals no compound ef-
fects when examining cell velocity. The same can be said for the cell displacement
measure, unless the parameter is assigned a value near the upper extreme. At
this point a trend does emerge, suggesting a signiﬁcant eﬀect on cell behaviour
although all other parameter values are also being perturbed. This supports the
previous ﬁnding in one-a-time analysis, where changing the same parameter inde-
pendently produced no signiﬁcant eﬀect on displacement unless set to its extreme
value, where the cell never enters a phase of chemotaxis towards a forming patch
(Figure 3.2c).
(ii) Cell Binding Probability Parameters
For both cell velocity and cell displacement measures (Figures 3.3d and 3.4d),
there is no trend between results obtained for the 500 parameter sets and the
value assigned to the probability that a stable bind occurs between two cells that
are in contact.
(iii) Adhesion Factor Related Parameters
Figure 3.3e reveals a very strong trend between the simulation cell velocity re-
sponses and the maximum probability that an LTin/LTi cell remains in prolonged
contact with an LTo cell. There is a marked reduction in velocity as this proba-
bility increases, although the values of the other ﬁve unknown parameters (Table
3.1) are also being perturbed. Such a strong correlation suggests that cell re-
sponse to adhesion factor expression is a key factor in aﬀecting cell velocity. For
the related parameter, that captures level of adhesion factor expressed with each
stable LTin/LTi cell contact with an LTo cell (Figure 3.3f), a visual eﬀect is ap-
parent, but no signiﬁcant correlation between the level of expression and velocity.
At this early time-point of development, few stable contacts may have occurred,
and combining this with a low level of expression with each contact means that
not enough adhesion factors are expressed to impact cell velocity. An increase in
the parameter value however does begin to reveal the retention aﬀect. However,
the absence of a clear trend between parameter value and velocity does suggest
that there is a large amount of uncertainty in the value of this parameter. This
conclusion is drawn as similar aﬀects on cell velocity can be observed for both
high and low parameter values.
For the cell displacement responses, there is no trend between simulation response
and the level of adhesion factor expression with each stable contact (Figure 3.4f).
Similar to the displacement results described in the chemoattractant section, a
trend does become apparent for extreme values assigned to the parameter that
captures the maximum probability that an LTin/LTi cell remains in prolonged
contact with an LTo cell (Figure 3.4e).
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3.5.3 Partitioning Variance in Simulation Response Between
Parameters
This analysis examined the six parameters speciﬁed in section 3.4, to determine the
proportion of variation in simulation response during hour 12 of development that can
be explained by perturbing the value of each parameter. Through use of the eFAST
approach (Marino et al., 2008; Saltelli, 2004) the sensitivity of the simulation to each
parameter is determined and quantiﬁed, and thus suggests the impact of each biological
factor on tissue development.
Using the sinusoidal curve sampling approach, 500 parameter value sets were gen-
erated, with each parameter being assigned a value within the ranges speciﬁed in Table
3.1. To determine the parameters that have a signiﬁcant inﬂuence on simulation out-
put, the eFAST analysis technique requires an additional ’dummy’ parameter that has
no eﬀect on simulation result. This ’dummy’ parameter was assigned a value range
of 1 to 10. Although the ’dummy’ has no inﬂuence on simulation output, the algo-
rithm will determine that a small proportion of variation in simulation response can be
accounted for by the ’dummy’. This proportion is used for statistical comparison pur-
poses, with the variance accounted for by each of the six parameters of interest being
compared with that assigned to the dummy, to determine if a simulation parameter
is more inﬂuential than one known to have no eﬀect. With the ’dummy’ added, there
are seven parameters (six plus the dummy), with 65 parameter values taken from each
curve, and three re-sampling curves employed, producing 1,365 parameter value sets,
or 195 per parameter, using the sampling procedure detailed in Section 2.4.4. For each
parameter value set, 500 runs were performed to mitigate aleatory uncertainty and
median simulation response values calculated.
Simulation responses were analysed using the Fourier frequency approach described
in section 2.4.4 (Marino et al., 2008; Saltelli, 2004). Plots are created for each simulation
output response (velocity and displacement), detailing the median First-Order (Si) and
Total-Order (STi) sensitivity indexes calculated for each parameter of interest (Figures
3.5a and 3.5b), generated from the Si and STi values calculated for each re-sample
curve. Sensitivity indexes and measures of signiﬁcance in comparison to the ’dummy’
parameter are detailed in Table 3.2.
Cell Velocity
Contrasting the ﬁrst-order sensitivity indexes (Si) for each parameter with those of the
dummy reveal that ﬁve of the parameters account for a statistically signiﬁcant portion
of simulation variance (p < 0.05 ). Of these, the probability that stable contact oc-
curs between an LTin/LTi cell can be discounted as, due to the eﬀect at the extreme
value (as seen in Figure 3.2d and explained in 3.5.1) this is an expected result. A
similar percentage of the variance is also explained by the chemoattractant expression
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parameters, a result contrasting those in analyses performed previously that revealed
chemoattractant expression has no appreciable eﬀect on cell behaviour. Of the re-
maining two, which both capture adhesion factor eﬀect and expression, the maximum
probability that adhesion factors prolong cell contact is signiﬁcant at the 1% level,
supporting the inference in the analyses above that adhesion factors have a key role in
aﬀecting cellular velocity.
When using the total-order sensitivity indexes (STi) to identify any non-linear ef-
fects between the parameter and its complementary set, all STi values are deemed to be
statistically signiﬁcant. As each includes the signiﬁcant variance caused by adjusting
the maximum probability adhesion factors prolong contact, a value that the ’dummy’
STi value does not include, this is to be expected.
Cell Displacement
When contrasted to the ﬁrst-order sensitivity index of the ’Dummy’ parameter, only
two of the six parameters are found to have a statistically signiﬁcant eﬀect (p < 0.05 )
on cell displacement (Figure 3.5b). The ﬁrst of these is the probability that stable
contact occurs between an LTin/LTi and LTo cell on contact (stableBindProbability).
For the reasons speciﬁed above in 3.5.3, this result is expected and thus can be over-
looked. The second is the initial level of chemoattractant expressed on LTo cell diﬀer-
entiation (initialChemokineExpressionValue), further supporting the small compound
eﬀect identiﬁed in latin-hypercube analysis (3.4b).
T-Test results contrasting each parameter total-order sensitivity index (STi) with
that of the dummy parameter reveals that none of the STi values are statistically
signiﬁcant. This suggests that there are no signiﬁcant compound eﬀects occurring
between the parameters, in terms of inﬂuencing cell displacement. This supports the
majority of the ﬁndings revealed in latin hypercube analysis (Section 3.5.2), with the
exception of a small trend that occurs when two of the parameters are at extreme
values (chemokineExpressionThreshold and maxProbabilityOfAdhesion).
3.6 Examining Hematopoietic Cell Behaviour During the Fi-
nal Hour of Development
The analysis in the previous section suggests a key role for adhesion factor expres-
sion during hour 12, with chemokine expression having no appreciable eﬀect on cell
behaviour. This section repeats this analysis but for a simulation time period that
represents hour 72, the ﬁnal hour of PP development. The same techniques as used
above are applied, and the same parameters examined (as speciﬁed in Table 3.1). This
analysis has been performed to reveal if the conclusions drawn above hold for a later
time-point of development, or whether the inﬂuence of each simulated biological factor
changes over time.
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Parameter Si P-Value STi P-Value
stableBindProbability 0.125 0.048* 0.217 0.029*
chemokineExpressionThreshold 0.124 0.063 0.269 0.010*
initialChemokineExpressionValue 0.123 0.048* 0.268 0.009**
maxChemokineExpressionValue 0.118 0.027* 0.271 0.049*
adhesionFactorExpressionSlope 0.342 0.048* 0.551 0.012*
maxProbabilityOfAdhesion 0.163 0.009** 0.310 0.008**
dummy 0.007 0.057
(a) Cell Velocity Response
Parameter Si P-Value STi P-Value
stableBindProbability 0.148 0.022* 0.322 0.268
chemokineExpressionThreshold 0.122 0.061 0.313 0.288
initialChemokineExpressionValue 0.107 0.019* 0.331 0.246
maxChemokineExpressionValue 0.134 0.084 0.376 0.198
adhesionFactorExpressionSlope 0.039 0.212 0.362 0.197
maxProbabilityOfAdhesion 0.100 0.087 0.434 0.097
dummy 0.023 0.256
(b) Cell Displacement Response
Table 3.2: Median sensitivity indexes and measures of statistical signiﬁcance for each
parameter examined using the eFAST technique, for both simulation cell behaviour
responses during hour 12. Si: First-Order Sensitivity Index; STi: Total-Order Sensitivity
Index. Both are calculated for each re-sample curve and the median value taken. P-
Value calculated using two-sample t-test to the distributions comprised of the results
from each re-sample curve. * indicates statistical signiﬁcance at 0.05 level, ** indicates
statistical signiﬁcance at 0.01 level.
3.6.1 Robustness to Parameter Perturbation
Each parameter in Table 3.1 has been considered independently, and assigned a value
within its set range prior to the simulation run. To mitigate aleatory uncertainty, 500
runs were performed for each value assigned to the parameter. The analysis uses the
same one-a-time analysis technique (Read et al., 2012) included within the spartan
package as used to explore hour twelve of development in the previous section.
(i) Chemokine Related Parameters
Figures 3.6a and 3.6b show the eﬀect of adjusting the initial level of chemokine
expression upon LTo cell diﬀerentiation and the saturation limit of chemokine
diﬀusion respectively. The analysis indicates that the value which captures the
initial level of chemokine expression, through use of the sigmoidal curve function
as described in Figure 2.8, has no impact on either cell behaviour measure at this
time-point. However, a change in the maximum level of chemokine expression
has a signiﬁcant eﬀect on both cell behaviour measures. A small change in this
parameter value produces behaviour that is statistically signiﬁcantly diﬀerent, or
to use the terminology in the A-Test, a ’large’ diﬀerence (Vargha and Delaney,
2000). The calibrated value for this parameter is 0.04, and these results suggest
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that there is only a small window +/- this ﬁgure before there is a change in cell
behaviour that Vargha and Delaney classify as ’medium diﬀerence.’ Thus unlike
the twelve hour timepoint, the level of expression of chemoattractants, and thus
the distance over which this diﬀuses, is highly inﬂuential at this time-point.
An alteration in the probability that an LTi cell does not respond to chemokine
in the vicinity also signiﬁcantly eﬀects both cell behaviour measures. In terms
of displacement, a change in the probability of just 0.2 produces cell behaviour
that is signiﬁcantly diﬀerent to that observed ex vivo. The results suggest that
the range of values that this probability can take can only fall within the range of
0.2-0.4. Thus the simulation is suggesting in this case that there is only a small
possibility that an LTi cell may not respond to chemokine expression.
(ii) Cell Binding Probability Parameters
A stable bind between an LTo and LTi cell upregulates expression of chemokines
and adhesion factors through lymphotoxin signalling. At the twelve hour time-
point, the simulation was not sensitive to this parameter (bar the case where set
to its extreme value of zero), however this is not the case during the last hour
of development (Figure 3.6d). Similarly to the chemokine parameters above, cell
behaviour at this time-point is highly sensitive to the value of this parameter.
Again if the Vargha-Delaney ’medium diﬀerence’ ﬁgures were to be taken as a
guide, signiﬁcantly diﬀerent cell behaviour emerges outside a window +/-0.2 of the
parameters calibrated value, and further increases outside this window produce
signiﬁcantly diﬀerent cellular behaviour.
(iii) Adhesion Factor Related Parameters
Figure 3.6f reveals that an increase in adhesion factor expressed on stable con-
tact between an LTo and LTin/LTi cell has no signiﬁcant diﬀerence on either cell
velocity or displacement. The value can also be halved with no impact on cell
behaviour, however a reduction of more than half reduces the amount of adhe-
sion factor in the environment to a level at which cell behaviour is signiﬁcantly
diﬀerent.
3.6.2 Identifying Compound Eﬀects on Cell Behaviour at E17.5
Through Simultaneously Perturbing all Unknown Pa-
rameter Values
The same 500 simulation parameter value sets that were generated for analysis at hour
twelve were used in this analysis to ensure the two sets of results could be compared.
Five-hundred simulation runs were performed for each parameter set to mitigate the ef-
fect of aleatory uncertainty on cell behaviour results, a ﬁgure established from analyses
in section 3.3. Median cell velocity and displacement results were calculated for each
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run at the 72 hour time-point, generating a distribution of 500 median cell behaviour
responses, for which the medians were again calculated and considered representative
simulator behaviour under the conditions speciﬁed in that parameter set. Taking each
parameter in turn, simulation responses were ordered by the value assigned to that
parameter, easing the identiﬁcation of compound eﬀects on cell behaviour and thus
the identiﬁcation of parameters that highly inﬂuence cell behaviour in the ﬁnal hour
of development.
(i) Chemokine Related Parameters
The analysis reveals there is no correlation between the value assigned to the
initial level of chemokine expressed by an LTo cell upon diﬀerentiation and either
cell velocity or displacement responses (Figures 3.7a and 3.8a). An alteration
in the maximum level of chemokine expression (Figure 3.8b) does reveal a trend
between the value of this parameter and cell displacement, although the other
ﬁve parameters are also being perturbed simultaneously. This supports the re-
sult observed in one-a-time analysis, where a change in this parameter alone
signiﬁcantly aﬀected cell displacement (section 3.5.1). Interestingly, although a
signiﬁcant aﬀect on cell velocity was observed when this parameter was adjusted
independently, no correlation is revealed between this parameter and cell velocity
when all are adjusted simultaneously (Figure 3.7b). This suggests that, in terms
of inﬂuencing cell velocity, the aﬀect of this parameter is very dependent on the
value of others.
A similar conclusion can also be drawn for the parameter that captures the prob-
ability that an LTi cell will not respond to localised chemokine expression. An
independent alteration of this parameter signiﬁcantly aﬀects cell velocity (Figure
3.7c), yet no trend becomes apparent when the value is adjusted at the same
time as the other ﬁve under examination. For the cell displacement measure, a
trend is apparent close to the extreme upper value, where an LTi cell will never
respond to chemokine expression, yet this is not continued through the lower 90%
of the value range, again suggesting that the aﬀect this parameter has may be
dependent on others in the simulation.
(ii) Cell Binding Probability Parameters
When examining both cell behaviour measures at this time-point, no correlation
is found between either measure and the probability an LTo and hematopoietic
cell bind upon contact (Figures 3.7d and 3.8d). A similar conclusion is again
drawn as detailed in the chemokine parameter analysis above: an alteration in
the value of this parameter alone causes a signiﬁcant alteration in cell behaviour,
yet as no eﬀect is apparent when a subset of parameters are all being perturbed
simultaneously, this eﬀect must be dependent on the value of other parameters.
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(iii) Adhesion Factor Related Parameters
The results of this analysis for both cell behaviour measures closely match those
revealed by tracking cells during hour twelve of development (Hour 12: Figures
3.3 and 3.4, Hour 72: Figures 3.7 and 3.8). There is a very strong correlation
between cell response to adhesion factors and cell velocity at both time-points.
The analysis reveals that this is the only compound eﬀect on cell velocity at during
hour 72 of development, suggesting that response to adhesion factors is the key
factor in aﬀecting cell velocity. This is in contrast to adhesion factor expression,
where no correlation between parameter value and velocity is observed. In the
previous section, for hour 12, it was noted that an eﬀect becomes apparent for the
latter parameter, where there are no results in the bottom left-hand corner of the
graph (Figure 3.3f), and it was noted that this was expected due to the nature
of the time-point being observed. In this case, no such eﬀect is apparent, as a
larger number of stable contacts will have occurred, mediated by chemokine levels
that are greatly higher than that at twelve hours. Thus the level of expression
is deemed to not have a signiﬁcant eﬀect on cell velocity response, as no trend is
observed.
For the cell displacement response, a correlation is apparent between the maxi-
mum probability that a cell is retained in a forming patch and displacement in
the ﬁnal hour of development, with displacement decreasing steadily as the prob-
ability increases (Figure 3.7e). This trend becomes stronger close to the extreme
value, where a cell would constantly be retained within a forming patch. The
same eﬀect was apparent during hour twelve (Figure 3.4e). No correlation was
found between the level of adhesion factor expressed with each stable contact and
cell displacement (Figure 3.8f), again matching the result seen in analysis of hour
12.
3.6.3 Partitioning Variance in Simulation Responses Between
Parameters
The eFAST approach (Marino et al., 2008; Saltelli, 2004) has again been used to parti-
tion variance in simulation results to quantify the sensitivity of the simulation to each
parameter at hour 72, and thus suggest the impact each has on cell behaviour. Similarly
to the latin-hypercube analysis above, the same 500 parameter sets that were generated
for analysis at the twelve hour time-point were used here, to ensure that results being
compared have been generated from the same parameter conditions. For each set of
parameter values generated, 500 simulation runs were performed to mitigate aleatory
uncertainty in cell behaviour responses as established in section 3.3. Simulation re-
sponses were analysed using the Fourier frequency approach described in Section 2.4.4.
Plots are created for each simulation output response (velocity and displacement) for
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hour 72, detailing the median First-Order (Si) and Total-Order sensitivity indexes cal-
culated for each parameter of interest (Figures 3.9a and 3.9b). Sensitivity indexes and
measures of signiﬁcance in comparison to the dummy parameter are detailed in Table
3.3.
Cell Velocity
A statistical comparison of the variance caused by each parameter of interest with
that of the dummy reveals that one parameter is statistically signiﬁcant, the maximum
probability that a cell responds to adhesion factor expression. As can be noted from
Figure 3.9a and Table 3.3, the technique reveals that a perturbation in this probability
accounts for 81% of the total variance. This supports latin-hypercube sampling ﬁndings
presented above, where it was revealed that this was the only parameter where a
correlation in value and cell velocity became apparent.
Cell Displacement
Four of the six parameters are identiﬁed as accounting for a statistically signiﬁcant
amount of variance in comparison to that of the dummy. The probability that two
cells form a stable bind is a result that becomes apparent due to the eﬀect the lower
extreme value has in inhibiting LTo cell diﬀerentiation, and will thus be disregarded.
The analysis suggests that signiﬁcant variance in cell displacement is inﬂuenced by
the probability an LTi cell responds to chemokine expression and the maximum level
of chemokine that can be expressed by an LTo cell. This further supports the role
of chemokine expression and response during hour 72, a factor deemed to have little
inﬂuence during hour twelve. Also, the maximum probability an LTi cell is aﬀected
by adhesion factors is shown to have a signiﬁcant impact, accounting for 40% of the
variance when taken as the parameter of interest. Analyses for hour twelve in section
3.5 suggested adhesion to be the key biological factor at the twelve hour time-point, and
this result suggests this still has a signiﬁcant role in the later stages of development.
The total-order, or STi results, reveal that these three parameters also have signiﬁcant
interactions with their complementary set. This may suggest that cell displacement
may inﬂuenced by a combination of these factors working together, rather than one or
two that are highly inﬂuential.
3.7 Discussion
3.7.1 A Representative Simulation Result
It has recently been noted that in many cases where modelling and simulation is applied
in the exploration of biological systems, little attempt is made to show how representa-
tive that simulation is of the biological system it captures (Read et al., 2012), and this
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Parameter Si P-Value STi P-Value
stableBindProbability 0.071 0.059 0.150 0.119
chemokineExpressionThreshold 0.013 0.085 0.086 0.272
initialChemokineExpressionValue 0.003 0.569 0.051 0.486
maxChemokineExpressionValue 0.022 0.106 0.056 0.472
adhesionFactorExpressionSlope 0.012 0.173 0.047 0.546
maxProbabilityOfAdhesion 0.818 0.004* 0.896 0.001**
dummy 0.004 0.051
(a) Cell Velocity Response
Parameter Si P-Value STi P-Value
stableBindProbability 0.078 0.01* 0.255 0.019*
chemokineExpressionThreshold 0.099 0.020* 0.199 0.038*
initialChemokineExpressionValue 0.005 0.302 0.059 0.297
maxChemokineExpressionValue 0.308 0.042* 0.414 0.031*
adhesionFactorExpressionSlope 0.018 0.179 0.108 0.197
maxProbabilityOfAdhesion 0.397 0.038* 0.471 0.036*
dummy 0.023 0.256
(b) Cell Displacement Response
Table 3.3: Median sensitivity indexes and measures of statistical signiﬁcance for each
parameter examined using the eFAST technique, for both simulation cell behaviour
responses obtained during hour 72. Si: First-Order Sensitivity Index; STi: Total-Order
Sensitivity Index. Both are calculated for each re-sample curve and the median value
taken. P-Value calculated using two-sample t-test to the distributions comprised of the
results from each re-sample curve. * indicates statistical signiﬁcance at 0.05 level, **
indicates statistical signiﬁcance at 0.01 level.
was one of the motivations behind the development of spartan (Section 2.4). This chap-
ter utilises spartan to provide a level of conﬁdence in the simulator as a representative
tool and suggest the degree of conﬁdence in the values assigned to parameters. Pre-
senting these alongside statistical analyses that have aimed to provide some biological
insight reveals a full picture of simulation dynamics, aiding the drawing of conclusions
as to what a simulation result actually means in terms of the real system.
In Chapter 1 it was noted that the process of Peyer’s Patch development is highly
stochastic (Figure 1.2) and diﬀers signiﬁcantly from mouse to mouse. Simulating this
process does therefore involve capturing this biological uncertainty. However, as noted
in the introduction of this chapter, an agent-based simulation of the process adds
a further level of uncertainty that must be considered when simulation results are
scrutinised in terms of the biological system captured. The objective is to produce a
simulation where uncertainty caused by implementation is mitigated (Helton, 2008),
and that inherently within the biological system matched. Through the use of the
aleatory analysis technique developed by Read et al (2012), it has been shown that
500 simulation runs are necessary to meet this requirement, and thus this number of
runs has been performed for all experiments in this chapter. With the exception of
analyses presented here and studies of Experimental Autoimmune Encephalomyelitis
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(EAE) by Read et al (2012), the presentation of such an analysis is rare, although
this is important in judging the relationship between the simulator and the real world
system. The development of these techniques and tools should hopefully encourage
more simulation developers to consider presenting such results alongside the biological
insight they claim the simulation provides.
The remaining sections of this discussion examine how the tools developed in this
completion of this thesis have been used to provide some biological insight into the
development of secondary lymphoid organs in the gut.
3.7.2 Simulated Cell Behaviour at the Twelve Hour Time
Point is Highly Inﬂuenced by Adhesion Factor Expres-
sion
A minute-by-minute time-lapse analysis of cell behaviour during hour 12 of PP devel-
opment, explored using an ex vivo culture system, reveals that there is a statistically
signiﬁcant diﬀerence in behaviour of cells that are within 50µm of their respective lig-
and and those that are further away (Patel et al., 2012). The initial sections of this
chapter have sought to use the simulator as a tool to explain the biological factors that
could be causing this change in behaviour.
The data presented here have shown that a statistically signiﬁcant change in cell
velocity is observed when the parameters that model the expression of adhesion factors
are adjusted. This is apparent both when the value of adhesion factor expression is
adjusted independently of all other parameters (Figures 3.2e and 3.2f), and when the
values of all unknown parameters are adjusted simultaneously (Figure 3.3e). Analysis
using an eFAST approach (Marino et al., 2008; Saltelli et al., 2000) also infers that a
large percentage of variation in simulation output can be accounted for by a change
in cell response to adhesion factors. In contrast, a change in the expression level of
chemoattractant molecules by an LTo cell has no signiﬁcant eﬀect on cell velocity using
either analysis technique.
The robustness to a change in expression value suggests that, at this early stage of
development, chemoattractants have no role in aﬀecting cell velocity. In contrast, the
simulation is less robust to a change in adhesion factor expression, implying that these
factors have a key role in inﬂuencing cell behaviour at this phase of development, and
that there is a higher degree of uncertainty in the value of adhesion factor expression
as these directly inﬂuence simulation output.
Previously published observations have suggested that a blockage of VCAM-1 ex-
pression leads to a profound reduction in PP formation (Finke et al., 2002), with the
assumption made that the remaining patches that do form are mediated by ICAM-1
and MAdCAM expression. If this was the case, it would be safe to assume that no
PP would form in the absence of adhesion factors. With data here suggesting no role
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for chemokine expression in the early stages of PP development, this provides evidence
that there is a phase in development where adhesion expression is the major factor.
This suggested phase would commence when the process is triggered by RET+ LTin
cells interacting with RET ligand expressing LTo cells (Veiga-Fernandes et al., 2007).
Such a phase would have been very diﬃcult to determine in a laboratory. As
noted in Chapter 2, it has not yet been possible to quantify the expression of adhesion
factors VCAM, ICAM, and MAdCAM by an LTo cell. Instead the simulator has been
used as a tool to explore the eﬀect of changing adhesion factor expression, producing
the results that has led to this hypothesis. This shows the strength and potential of
simulation as an experimental tool. Future immunoﬂuorescence staining investigations
could potentially examine this hypothesis and detect adhesion expression levels in an
ex vivo culture system, to both conﬁrm or deny this hypothesis, while informing future
development of the tool.
3.7.3 A High Level of Chemoattractant Expression Would Be
Required to Inﬂuence Cell Displacement at the Twelve
Hour Time-Point
The data presented in this chapter suggests that a change in chemoattractant expres-
sion parameters has no signiﬁcant eﬀect on cell displacement during hour twelve unless
set to, or near to, the upper extreme value. This result becomes apparent when the val-
ues of all six unknown parameters (Section 3.4) are altered sequentially (Figure 3.4b),
suggesting the emergence of an eﬀect at and near to chemokine expression saturation.
If this extreme value eﬀect had not been elucidated, it would be reasonable to draw
the conclusion that chemoattractant expression has no signiﬁcant inﬂuence on cell
displacement at this time-point in development. As this is not the case, it is important
to consider what this result means in terms of the biological system that has been
captured.
As the process of calibration in section 2.2.6 has established values that produce
cellular behaviour statistically similar to that seen ex vivo, assigning the chemokine
parameters values at which this eﬀect becomes apparent represents the simulation of
an over-expression of chemoattractant factors. Although the expression of chemoat-
tractant factors has yet to be quantiﬁed experimentally, the setting of these parameters
to such extreme values can be deemed as not biologically plausible. This hypothesis
is based on the statistics that cells further than 50µm from a primordial patch behave
statistically diﬀerently, a statistical diﬀerence that would not be apparent if chemoat-
tractant expression was this high. One would also expect to see more cells within a
primordial patch if this was the case. However, this result suggests that an over ex-
pression of chemoattractant molecules at this early time point of development could
be inﬂuential, and is a result that would be very diﬃcult to establish biologically.
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3.7.4 Chemokine Expression and Response a Key Factor Dur-
ing Hour 72
The chemokine result at twelve hours is interesting as previously published studies
suggest a key role for chemokine expression in PP development (Cyster, 1999; Luther
et al., 2003; Ohl et al., 2003). For this reason, it made sense to examine the factors
aﬀecting cell behaviour during hour 72. Should the same result be repeated, this would
call into question whether the simulator correctly captures the emergent behaviour that
was speciﬁed in the domain model.
Performing the same analyses for the ﬁnal hour of development does reveal a key
role for chemokines in inﬂuencing cell displacement. An individual alteration in any of
the three parameters that capture chemokine expression and response has a signiﬁcant
impact on cell behaviour, suggesting that at this time-point, simulation behaviour is
no longer robust to a change in these parameter values. Statistical responses generated
through use of the eFAST technique (Marino et al., 2008; Saltelli et al., 2000) reveal that
the maximum level of chemokine expression and the probability an LTi cell responds
to chemokine expression are two of three parameters that account for a statistically
signiﬁcant proportion of variance in results. Analysis using a latin-hypercube approach
(Read et al., 2012) also suggests there is a clear trend between cell displacement and
the level of chemokine expressed by the LTo cell at this time-point. Considering the
results of all these analysis together concludes that chemokine expression is inﬂuenc-
ing simulated cell behaviour at this time-point, in agreement with published studies
(Cyster, 1999; Luther et al., 2003; Ohl et al., 2003). The contrast in results between
twelve and 72 hours suggests there could be a point in the 72 hour period where the
main biological factor that inﬂuences cell behaviour changes. The next section of the
discussion examines that hypothesis in more detail.
Results from both the eFAST and latin-hypercube analysis techniques suggest that
a change in adhesion factor response remains the key factor in aﬀecting cell velocity, as
found at the twelve-hour time-point. Statistical responses from the eFAST technique
suggest that a large proportion of variation in displacement can be accounted for by
a change in the value of the parameter that captures adhesion response, with this
parameter being the only one to have a statistically signiﬁcant contribution. This
suggests that adhesion factor response is key throughout the whole time-period rather
than just at 12 hours. The same parameter is also found to explain a signiﬁcant
proportion of the variance for the cell velocity response (being the third of the three that
were noted as signiﬁcant in the previous paragraph). Thus, in contrast to suggestions
in the previous paragraph, there may not be a phase where the biological factor that
aﬀects cell behaviour changes from adhesion to chemokine, rather a time-point where
chemokine expression becomes inﬂuential.
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3.7.5 The Potential for Phases of Development Between E14.5
and E17.5
This chapter set out to suggest the key biological factors inﬂuencing cell behaviour
during hours 12 and 72 of development, and examine whether conclusions drawn at
hour 12 diﬀered from hour 72. The simulation captures the period between phases one
and two of Adachi et al’s (1997) three phases of Peyer’s Patch development, the ﬁrst
being the appearance of VCAM-1+ stromal cells, and the second the identiﬁcation of
clusters of hematopoietic cells. Data presented here does show that the inﬂuence of
simulated biological factors does change between hour 12 and 72.
These data could be used to suggest further phases of PP development, occurring
after the appearance of VCAM-1+ stromal cells. The ﬁrst of these is a period where
hematopoietic (LTin/LTi) cell behaviour is inﬂuenced by adhesion factor expression.
Statistical analysis results show that this is the case at the twelve hour time-point.
This could be deemed a ’triggering’ phase, where LTo cell diﬀerentiation has occurred
through RET signalling (Veiga-Fernandes et al., 2007) and adhesion factor expression
is upregulated, aﬀecting the behaviour of cells around a forming PP. Use of the same
statistical techniques reveals that by the ﬁnal hour, chemokine expression and response
has become inﬂuential. This inﬂuences cell displacement, mediating recruitment of LTi
cells towards a forming patch (Cyster, 1999; Luther et al., 2003). Thus this could be
referred to as a ’clustering’ or ’aggregation’ phase, after which Adachi’s second phase
occurs: the visual identiﬁcation of hematopoietic cell clusters (Adachi et al., 1997).
The ex vivo studies produced cell behaviour results that informed the calibration of
the simulated cell behaviour at hour 12 (Patel et al., 2012). The resultant simulation
has now produced cell behaviour statistics that could be veriﬁed in further ex vivo
work that examines hour 72. This would verify whether cell behaviour during the ﬁnal
hour of development has been captured correctly, and thus go some way to supporting
the phases hypothesis generated above. Experimentation using the simulator can take
this further. It is much easier to examine cell behaviour at a number of time-points in
simulation than it would be in the laboratory. Performing the same analyses under-
taken in this chapter at a number of time-points in development would reveal where
the suggested ’triggering’ phase ends and the ’clustering’ phase starts, providing fur-
ther insight into each phase. Use of simulation as a time-lapse tool to perform such
investigations is examined in a later chapter of this thesis.
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Figure 3.1: Examining the eﬀect of aleatory uncertainty on the results of the simulation
for a variety of sample sizes. For each sample size, twenty runs are performed, with no
parameters changed each time. Diﬀerence between the distributions is determined using
the Vargha-Delaney A-Test (2000), with diﬀerence categorised by the limits set in Table
2.5. Using this technique, the number of runs necessary to produce a robust result can
be ascertained. As can be seen in Figure 3.1d, there is little reduction from 500 runs
onwards, making this a representative sample size to use
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Figure 3.2: Determining the robustness of simulated cell behaviour responses during
hour 12 of development. The six parameters for which a value is unknown were examined
in turn, and the value of each perturbed within a speciﬁed range. Simulation results
were compared to those generated during calibration, using the Vargha-Delaney A-Test,
to determine if a signiﬁcant change in cell behaviour has occurred
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Figure 3.3: Identifying any compound eﬀects on cell velocity at hour 12 through
latin-hypercube sampling, a technique that perturbs the value of all parameters simul-
taneously. Inﬂuential parameters can be identiﬁed through trends of points within each
plot and through the value of the Partial Rank Correlation Coeﬃcient speciﬁed in the
graph header, as described in section 2.4.3.
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Figure 3.4: Identifying any compound eﬀects on cell displacement at hour 12 through
latin-hypercube sampling, a technique that perturbs the value of all parameters simul-
taneously. Inﬂuential parameters can be identiﬁed through trends of points within each
plot and through the value of the Partial Rank Correlation Coeﬃcient speciﬁed in the
graph header, as described in section 2.4.3.
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(a) eFAST Sensitivity Indexes for Cell Velocity Response
(b) eFAST Sensitivity Indexes for Cell Displacement Response
Figure 3.5: Hour 12 sensitivity indexes for each parameter where a value is unknown,
calculated using the Extended Fourier Amplitude Sampling Test (eFAST). Black: the
fraction of model output variance accounted for by a variation in the value of that
parameter; Grey: remaining variance accounted for by higher-order interactions between
this parameter and its complementary set.
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Figure 3.6: Determining the robustness of simulated cell behaviour response at the
end of the development period. The six parameters for which a value is unknown were
examined in turn, and the value of each perturbed within a speciﬁed range. Simulation
results were compared to those generated during calibration, using the Vargha-Delaney
A-Test, to determine if a signiﬁcant change in cell behaviour has occurred.
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Figure 3.7: Identifying any compound eﬀects on cell velocity at hour 72 through
latin-hypercube sampling, a technique that perturbs the value of all parameters simul-
taneously. Inﬂuential parameters are identiﬁed by trends that emerge in the simulation
results, and through the Partial Rank Correlation Coeﬃcient speciﬁed in the graph
header.
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Figure 3.8: Identifying any compound eﬀects on cell displacement at hour 72 through
latin-hypercube sampling, a technique that perturbs the value of all parameters simul-
taneously. Inﬂuential parameters are identiﬁed by trends that emerge in the simulation
results, and through the Partial Rank Correlation Coeﬃcient speciﬁed in the graph
header.
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(a) eFAST Sensitivity Indexes for Cell Velocity Response
(b) eFAST Sensitivity Indexes for Cell Displacement Response
Figure 3.9: Hour 72 Sensitivity indexes for each parameter where a value is unknown,
calculated using the Extended Fourier Amplitude Sampling Test (eFAST). Black: the
fraction of model output variance accounted for by a variation in the value of that
parameter; Grey: remaining variance accounted for by higher-order interactions between
this parameter and its complementary set.
Chapter 4
Exploring Factors Aﬀecting Peyer’s
Patch Characteristics Through
Simulation
A combination of a number of previously published laboratory studies has led to the
formation of a basic model describing Peyer’s Patch development. However these
investigations have left a number of interesting questions that are diﬃcult to address.
Simulating the process makes it possible to perform in silico experimentation that can
attempt to address these open questions. In this chapter, the simulator is utilised as a
tool for replicating previously published explorations and performing novel explorations
that cannot be performed in a laboratory. Furthermore, the techniques in the spartan
statistical toolkit developed in the course of this study have been utilised to analyse
simulation results and attempt to quantify the role of each biological factor in
inﬂuencing Peyer’s Patch physical characteristics. The results of these explorations
may then inform future laboratory studies that attempt to further understand
lymphoid organogenesis.
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4.1 Introduction
The analyses performed in the previous chapter examined the ﬁrst of the emergent
behaviours identiﬁed in the domain model (Figure 2.1), the change in cell behaviour
in the location of PP genesis. This chapter examines the second, the formation of
aggregations of LTin and LTi cells in the vicinity of LTo cells by the end of hour 72
(E17.5), aggregations that mature from E18.5 into secondary lymphoid organs.
The calibration of the simulator and conclusions drawn from analyses in the previous
chapter are aided greatly by the availability of cell behaviour responses, obtained from
the ex vivo culture system explorations (Patel et al., 2012). Statistical techniques have
been used to ensure that there is no statistically signiﬁcant diﬀerence between cell
behaviour produced by the simulator and the measures observed ex vivo. However,
there is currently little biological data available that provides a quantiﬁcation of what
a ’patch’ is at this time-point of development, for example in terms of size or number
of cells in the aggregation. The existence of PP at this time-point has, to date, been
noted visually rather than through use of any statistical measure. What is known is
that the aggregations can form in 3D, protruding away from the mucosal epithelium
(Jung et al., 2010; van de Pavert and Mebius, 2010). This is in contrast to the simulator
developed in Chapter 2, where aggregations of LTin and LTi cells form on a 2D plane.
It could be suggested therefore that it would be diﬃcult to compare the result from the
simulator to any biological data that was available. However, the emergent behaviour
of interest here is the aggregation of cells, with the aim to understand how this is
aﬀected by other biological factors, rather than replicating the real characteristics of
a developing PP. Thus a 2D plane is a suitable abstraction. With this in mind, the
simulator produces three responses deemed to be patch characteristics: area of the
aggregation that is formed, the level of chemokine expressed, and the level of adhesion
factor expressed. The ﬁrst gives an indication of the ability of the patch to recruit LTi
cells through chemotaxis (Cyster, 1999; Luther et al., 2003), whereas the latter two
give an indication of the number of cellular interactions that have occurred, resulting
in the upregulation of adhesion and chemokine expression (van de Pavert and Mebius,
2010; Randall et al., 2008). Also, similar to the traditional method of identifying PP
at this development phase, the simulator produces a visual representation of the gut
tract, showing the location of any cell aggregations that are formed by hour 72. These
simulation responses and output snapshots can thus be used as a basis for analysing
aggregation development, to understand how this is aﬀected by each biological factor
captured in the simulation. Baseline behaviour, to which the simulation results under
diﬀering conditions is compared, has been set using the calibration methods detailed in
section 2.2.6. A comparison between the baseline and a simulation run under diﬀerent
parameter conditions can be used to suggest the factors inﬂuencing the number of
patches that form and the three patch characteristic responses noted previously.
The ﬁrst section of this chapter utilises the visual output to judge how successfully
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the simulator replicates previously published in vivo and in vitro experiments. The
key factors in the development of PP, detailed in section 1.3.2, have been established
using current laboratory techniques. The objective of the initial section of this chapter
is to ensure that the simulator produces results that match phenotypes in the rele-
vant publications that were observed through use of antibody staining of LTi and LTo
cells. These include replicating the gut of developing mice deﬁcient for certain genes
(Eberl et al., 2004; Luther et al., 2003; Veiga-Fernandes et al., 2007) and replicating an
over-expression of key factors (Meier et al., 2007). The results of these investigations
were taken into consideration when the domain model was constructed. Replicating
previously published results provides a further degree of conﬁdence that the simulator
correctly captures this domain model upon which it is based.
With this assured, the simulator can act as a tool through which novel in silico ex-
perimentation can be performed. Such investigations can help generate new hypotheses
on open questions that have yet to be explored (a range of which were discussed in
section 1.3.4), potentially feeding future laboratory investigation (Andrews et al., 2010;
Germain et al., 2011). This chapter details three such investigations. The ﬁrst of these
explores the role of the LTin cell population in PP development. It was noted in the
section 1.3.3 that the role of LTin cells has largely remained unknown, although the ex
vivo work by Patel et al (2012) has suggested a role in early stages of development. In-
vestigations in this chapter use the simulator to examine if patch characteristics change
when the LTin cell population is increased and decreased. This change is simulated
by changing the parameter that speciﬁes the number of LTin cells at E15.5, a ﬁgure
that has been estimated from ﬂow cytometry results gathered at this time-point. With
data from other time-points unavailable, a linear input rate has been implemented
where a certain number of cells migrate into the gut at each time-step, ensuring the
correct number of cells are present at the time-point representing E15.5. The second
investigation in this chapter uses the simulator to examine this input rate, changing
this from a straight line rate to an exponential and square root function that passes
through the same cell number point at E15.5, to determine if a change in the migra-
tion rate of LTin cells has an impact on PP characteristics. Performing these two in
silico investigations may provide further hypotheses on the role of LTin cells in PP
development. Additionally, the simulator has been used to investigate the geography
of PP development. In the current model, LTo cells can be expressed anywhere on
the gut surface, and a percentage of these express the ligand for RET, and have the
potential to form PP (Veiga-Fernandes et al., 2007). However, some studies suggest
that PP tend to form on the intestines antimesenteric border (Hoorweg and Cupedo,
2008; Randall et al., 2008), suggesting this is the area where LTo cells that have the
potential to form PP reside. In simulation terms, the anti-mesenteric border would
represent a small band across the length of the simulated gut. This has been simulated
by restricting RET ligand expressing LTo cell placement to a small band across the
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centre, then comparing the number of PP that are formed under this condition with
that of the current calibrated simulator.
Finally, the chapter returns to a theme examined in the previous chapter, the eﬀect
of parameters in the simulation for which a value is currently unknown (Table 3.1).
In the previous chapter, the spartan statistical toolkit developed during the course of
this study was used to examine how changes in the values of these parameters aﬀected
cell behaviour in the vicinity of a forming PP. This chapter uses the same techniques,
examines the same parameters, but this time examines the eﬀect a change in these
parameters has on the formation of cell aggregations that mature to become PP. In
section 2.2.6, it was detailed how a baseline behaviour for the formation of one patch has
been established using an experimental set up that restricted LTo cell placement such
that the simulator forms one patch, always in the same location. With this in place,
the six parameters for which a value is unknown are perturbed using the techniques
available in the spartan package, to examine how a change in these factors aﬀects
the three characteristics of that patch described earlier in this section (patch area,
level of chemokine expressed, and level of adhesion factors expressed). This statistical
investigation provides an overall picture of the role of each parameter in the producing
the two emergent behaviours observed.
4.2 Aims
The examinations in this chapter use the simulation platform as an experimental tool
to achieve the following aims:
1. To perform previously published experiments on the simulator and determine if
the same result is replicated.
2. To perform in silico experimentation that could provide novel insights into lym-
phoid tissue development.
3. To determine the key biological factors that inﬂuence the size and characteristics
of a primordial Peyer’s Patch.
4.3 Replicating Previously Published Experimental Results
The simulation has been run under the following conditions from the established liter-
ature: Figure 4.1a - Normal parameter setting (control wild type mice); Figure 4.1b -
RET deﬁciency (RET−/− mice, (Veiga-Fernandes et al., 2007)); Figure 4.1c - chemokine
knockout (CXCL13−/− , CCL19/21−/− mice, (Luther et al., 2003)); Figure 4.1d - no
LTin cells (ROR−/− mice, (Eberl et al., 2004)); Figure 4.1e - doubling number of LTi
cells (IL-7Tg mice, (Meier et al., 2007)).
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Consistent with established results, no PP are observed in either RET, chemokine
or LTi deﬁcient mice. In mice with increased numbers of LTi cells in the simulation,
more, larger PPs were observed to develop consistent with published results.
4.4 Novel in silico Experimentation
4.4.1 Producing a Representative Result that Minimises Aleatory
Uncertainty
As examinations in this chapter explore patch characteristic simulation responses and
not the same cell behaviour responses conducted previously, the aleatory analysis tech-
nique by Read et al (2012) described in section 2.4.1 has been repeated. To determine
the number of replicate runs required to reduce aleatory uncertainty in patch charac-
teristic measures, the same sample sizes were examined as previously (1, 5, 50, 100,
300, 500, 800). Figure 4.2 details the maximum A-Test response for each sample size
examined. This indicates that for analyses where the focus is on patch characteristics,
300 runs is suﬃcient to reduce the eﬀect of aleatory uncertainty, in contrast to the 500
required for cell behaviour measures. Thus 300 simulation runs were performed for
each investigation conducted using the simulator in this chapter.
4.4.2 Investigating the Impact of LTin Cell Number on PP
Formation
LTin cell numbers have been estimated using results from ﬂow cytometry experiments,
as explained in Chapter 2. The estimate of cell number at E15.5 has been used to
establish a cell migration rate, and thus is directly linked to the number of LTin cells
in the simulation. It has been suggested that this cell population has a role in the early
initiation of PP development (Patel et al., 2012; Veiga-Fernandes et al., 2007), with LTi
cells having the main role in cell aggregation (van de Pavert and Mebius, 2010; Randall
et al., 2008). As yet the eﬀect of a reduction or increase in LTin cell numbers on PP
formation has not been established. This section examines the use of the simulator to
suggest the eﬀect on PP formation when the cell population is decreased and increased.
To examine the eﬀect of a decrease in LTin cell numbers, simulations have been
run for gut surface area percentages of 0.05% to 0.45%, with an increment of 0.05.
From this percentage, the simulator calculates how many cells should be present at
the twenty-four hour time-point. For each value examined, 300 simulation runs were
performed to mitigate the eﬀect of aleatory uncertainty. Median values for patch area
and patch number were calculated for each of the 300 runs, producing a distribution
of 300 results for each LTin percentage value examined. Figure 4.3a is a plot of the
median calculated from the 300 median patch areas for each value, revealing a decrease
132
CHAPTER 4. EXPLORING FACTORS AFFECTING PEYER’S PATCH
CHARACTERISTICS THROUGH SIMULATION
in patch area at 72 hours as LTin cell number decreases. To gain a statistical measure
of the eﬀect the decrease has had, the distribution of 300 patch characteristic responses
was compared to a distribution generated from 300 runs of the simulator at baseline
values, using the Vargha-Delaney A-Test (Vargha and Delaney, 2000). A-Test scores
for each LTin percentage value have been plotted in Figure 4.3b. This reveals that the
percentage of area occupied by LTin cells at E15.5 can be reduced by 0.15% (0.20%)
before a change in response is observed that Vargha-Delaney classify as ’small’. In terms
of patch area, a reduction in cell number approaches the statistical eﬀect classiﬁed as
’medium’ when the percentage is reduced further than 0.20%, however never meets that
classiﬁcation. For patch number however, a trend emerges between the distribution of
number of patches formed and the number of LTin cells in the simulation, with the
diﬀerence between distributions becoming more statistically signiﬁcant as LTin cell
numbers decrease. Thus it could be concluded that LTin cell number could have a role
in controlling the number of PP that form.
To examine the eﬀect of an increase in LTin cell number, simulations have been
run that model a 2, 3, 4 and 5 fold increase in cell number. For each percentage
examined, 300 simulation runs have again been performed and the medians taken for
each patch characteristic for each run. The median patch area for each percentage
is plotted in Figure 4.3c. Patch area increases as cell number increases, however this
begins to stabilise after a 3 fold increase in LTin cell number. The distributions for
each patch characteristic response have again been compared using the Vargha-Delaney
A-Test (Vargha and Delaney, 2000) (Figure 4.3d). This reveals a statistically ’small’
diﬀerence by Vargha-Delaney’s criteria when the cell population is doubled, an eﬀect
that increases to ’medium’ for a 3 fold increase. However, the statistical diﬀerence
stabilises after this point, suggesting that a further increase in LTin cell numbers has
no eﬀect on the patch characteristics observed.
4.4.3 Investigating LTin Cell Migration Rate
It was noted in the previous section that ﬂow cytometry has been used to establish
an estimate of the number of LTin cells present in the gut at the 24 hour time-point.
In the current simulation, a linear input rate is used to create the number of LTin
cells at each time-point such that the required number are present at 24 hours, using
equation 2.3 speciﬁed in Figure 2.10. This is exempliﬁed by the red line on the plot
in Figure 4.4a. However, the assumption that cells migrate into the gut in such an
orderly manner is questionable. With no further biological data available, the simu-
lator has been used to examine the eﬀect on PP characteristics if this migration rate
was changed. Two alternative rates have been investigated that replace equation 2.3:
an exponential rate where cell migration is initially slow and increases rapidly (green
line in Figure 4.4a), and a square root function rate that models the opposite eﬀect
(Black line in Figure 4.4a). The replacement equations calculate the number of LTin
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cells that should be present at the current simulation time-step. The number of cells
currently within the simulation is subtracted from this to generate the input rate per
step. In these calculations, constants have been calculated to ensure that the function
creates the correct number of LTin cells at E15.5.
Square Root:
Required LTin Cells In This Time-Step = (27.8∗Number of Time-Steps Elapsed)0.5
(4.1)
Exponential:
Required LTin Cells In This Time-Step = 1.00368Number of Time-Steps Elapsed (4.2)
For each migration rate function, 300 simulation runs have been performed to mit-
igate any aleatory uncertainty in patch characteristic results. For each run, median
patch number and patch area at the 72 hour time-point have been calculated and
plotted in Figures 4.4b and 4.4c respectively. To gain a statistical measure of the im-
pact this change has had, the distribution of patch characteristic medians calculated
for the exponential and square root functions has been compared to results from the
calibrated simulation using the Vargha-Delaney A-Test (Vargha and Delaney, 2000).
Results from this comparison are noted above the respective bar within the plot.
Simulation responses reveal that a change in LTin migration rate to that of a square
root function has no statistically signiﬁcant eﬀect on the area of PP generated. An
eﬀect classiﬁed by the test as ’small’ is observed when contrasting number of patches
generated for the same migration rate function, with a square root input function
producing slightly fewer patches. When modelling cell input through use of an ex-
ponential function, larger statistical diﬀerences are observed for both patch area and
number, with the Vargha-Delaney test resulting in a ’medium’ diﬀerence for both patch
characteristics, and fewer and smaller PP. This could suggest that LTin cell migration
could potentially have a role in restricting the number and size of aggregations of cells
that form by hour 72.
4.4.4 Investigating the Geography of PP Formation
In the current model, LTo cells that have the potential to form PP can be placed at any
coordinate in the simulated tract. With some studies suggesting PP formation is lo-
calised to the anti-mesenteric border (Hoorweg and Cupedo, 2008; Randall et al., 2008),
LTo cell placement was restricted to a 15% band across the centre of the simulated gut,
a band which has been used to represent that region. This percentage represents a best
estimate as no biological measure was available. The calibrated simulation was run 300
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times for both a restriction of 15% and no restriction. Under position restriction, the
model predicts that few PP would develop in contrast to normal conditions (For 100%
of the gut length - 15% restriction: 3.8+/−0.75 patches; No restriction: 11.4+/−0.8
patches; Mann-Whitney test p=7x10−9).
The current calibrated simulator produces a representative number of patches when
only 0.25% of the available LTo cells are set to have the potential to form PP (revealed
in calibration in section 2.2.6). As the above result suggests that fewer patches are
formed when cell placement is restricted to the anti-mesenteric border, simulation runs
were performed to determine the number of patches produced if this percentage was
increased. Results from this analysis have been plotted in Figure 4.5, which details
number of patches along the whole intestine length rather than 10% as examined
previously. When considering the whole length, experimental results suggest 8-12 PP
are formed (Figure 1.2). The results in Figure 4.5 suggest that under a restricted
condition, a greater number of LTo cells could have the potential to form PP, with the
potential for this value to be near 2%.
At the current stage of biological understanding, it is not possible to conclude
which theory is correct, either that there is a large restriction on the LTo cells that
can potentially form patches, or there is a restriction in the geographic area where PP
formation can occur. However, the simulation has suggested that both methods do
form potential biological methods by which patch number is controlled.
4.5 Determining the Role of Simulation Parameters in Aggre-
gation Size and Formation
The analyses in the previous chapter explored the impact that uncertainty in the value
of six simulation parameters (Table 3.1) has on simulated cell behaviour during hour
twelve and seventy-two of development . The remaining part of this chapter explores
the impact that uncertainty in the value of these parameters has in the aggregation of
hematopoietic cells, or the formation of a PP.
This analysis has been conducted by ﬁxing one LTo cell at the centre of the simu-
lated intestine tract at the beginning of the simulation. This restriction is in place to
ensure that the analysis results reﬂect a change in parameter value, and are not a re-
ﬂection of any eﬀect caused by a change in location of the LTo cell. These experiments
can be recreated in the publicly available simulator by setting the relevant simulation
parameter controlling LTo cell positioning accordingly. Statistical methods within the
spartan toolkit compiled in the completion of this study have been used to perturb
the value of six parameters of interest and assess the impact on the cell aggregation
that forms. The statistical techniques examine three patch characteristics that are
output as simulation responses: the 2D area of the aggregation (calculated as detailed
in Section 2.2.5) and the ﬁnal expression levels of chemokine and adhesion factors.
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4.5.1 Parameter Robustness
One-a-time analysis (Read et al., 2012) was used to determine how sensitive the for-
mation of PP is to the value of the six parameters detailed in section 3.4. Each was
examined in turn, over the same values used in previous analyses and described in
Table 3.1. Three-hundred simulation runs were performed for each parameter value
to mitigate the eﬀect of aleatory uncertainty. The distribution of patch characteristics
obtained for that parameter value were then contrasted with a distribution of patch
characteristics obtained from the simulator at baseline values using the Vargha-Delaney
A-Test (Vargha and Delaney, 2000).
(i) Chemokine Related Parameters
Chemokine expression level is modelled by a use of a sigmoidal function as detailed
in Figure 2.8, where two constants are used to set the initial level of expression on
LTo cell diﬀerentiation and a maximum level of expression. An alteration in the
constant that captures initial level of chemoattractant expression (Figure 4.6a)
upon LTo cell diﬀerentiation has no signiﬁcant eﬀect on the size of the patch that
is formed or the level of adhesion factor expression at the end of the development
period. In contrast, an alteration in the initial chemokine expression level signiﬁ-
cantly eﬀects the level of chemoattractants expressed by the LTo cell at the end of
the 72 hour period. As the ﬁnal expression level is dependent on both this initial
level and cellular interactions that upregulate the expression of chemoattractants,
changing the curve, this result could suggest that the patch characteristics ob-
served in the baseline simulation occur through a restricted number of cellular
interactions. A restricted number of interactions could make it impossible to
recreate the baseline ﬁnal chemokine level, thus explaining why there is a signif-
icant diﬀerence if the initial value is changed. In terms of assessing the current
value assigned to this parameter, it becomes apparent that there is a large degree
of uncertainty in what this value should be.
When examining Figure 4.6b, it should be noted that one of the patch character-
istic cell responses, chemokine expression value at the end of the 72 hour period,
is directly aﬀected by a change in this parameter. For this reason, a trend is
revealed where there is a signiﬁcant diﬀerence in chemokine expression level at
the end of the development period for any value other than the calibrated base-
line. This suggests that for the baseline simulation, the maximum chemokine
expression level is always reached, through the increase in chemokine expression
brought about by stable cellular contacts. Thus if this threshold is changed, the
new threshold is also reached, and thus the A-Test reports a signiﬁcant change
in result. This would suggest that determining a value for the maximum level
of chemokine expression using the simulator would be diﬃcult. Unsurprisingly,
an increase in the maximum level of chemoattractant that can be expressed does
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cause an eﬀect on both patch area and adhesion factor expression that Vargha and
Delaney deem a ’medium eﬀect’. An increase in this parameter aﬀects LTi cells
over a greater distance from the LTo cell, thus promoting LTi cell chemotaxis and
more cellular contacts, further upregulating adhesion factor expression and thus
the number of cells retained in a forming patch. For this parameter, the whole
range has not been analysed, as this represents a constant that is used in the
sigmoidal curve calculation that captures the distance over which the chemokine
is diﬀused. It would be assumed that a further increase in this parameter, and
thus range of chemokine expression, would lead to a continuation of the trend
seen for both these output responses, and a signiﬁcant diﬀerence between the
baseline patch characteristics.
Figure 4.6c is the same analysis for the parameter that captures the probability
an LTi cell will not respond to chemokine level in its vicinity. An increase in this
probability thus has a signiﬁcant eﬀect on all patch characteristic measures, as
impairing LTi cell chemotaxis results in less cellular contacts and therefore less
upregulation of adhesion and chemoattractant factors.
(ii) Cell Binding Probability Parameters
Figure 4.6d details the aﬀect of changing the probability that a stable bind occurs
when an LTo is in contact with an LTin/LTi cell. Such stable binds promote
further upregulation of chemokines and adhesion factors. The results suggest
that an alteration in the value of this probability has no signiﬁcant eﬀect on the
formation of the PP. A signiﬁcant eﬀect is noticed when the parameter is assigned
a value of zero but, as noted in analyses in the previous chapter that examine this
parameter, this is an expected result, as a probability of zero would mean that a
stable bind never occurs, and thus the LTo will never diﬀerentiate and produce
the adhesion factors and chemokines required for PP formation.
(iii) Adhesion Factor Related Parameters
This analysis reveals that a change in adhesion factor expression by an LTo cell
(Figure 4.6e) or the maximum probability an LTin/LTi cell will remain in pro-
longed contact with an LTo cell (Figure 4.6f) has no eﬀect on any of the three
patch characteristic simulation responses. This suggests that other biological fac-
tors are key to the formation of the aggregation, as a reduced or over expression
still results in the same patch characteristics. This is in contrast to previous
analyses that reveal adhesion factors play a key role in simulated cell behaviour
(Section 3.7.2).
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4.5.2 Compound Eﬀects between Parameters
Using the latin-hypercube sampling approach described in section 2.4.3, 500 sets of
simulation parameter values were generated, with values for each of the six parameters
of interest (detailed in Section 3.4) chosen from within the ranges speciﬁed in Table
3.1 such that any potential correlations are negated. For each parameter set, 300
simulation runs were performed to mitigate the eﬀect of aleatory uncertainty. Each
run produces a set of output responses that describe the patch formed. Thus for each set
of parameters, a distribution of 300 patch characteristics is generated. For each patch
characteristic simulation measure, the median is taken of this distribution, and assigned
as the simulation result under the conditions set by that parameter set. Each of the
parameters was taken in turn and plots generated for each patch characteristic response,
detailing the median responses observed for all values assigned to that parameter. With
this resulting in eighteen separate plots, many of which reveal no compound eﬀect, only
a selection of these have been included in this thesis within Figure 4.7, but each result
is detailed in the section below.
(i) Chemokine Related Parameters
No correlation is apparent between the initial level of chemokine expression on
LTo cell diﬀerentiation and the resultant patch area (plot not shown). The same
conclusion can also be drawn for the chemokine and adhesion factor expression
level measures.
However a signiﬁcant trend does emerge when the parameter that captures max-
imum chemokine expression is adjusted (Figure 4.7a), supporting evidence in
one-a-time analysis that this is a key parameter in controlling patch area, and
further supporting concerns in the uncertainty of this parameter value. A small
trend is also apparent between this parameter and the level of adhesion factor
expression reached by the LTo cell (Figure 4.7b). As an increase in maximum
chemokine expression increases the distance over which LTi cell behaviour is af-
fected, more cells would be recruited and more stable cellular contacts should take
place, explaining the increase in adhesion factor expression. Finally, a large trend
was observed for the chemokine expression level patch characteristic response. As
a change in this parameter directly eﬀects this simulation response, as discussed
in one-a-time analysis (Section 4.5.1), this is an expected result of this analysis,
and can thus be discounted (plot not shown).
When ordering results by the probability that an LTi cell does not respond to
chemoattractant expression in its vicinity, a correlation between the parameter
value and patch area does become apparent (Figure 4.7c), and becomes stronger
as this probability is increased. When examining the eﬀect of perturbing this
parameter on adhesion factor expression (not shown), a similar eﬀect is observed,
with a correlation appearing at upper extreme values. As this probability aﬀects
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the recruitment of LTi cells towards an aggregating patch, this suggests the prob-
ability is an important factor in the size of the patch generated. The result also
suggests that as the correlation is stronger towards extreme values, there could
potentially be a large window of values beneath this extreme range that the true
value for this parameter could fall within. No correlation is apparent between the
value assigned to this parameter and the level of chemokine expression at the end
of the development period.
(ii) Cell Binding Probability Parameters
This analysis reveals no trend between the probability that a stable bind oc-
curs between an LTo and an LTin/LTi cell and the resultant patch area (not
shown). The same conclusion was also drawn for chemokine expression response
(not shown). When considering the level of adhesion factor expression, a small
trend is apparent for probabilities between 0 and 0.1 (Figure 4.7d). As noted
when this parameter was examined previously, this small trend can be explained
by the fact that setting this parameter to zero results in no cell binding and no
upregulation of the factors that cause patch aggregation, and thus such a small
trend is expected.
(iii) Adhesion Factor Related Parameters
Figures 4.7e and 4.7f support the conclusion drawn in one-a-time analysis above;
that the value of adhesion factor expression does not have a key role in the
formation of a PP. No trend becomes apparent for either parameter. This is also
the case for both the adhesion and chemokine expression responses (not shown).
4.5.3 Partitioning of Variance
The extended Fourier Amplitude Sampling Test (eFAST) (Marino et al., 2008; Saltelli
et al., 2000), detailed in section 2.4.4, has been used to determine the proportion of
variance in patch characteristic responses that can be explained by each of the pa-
rameters investigated. Five-hundred sets of parameter values were generated, with
each parameter being assigned a value within the ranges speciﬁed in Table 3.1. The
’dummy’ parameter used for statistical comparison was again set a value range of 1 to
10 and included in the sampling procedure. For each parameter value set, 300 runs
were performed to mitigate aleatory uncertainty that could aﬀect patch characteristic
results. Simulation responses are analysed using the Fourier Frequency approach de-
scribed in 2.4.4 (Marino et al., 2008; Saltelli, 2004), and plots produced detailing the
median First-Order (Si) and Total-Order (STi) sensitivity indexes for each parame-
ter. The sensitivity indexes and measures of signiﬁcance in comparison to the dummy
parameter are detailed in Table 4.1.
(i) Patch Area
4.5. DETERMINING THE ROLE OF SIMULATION PARAMETERS IN
AGGREGATION SIZE AND FORMATION 139
Contrasting the ﬁrst-order sensitivity indexes (Si) for each of the six parameters
with those of the dummy (Figure 4.8a) reveal that three parameters account for
a statistically signiﬁcant proportion of the variance (where p < 0.05 ) . Similar
to the previous analyses performed using this approach, one of these parame-
ters is the probability that a stable bind is formed on contact with an LTo and
hematopoietic (LTin/LTi) cell, a result that will become apparent due to the ef-
fect the lower extreme value has on both cell behaviour and patch formation. The
remaining parameters are chemokine related; the probability an LTi cell responds
to chemokine in the vicinity and the maximum level of chemokine expression.
This supports the trends observed in the latin-hypercube sampling analysis per-
formed previously, that the key pathway in patch size is the expression of and
response to chemokines.
When examining the total-order sensitivity indexes (STi) in Figure 4.8a, that
identify compound eﬀects between the parameter and its complementary set, the
probability that an LTi cell responds to chemokine is again revealed as being
signiﬁcant. This result suggests that the response to chemokine expression by an
LTi cell is key to the aggregation of patches, rather than the amount of adhesion
factor expression that is retaining these cells in the vicinity of the LTo.
(ii) Adhesion Factor Expression Level
This analysis technique determines that three of the six parameters examined ac-
count for a signiﬁcant proportion of variance in adhesion factor expression caused
by parameter perturbation (Figure 4.8b). Two are the same chemokine param-
eters that account for a signiﬁcant proportion in patch area as described above.
The third is an alteration in the expression level of adhesion factors on each sta-
ble contact. As this is directly linked to the response being measured (the ﬁnal
level of adhesion factor expression), this is a result that is to be expected. How-
ever the analysis has given further support to the identiﬁcation of the chemokine
expression and response pathway as the key reason for variance in simulation
results.
Signiﬁcant compound eﬀects (STi values) are revealed for four of the parame-
ters, the three that capture the chemokine expression and response pathway and
the expression level of adhesion factors. As noted above, one would expect a
change in the expression level of adhesion factors to inﬂuence the ﬁnal level of
adhesion factor expression within a forming patch, and thus it is no surprise this
is revealed as a parameter that strongly interacts with the complementary set.
Again chemokine expression and response parameters are revealed as key to vari-
ance in adhesion levels, although the values of all parameters are being perturbed
simultaneously.
(iii) Chemokine Expression Level
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An initial examination of the graph in Figure 4.8c reveals that a large percentage
of the variance in ﬁnal chemokine expression level can be explained by compound
eﬀects between each parameter and its complementary set (the STi measure).
In this case, as observed in the latin-hypercube analysis above, the ﬁnal level of
chemokine expression achieved is directly inﬂuenced by changing the value of the
maximum chemokine expression parameter. As this is the case, this analysis is
aﬀected by this link, and no further meaningful result has been produced. Thus
these results can be disregarded.
Parameter Si P-Value STi P-Value
stableBindProbability 0.043 0.049* 0.226 0.097
chemokineExpressionThreshold 0.278 0.003** 0.501 0.015*
initialChemokineExpressionValue 0.043 0.074 0.311 0.068
maxChemokineExpressionValue 0.422 0.033* 0.311 0.068
adhesionFactorExpressionSlope 0.031 0.133 0.246 0.142
maxProbabilityOfAdhesion 0.025 0.117 0.142 0.288
dummy 0.011 0.099
(a) Patch Area Response
Parameter Si P-Value STi P-Value
stableBindProbability 0.144 0.101 0.216 0.135
chemokineExpressionThreshold 0.403 0.002* 0.568 0.003**
initialChemokineExpressionValue 0.033 0.120 0.167 0.006**
maxChemokineExpressionValue 0.274 0.028* 0.441 0.018*
adhesionFactorExpressionSlope 0.025 0.001** 0.185 0.013*
maxProbabilityOfAdhesion 0.077 0.087 0.288 0.099
dummy 0.006 0.058
(b) Adhesion Factor Expression Level Response
Parameter Si P-Value STi P-Value
stableBindProbability 0.108 0.120 0.750 0.130
chemokineExpressionThreshold 0.105 0.088 0.762 0.088
initialChemokineExpressionValue 0.108 0.082 0.766 0.084
maxChemokineExpressionValue 0.336 0.070 0.906 0.048*
adhesionFactorExpressionSlope 0.096 0.247 0.667 0.266
maxProbabilityOfAdhesion 0.093 0.266 0.661 0.269
dummy 0.072 0.518
(c) Chemokine Expression Level Response
Table 4.1: Median sensitivity indexes and measures of statistical signiﬁcance for each
parameter examined using the eFAST technique, for all patch characteristic responses.
Si: First-Order Sensitivity Index; STi: Total-Order Sensitivity Index. Both are calcu-
lated for each re-sample curve and the median value taken. P-Value calculated using
two-sample t-test to the distributions comprised of the results from each re-sample curve.
* indicates statistical signiﬁcance at 0.05 level, ** indicates statistical signiﬁcance at 0.01
level.
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4.6 Discussion
4.6.1 Simulation as a tool for hypothesis generation
The pairing of computer simulation with current laboratory approaches is becoming
increasingly prevalent as it provides a means to perform investigations that either
cannot currently be performed by other means, or that can inform future laboratory
investigations (Andrews et al., 2008; Germain et al., 2011). Investigations that apply
this technique can be termed in silico experimentation. This approach has yet to be
utilised to explore secondary lymphoid organ development. However the simulation
platform developed as described in Chapter 2 makes such explorations possible.
Three novel in silico explorations have been detailed in this chapter. Although much
of the underlying detail of PP development is now well understood (van de Pavert
and Mebius, 2010; Randall et al., 2008; Veiga-Fernandes et al., 2007), there remain
interesting questions that have yet to be addressed. The variation in patch number,
size, and location between the diﬀerent intestine observations in Figure 1.2 for mice
and in studies by Cornes (1965) is one example. The three explorations conducted in
this chapter suggest hypotheses that could explain some of this variability, as well as
addressing further uncertainty surrounding the role of LTin cells (Patel et al., 2012).
Firstly the impact of changing the LTin cell population size was examined (Figure
4.3). Data presented here suggests that the number of PP that form by the end
of hour 72 is related to the number of LTin cells in the gut. A reduction in cell
number leads to a statistically signiﬁcant change in the number of patches, although
not a signiﬁcant reduction in patch area. The opposite eﬀect on patch number is
observed when the number of LTin cells is increased by 2 and 3 fold, however no
further increase in patch area or number occurs when LTin cell population is increased
by 4 and 5 times. Previous experimental work has shown that LTin cells express RET,
which binds to an LTo cell expressing ARTN, initiating LTo cell diﬀerentiation and the
process of PP formation (Patel et al., 2012; Veiga-Fernandes et al., 2007). Explorations
using the simulator suggest that not only do LTin cells trigger the process, they could
potentially control PP number. Small variations in LTin cell number between samples
may then explain the variation seen in Figure 1.2. However, the trend between patch
number and LTin cell number does not continue for a vast overexpression of LTin
cells. This is potentially explained by limited RET ligand availability, and thus a
continued overexpression has no impact, especially as LTin cells are not thought to
express receptors for chemoattractants and are rarely recruited into PP (Randall et al.,
2008). This is in contrast to an overexpression of LTi cells, which has been done
experimentally and does lead to a signiﬁcant diﬀerence in PP size (Meier et al., 2007).
Results that help form the above hypothesis are based on the assumption that
LTin cells migrate into the gut at a set rate that does not change through the course
of the simulation. Whereas ﬂow cytometry results have been used to estimate LTin
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cell count at E15.5, no further time-point data was available, explaining the need to
make this assumption. The second in silico exploration examined the eﬀect on PP
characteristics if LTin migration rate was not constant, but either high initially and
tails oﬀ (a square root function), or low initially and increases rapidly (an exponential
function). These input functions were both investigated and results presented in Figure
4.5. Input rate functions were generated such that each method of setting the rate led
to the creation of the number of cells estimated using ﬂow cytometry results at E15.5.
Changing the migration rate to a use a square root function had no signiﬁcant impact
on the number and area of patches observed (Figures 4.4b and 4.4c). However it
can be observed in the same ﬁgures that patch number and area did reduce if cell
migration is modelled using an exponential curve, where migration is initially slow
and rapidly increases. This could suggest that it is not only LTin cell number that is
controlling patch number, but the rate of LTin migration into the gut could also be
inﬂuential. Future laboratory investigations should test this hypothesis, by performing
ﬂow cytometry on guts taken from human-CD2-GFP transgenic mice at diﬀerent time-
points, through which estimations of cell counts can be made and used to set a realistic
LTin input curve. If this data was made available, the simulator could have a key role
in furthering the understanding of the role of LTin cells, providing more weight to the
hypotheses generated.
The ﬁnal in silico exploration performed in this chapter considered an alternative
method of controlling the number of PP that develop over the 72 hour period. The
current model makes the assumption that LTo cells that express RET ligand could
be present at any point on the gut surface. Flow cytometry results were used to es-
timate that 20% of the surface area of the gut contains cells that have the potential
to form PP, but simulation calibration results suggested that the correct number of
PP are formed if only 0.25% of this 20% express RET ligand (Section 2.2.6). How-
ever, it has been observed that PP tend to form opposite the mesentery, known as the
anti-mesenteric border (van de Pavert and Mebius, 2010; Randall et al., 2008). The
mesentery attaches the small intestine to the abdominal cavity, and contains vessels
through which hematopoietic cells migrate into the intestine (Eberl et al., 2004). One
theory concerning why PP form in this particular region could be that the expres-
sion of RET ligand is restricted to LTo cells opposite the mesentery. A restriction
was implemented such that only LTo cells placed within a set region could express
RET ligand. Unsurprisingly when run under these conditions, the number of patches
formed by the calibrated simulator fell sharply (Figure 4.5). With this result taken
into consideration, the simulator was used to investigate how much the percentage of
active LTo cells in the simulation could be increased with this restriction in place. A
representative number of patches (8-12 in the mouse, Figure 1.2) were observed when
increasing this percentage to 2%. The exploration does suggest RET ligand expression
restriction could be a further method by which patch formation is controlled. As RET
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is known to be a key initiator in the development process (Veiga-Fernandes et al., 2007)
this hypothesis could hold. However, there is still little biological evidence to suggest
that such a geographic restriction occurs, and some patches do form that are not on the
anti-mesenteric border. It is not known how plausible it is as to whether only 0.25%,
or indeed 2%, of the large number of LTo cells on the gut surface possess the ability to
form PP. If this is plausible, this itself could be the factor controlling PP number, and
it would be assumed that there is some unknown factor causing an early diﬀerentiation
of this selected set of LTo cells. If these percentages were implausible, this suggests
patch number is being controlled another way, potentially by the physical geometry of
the intestine or environmental changes as the gut develops. The simulator can produce
hypotheses but there is currently little geographic data on which these can be based
and thus supported.
4.6.2 Statistical Analysis Reveals Chemokine Expression Dom-
inant Factor in Patch Aggregation
It has previously been suggested that the process of PP development is chemokine
driven (Luther et al., 2003; Randall et al., 2008). This conclusion has been drawn
from studies of mice deﬁcient for genes encoding a particular function (Eberl et al.,
2004; Luther et al., 2003; Meier et al., 2007; Veiga-Fernandes et al., 2007). However
no study has yet been undertaken to quantify the eﬀect of changing the levels of
each biological factor involved in organogenesis. The statistical techniques compiled
within the spartan package have been utilised to reveal the key factors in causing cell
aggregation throughout the simulated time. This has been achieved by examining the
six biological factors for which a value remains unknown (Table 3.1), and exploring the
eﬀect on cell behaviour when the value of these parameters is perturbed.
Application of latin-hypercube (Read et al., 2012) and eFAST (Marino et al., 2008;
Saltelli et al., 2000) techniques provides an indication of the inﬂuence of a particular
factor. Analyses using these approaches has revealed a signiﬁcant role for chemokine
expression and response, suggested by Partial Rank Correlation Coeﬃcients calculated
from latin-hypercube simulation results (Figure 4.7) and by eFAST sensitivity indexes
(Table 4.1). Previous analyses in this thesis have suggested that adhesion factors have
a key role in inﬂuencing cell behaviour, however a change in the value of adhesion factor
expression has no impact on the three patch characteristics the simulation produces.
Thus the simulation agrees with the hypotheses in the literature, that the process is
chemokine dependent.
Previous studies by Meier et al (2007) examined the role of LTi cells in tissue de-
velopment using IL-7 transgenic mice. This revealed that an overexpression of IL-7
led to a larger number of LTi cells in the gut and larger Peyer’s Patches. In contrast,
mice deﬁcient for LTi cells do not have the ability to form PP (Sun, 2000; Yokota
et al., 1999). A number of studies have revealed that LTi cells express receptors for
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chemokines CXCL13, CCL19 and CCL21 expressed by the LTo cell (Luther et al.,
2003; Ohl et al., 2003). In the study in this thesis, an assumption was made in the
domain model that an LTi cell may not always respond to chemokine in its vicinity. In
the platform model, this is captured as a probability that the cell may not respond to
chemokine expression. Statistical analyses of a change in this probability reveals it is
inﬂuential in aﬀecting patch area and chemokine expression when perturbed individu-
ally (Figure 4.6c), and is an inﬂuential pathway in aﬀecting both these measures when
the six parameters of interest are being perturbed simultaneously (Figure 4.7c). This
suggests it is not suﬃcient to state that the process of PP development is dependent
on chemokine expression: the result is dependent on both the expression of and LTi
response to chemokines. During calibration, this probability was determined to be a
low value (0.3%), suggesting it is unlikely an LTi cell will not respond to chemokine
expression in the vicinity. It is unknown as to whether this is biologically plausible,
or whether the aﬃnity between the receptor and chemokine expressed needs to be
stronger. If this was the case, this would also imply that LTi cells have a role in
controlling Peyer’s Patch size, through limiting response to environmental factors.
4.6.3 An Interaction Focused Rather Than Reductionist Ap-
proach
The use of simulation to study cellular interactions shifts the focus from an examination
of each individual component part to that of the higher order behaviour and how this
emerges from components that lack the capability to create this phenomena alone
(Germain et al., 2011). A large number of published studies exist that examine the
role of particular biological components involved in PP development (Eberl et al., 2004;
Luther et al., 2003; Meier et al., 2007; Veiga-Fernandes et al., 2007). However, the patch
characteristic analyses in this chapter provides good examples of why taking such a
reductionist approach does not reveal the full picture concerning the system dynamics.
This section discusses one such example.
One-a-time analysis was performed for each parameter using the technique de-
scribed by Read et al (2012), and revealed that a signiﬁcant change in the level of
chemokine expression reached by the LTo cell when the initial level of expression on
cell diﬀerentiation was altered (Figure 4.6a). In some respects this mimics a reduc-
tionist approach that considers the eﬀect of each component individually, and draws
conclusions concerning how the component aﬀects system dynamics just from this
examination. Thus in this example, it would be assumed that the initial level of
chemokine expression is an important factor. However, perturbing the value of initial
chemokine expression level with the other ﬁve parameters being examined simultane-
ously, using both latin-hypercube sampling (Read et al., 2012) and eFAST techniques
(Marino et al., 2008; Saltelli et al., 2000) reveals no trend in simulation response. The
parameter may be inﬂuential when examined on its own, but this inﬂuence is largely
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dependent on the value assigned to other parameters in the model.
It is examples like this that highlight reasons for integrating modelling, simulation
and statistical analysis techniques with current laboratory techniques. The quantitative
analyses that have been performed on six simulated biological components in this and
the previous chapter cannot be performed in a lab, and have the potential to oﬀer
biological insight that cannot be revealed in other methods (Germain et al., 2011).
The development of structured methods in the creation of models and simulations,
such as that of the CoSMoS process (Andrews et al., 2010), and the availability of
statistical toolkits such as spartan, is making it possible to generate models where
although some detail is abstracted from system dynamics, the level of conﬁdence in
the simulator as a representative tool can be established (Andrews et al., 2008; Polack
et al., 2010; Read et al., 2012). Establishing a level of conﬁdence is vital if meaningful
results are to be produced that shift the ﬁeld towards utilising an interaction based
approach.
4.6.4 A Simulation Approach Can Have Limitations
This discussion has raised the prospect of studies being conducted where a robust
model and simulation is produced, statistical analyses used that establish the conﬁ-
dence in results generated, and in silico experimentation performed to reveal additional
biological insight. Previous sections of this discussion detail areas of the biological un-
derstanding where taking this approach in examining PP development has produced
some hypotheses that could address some unanswered questions concerning system dy-
namics. However, it must be noted that this should not be considered the end of the
process, and explorations using simulation can raise additional questions.
Previously published studies have detailed a role for chemokine expression and
response in the development of PP (Ansel et al., 2000; Luther et al., 2003). This
chapter has taken this forward and provided a quantitative examination of the eﬀect
of changing chemokine expression levels, a feature that has been determined to be a
key pathway in the simulation. However it has been diﬃcult to set an exact value for
the maximum level of chemokine expression by an LTo cell, and there is a large degree
of uncertainty in the value of this parameter. It has been demonstrated that a change
in the maximum level of expression always changes the level of chemokine expressed
reached by the LTo cell, suggesting this threshold is always met (Figure 4.6b).
This does not detract from the identiﬁcation of this as a key pathway, more em-
phasises the fact that simulation can provide some key insight, but does have some
limitations. In this case, it has not proved possible to reveal the maximum level of
chemokine expressed by an LTo. However this could be achieved with more biological
information, which could come in one of three forms. The ﬁrst is a quantitative study
of chemokine expression at diﬀerent time-points in development, although this is very
diﬃcult to achieve in the lab. This data could then inform the setting of the constants
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controlling the sigmoid curve that models chemokine expression. Secondly, and much
more tractable, is a study of LTi cell behaviour at diﬀerent time-points in development.
This could be done in a similar way to the ex vivo work produced by Patel et al (2012),
and cells tracked in an explant culture system during a variety of hours of development.
Changes in LTi cell behaviour over time, and at certain distances from an LTo cell,
would provide a means of calculating how chemokines are diﬀused over time, and thus
the simulator could be recalibrated based on cell behaviour. Finally, reevaluating the
measures that deﬁne a patch could also be beneﬁcial. If it was possible to determine
the number of LTi cells within an aggregation at certain time-points, chemokine ex-
pression could be modelled in such a way that aims to recruit LTi cells in such a way
that recreates that dynamic.
The approach to simulation construction in this thesis has followed the framework
in the CoSMoS process (Andrews et al., 2010), which deﬁnes the generation of a series
of models, from which a simulation is implemented. One of the key points in this
framework is that the process has no end point: results from simulation may then
feed further work in developing the model, either by examining the abstractions and
assumptions that were made or through performing work in the lab that then feeds a
further iteration of the model. In some respects, work in this thesis is the end of one
iteration. Experiments have been suggested that could improve the model, and if these
were completed, the process would then begin again, and potentially the limitation
identiﬁed above could be addressed.
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(a) Control: Wild-Type Mice (Simulation
under baseline conditions)
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(b) RET Deﬁcient Mice (Veiga-Fernandes
et al., 2007)
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(c) Chemokine deﬁcient mice (Luther et al.,
2003)
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(d) RORγ deﬁcient mice (Eberl et al., 2004)
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(e) IL-7Tg mice (Meier et al., 2007)
Figure 4.1: Use of the simulator to reproduce previously published results. Graph
represents 10% of the foetal intestine length. Circles represent the locations of LTin and
LTi cells. This ﬁgure has been adapted from that included within Alden et al (2012b)
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Figure 4.2: Examining the eﬀect of aleatory uncertainty on the results of the simulation
for a variety of sample sizes. This summarises the maximum A test score for patch
characteristic measures when the sample size is varied. Where the maximum score was
less than 0.5, the corresponding value above 0.5 has been assigned. This has been done
as the magnitude of the eﬀect is of more interest than the direction. For each sample
size, twenty runs are performed, with no parameters changed each time. Using this
technique, the number of runs necessary to produce a robust result can be ascertained.
In this case, there is little reduction from 300 runs or greater.
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Figure 4.3: Use of the simulator to investigate the impact of LTin cell number to
simulation result. Top: investigating a decrease in LTin cell number; Bottom: investi-
gating a 2,3,4, and 5 fold increase in the number of LTin cells. Simulations were run
300 times for each LTin cell parameter value and medians taken for both Patch Area
and Patch Number. The left column contains a boxplot of the patch area for each value
the parameter has been assigned. The right column contains the result of a comparison
between patch characteristics observed at baseline values and those observed when the
parameter is perturbed, using the Vargha-Delaney Test (Vargha and Delaney, 2000).
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(c) A comparison of median number of PP
at hour 72 for three LTin cell migration rate
functions
Figure 4.4: Investigating LTin cell migration rate by changing the input rate function
within the simulator. (a): Flow cytometry data has been used to estimate the number of
LTin cells present in the simulator at E15.5 (blue line). With cell counts at other time-
points unavailable, the simulator assumes a linear input rate, that meets the number
of LTin cells observed at E15.5, and continues at the same trajectory until E17.5 (red
line). However this may not be the case. To investigate the eﬀect that cell input
rate has on results, two alternative input rates have been investigated, an exponential
(green line) and square root (black line) function. These three lines converge at E15.5,
matching the number of cells observed by ﬂow cytometry. Three hundred simulation
runs have been performed for each input rate function and median patch characteristics
calculated. (b): A comparison of the median patch area observed for each input rate
function. (c): A comparison of the median number of patches for each function. Results
for the exponential and square root functions have been contrasted to the linear input
rate using the Vargha-Delaney A-Test (Vargha and Delaney, 2000), the result of which
is noted on the plot. Error bars are s.e.m.
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Figure 4.5: An investigation into how geographic restriction of RET ligand expression
aﬀects PP formation. Simulations were run with active RET ligand expressing LTo cell
position restricted to a 15% band across the centre of the tract, and the number of
patches formed compared with the case where there is no restriction. The percentage
of LTo cells capable of forming PP was also investigated for both conditions. 300 runs
performed for each condition. Black: 15% position band restriction; Grey: no restriction.
Error bar: s.e.m.
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Figure 4.6: Determining the robustness of patch characteristic responses at the early
time-point in development. The six parameters for which a value is unknown were
examined in turn, and the value of each perturbed within a speciﬁed range. Simulation
results were compared to those generated during calibration, using the Vargha-Delaney
A-Test, to determine if a signiﬁcant change in cell behaviour has occurred
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Figure 4.7: Identifying any compound eﬀects on patch characteristics through latin-
hypercube sampling, a technique that perturbs the value of all parameters simultane-
ously. Inﬂuential parameters are identiﬁed by trends that emerge in simulation results,
and through Partial Rank Correlation Coeﬃcients speciﬁed in the graph header.
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(a) Initial level of chemoattractant expression at LTo diﬀerenti-
ation
(b) Saturation limit of chemoattractant expression
(c) Chemokine Level at which LTi chemotaxis occurs
Figure 4.8: Using the Extended Fourier Amplitude Sampling Test (eFAST) to explore
the inﬂuence each parameter for which a value is unknown has on PP formation. Black:
the fraction of model output variance accounted for by a variation in the value of that
parameter (Si); Grey: remaining variance accounted for by higher-order interactions
between this parameter and its complementary set (STi).
Chapter 5
Time-Lapse Analysis through
Simulation
Data presented in this thesis suggests that Peyer’s Patch development may be
biphasic, the ﬁrst phase mediated by adhesion factor expression and the second by
chemokine expression and response. This hypothesis is drawn from a statistical
analysis of simulated cell behaviour during two distinct time-points, hour 12 and hour
72. This chapter demonstrates a novel use of simulation and statistical techniques to
perform a time-lapse analysis of cell behaviour, to suggest the point in the
development period where a change in phase occurs.
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5.1 Introduction
The analyses in the previous chapters of this thesis have utilised statistical tools to
suggest which biological parameters are inﬂuencing cell behaviour during hour twelve
and seventy-two of development. It has been determined that, in simulation, adhesion
factors are inﬂuential in causing the emergent cellular behaviour observed at the twelve
hour timepoint, and that chemoattractant factor expression has no role in inﬂuencing
cell behaviour. However, performing the same analyses for cell behaviour during hour
72 of development reveal that chemoattractant expression is inﬂuential at the end of
the process, as suggested in the literature (Adachi et al., 1997; Eberl et al., 2004). This
could suggest the existence of two distinct phases of Peyer’s Patch development within
the 72 hour period; the ﬁrst mediated by adhesion and the latter mediated by chemoat-
tractant expression, and raises the important question of when a biological factor such
as an adhesion factor or chemokine becomes inﬂuential in tissue development.
Current confocal microscopy techniques allow for the behaviour of cells to be tracked
over a set time period, a technique utilised to generate the cell behaviour results on
which this simulator was calibrated (Patel et al., 2012). Although such time-lapse
analysis has proven useful in examining cell behaviour and how this changes, it does
not further the understanding of the role each biological factor has in the behaviour
that is observed. Although it is possible to use the technique to examine cell behaviour
under diﬀerent conditions, for example within an ex vivo culture system, such an
experimental set up can be time consuming and expensive, especially when examining
the system under a number of conditions.
Although the integration of computer simulation with current experimental results
is becoming a popular approach in furthering the understanding of biological systems,
the application of simulation as a tool to perform time-lapse experimentation has been
limited. The only example of such an application to date is in studies of granuloma
performance for controlling Mycobacterium tuberculosis infection (Ray et al., 2009),
where agents within the system have been tracked constantly through the simulation
time period and sensitivity analysis techniques used to examine behaviour at regular
time intervals. Utilising such an approach has the potential to not only suggest the
biological factors that are highly inﬂuential, but suggest the time-points where sys-
tem dynamics are inﬂuenced by particular parameters, potentially revealing that the
behaviour that emerges through these system dynamics occurs in distinct phases.
This chapter examines the use of computer simulation as a tool to perform a time-
lapse analysis of cell behaviour responses in PP development. The simulator has been
conﬁgured such that cell behaviour responses are recorded at twelve hour intervals, thus
it is possible to examine changes in cell behaviour over time. This can be achieved us-
ing the same sensitivity analysis techniques that were utilised in the previous chapters
and included within the spartan package. Firstly, simulation robustness to parame-
ter perturbation is examined using the one-at-a-time technique (Read et al., 2012).
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Each of a set of parameters of interest is examined in turn, and its value perturbed
individually within a set range. This technique has been used in previous chapters to
determine the eﬀect that this parameter value change has on cell behaviour. A time-
lapse analysis will reveal if and when such a parameter change becomes inﬂuential.
Secondly, the latin-hypercube sampling (Read et al., 2012; Saltelli et al., 2000) and
eFAST global sensitivity analysis techniques (Marino et al., 2008; Saltelli, 2004) have
been used to perturb the values of a subset of parameters simultaneously and exam-
ine any compound eﬀects that become apparent. Both of these techniques produce a
statistical measure that determines how inﬂuential a particular parameter is, a Partial
Rank Correlation Coeﬃcient for latin-hypercube and a First-Order Sensitivity Index
for eFAST. Examining how these statistical values change over time gives an indication
of the time-points where each parameter becomes inﬂuential.
This chapter concludes by examining a set of cell responses that have yet to be con-
sidered within this thesis. All analyses to date have considered responses of simulated
cells that are near to a forming patch, as these behave statistically diﬀerently to those
that are further away. This statistical diﬀerence was observed at twelve hours, and cell
behaviour calibrated accordingly. The calibrated simulator has been run for the full
seventy-two hour period and behaviour of cells away from a forming patch captured at
twelve hour intervals and compared with behaviour at twelve hours observed ex vivo .
This indicates the time-point when the interactions of cells within a forming patch af-
fect the behaviour of cells further away, through the upregulation of chemoattractants
expressed on interactions with LTo cells.
5.2 Aims
Explorations in this chapter utilise the simulator and statistical tools within the spartan
toolkit to perform a time-lapse analysis that addresses the following aims:
1. Determine whether there are set time-points in development where a biological
factor becomes inﬂuential, by examining changes in cellular behaviour over time.
2. Determine if and when the behaviour of cells over a distance of 50µm is aﬀected
by cellular interactions within a primordial patch
5.3 Parameter Value Robustness over Simulation Time
Sections 3.5.1 and 3.6.1 examine how robust simulation behaviour is to a perturba-
tion in the value of each parameter detailed in Table 3.1, with analyses focusing on
hours twelve and seventy-two of development respectively. This reveals the impact that
each parameter has individually on cellular behaviour, while also further supporting
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the identiﬁcation of parameters for which there is a high level of uncertainty in their
true value. In this section the same analysis is performed, but for twelve hour intervals
throughout the seventy-two hour run. Each parameter was perturbed individually, and
assigned a value within the range set in Table 3.1. For each value the parameter was
assigned, 500 simulation runs were performed to mitigate the eﬀect of aleatory uncer-
tainty. Medians of the cell velocity and displacement responses were then compiled
for the 500 runs, creating a result distribution where the simulation was run under
that criteria. This was contrasted to a distribution generated from 500 runs of the
simulation at calibrated values using the Vargha-Delaney A-Test.
(i) Chemoattractant Related Parameters
A change in the initial level of chemokine expression on LTo cell diﬀerentiation
has previously been seen to have no eﬀect on cell behaviour at either hour twelve
and seventy-two of development. It is thus of little surprise that performing the
same analysis at twelve hour intervals reveals the same result. This could suggest
that there is an large degree of uncertainty in the actual value of this parameter.
In contrast, previous analyses revealed that although changing the maximum
level of chemokine adhesion had no impact on cell behaviour at twelve hours
(Figure 3.3b), there was a signiﬁcant eﬀect observed on cell behaviour during
hour seventy-two (Figure 4.6b). Performing the same analysis for data captured
at twelve hour intervals reveals that a perturbation in parameter value causes a
signiﬁcant alteration in cell behaviour from hour 36 onwards, with a large dif-
ference between both cell displacement and velocity responses between hour 24
and hour 36 (Figures 5.1b and 5.2b). The same eﬀect is seen for the parameter
that captures LTi response to chemokine (Figures 5.1c and 5.2c). As this param-
eter is perturbed individually, the analysis reveals that there is a large degree of
uncertainty in the true value of chemokine expression and response parameters,
and this has to be taken into account when understanding cell behaviour after 36
hours.
(ii) Cell Binding Probability Parameters
It has been discussed in previous analyses that cell binding probability is a diﬃcult
parameter to assess due to the eﬀect observed when assigned a value of zero: no
LTo cell diﬀerentiation and thus no chemokine and adhesion factor expression.
A signiﬁcant diﬀerence in cell behaviour would therefore be expected where this
parameter is zero, and this is observed for all time-points examined (Figures 5.1d
and 5.2d). Other than this eﬀect, the same observation is made as that drawn with
the chemokine parameters above, that increasing just the value of this parameter
has a signiﬁcant eﬀect on cell behaviour after the 36 hour time-point. Increasing
this probability alone should lead to more stable contacts between hematopoietic
cells and LTo cells, thus an increase in chemokine and adhesion factor expression,
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inﬂuencing the behaviour of cells close to a patch. This further supports a growing
conclusion that chemokine expression and response is important after the 36 hour
time-point, and uncertainty in parameter values that are related to this pathway
are an important consideration in analysing behaviour from that point onwards.
(iii) Adhesion Factor Related Parameters
One-a time analysis in Chapter 3 suggests that LTin/LTi cell response to adhesion
factors has a key role in inﬂuencing cell velocity at the twelve hour time point.
An examination of the robustness of simulation behaviour to this parameter over
time reveals that this eﬀect increases as simulation time elapses (Figure 5.1e),
suggesting a strong relationship between the value of this parameter and cell
velocity. For displacement, previous analysis revealed that a perturbation in
parameter value had no eﬀect on cell displacement during hour twelve, and thus
there was a larger degree of uncertainty in the true value of this parameter.
However a time-lapse analysis reveals a perturbation in expression would have a
signiﬁcant eﬀect from hour 36 onwards (Figure 5.2e). It can be suggested that
this aﬀect becomes apparent due to the inﬂuence of chemoattractants later in the
process. It has been revealed in previous analyses that chemoattractants have no
role early on in development, but do become inﬂuential throughout the process.
As this happens, more cells will be brought towards a forming patch, resulting
in more contacts and a further upregulation of chemoattractants and adhesion
factors. As the level of adhesion factors expressed increases, the probability an
individual cell responds to this expression increases until the threshold set by this
parameter is hit. From 36 hours onwards, a larger number of cellular contacts
will have occurred, resulting in a high level of adhesion factor expression. Thus a
change in this parameter has a direct impact on cell displacement when adhesion
factor expression is high.
In contrast, for the parameter that captures expression level of adhesion fac-
tors with each stable contact, no signiﬁcant change in cell behaviour is observed
throughout the simulation time period for each parameter value studied (Fig-
ures 5.1f and 5.2f). As noted in previous discussions concerning this parameter,
a small eﬀect is seen for a low level of adhesion factor expression, yet a large
increase after that point yields no diﬀerence, suggesting that too low a level of
adhesion is inﬂuential, yet an overexpression has no signiﬁcant eﬀect.
5.4 Identifying the time-point at which a parameter becomes
inﬂuential
Analyses in Chapter 3 used two global sensitivity analysis techniques (latin-hypercube
sampling and eFAST (Read et al., 2012; Saltelli et al., 2000)) to identify parameters
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that have a highly inﬂuential eﬀect on simulated cell behaviour, thus suggesting the
key biological pathways in the development process. Here, these two analyses have
been performed for cell responses captured at twelve hour intervals for each of the
runs described in Chapter 3, making it possible to determine if and when statistical
measures generated by the technique change over time.
5.4.1 Parameter Value Sampling using Latin-Hypercube Ap-
proach
Time-lapse results have been generated using the same 500 parameter value sets that
were created using a latin-hypercube approach (detailed in Figure 2.20) to examine
behaviour at hours twelve and seventy-two (sections 3.5.2 and 3.6.2). For each value
set the simulation was run 500 times to mitigate the eﬀect of aleatory uncertainty,
and behaviour measures for cells within 50µm of a forming PP captured at twelve
hour intervals. For each time-point in each run, the median of each cell behaviour
response was calculated, producing a distribution of 500 medians for each response. The
median was again taken for this distribution, producing cell behaviour responses that
summarise the behaviour of the simulation under a particular parameter value set at a
particular time-point. Taking each parameter in turn, and each time-point, a Partial
Rank Correlation Coeﬃcient (PRCC) was generated that gives a statistical measure of
any compound eﬀects between the parameter being examined and simulation result at
that time-point. For each parameter, the PRCC values calculated for each time-point
were plotted, making it easier to visualise changes in PRCC value over time, and thus
any emergence in compound eﬀects between parameters over simulation time (Figure
5.3).
For the cell velocity response, no increase in correlation value appears over simula-
tion time for the parameters that capture the initial and maximum levels of chemokine
expression by an LTo cell (Figures 5.3a and 5.3b). The same conclusion can be
drawn for the parameter that captures the probability an LTi cell does not respond to
chemokine expression in its locality (Figure 5.3c). This supports previous conclusions
put forward in this thesis that chemokine expression has no signiﬁcant eﬀect on cell
velocity. When considering Figure 5.3d, the probability two cells form a stable bind
upon contact, it can be noted that the PRCC values are higher than those for the
chemokine parameters, but no trend in correlation value over time is observed. The
higher PRCC values are expected due to the eﬀect that setting this parameter to its
extreme value of zero has on simulation response (that LTo cells cannot diﬀerentiate
and express adhesion factors and chemokines). Thus this eﬀect has been discounted
throughout this study. In contrast, there is a strong correlation between the value
assigned to the parameter that captures the probability that an LTin or LTi cell is
retained by adhesion factor expression and cell velocity, and this remains the case for
each time-point, suggesting this is the key factor in inﬂuencing cell velocity (Figure
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5.3e). Any correlation between the level of adhesion factor expressed with each stable
cellular contact and cell velocity does decrease between 12 and 36 hours (Figure 5.3f),
potentially suggesting that adhesion factor expression is inﬂuential in early stages of
development but not through the whole time period.
When considering cell displacement, the response to and expression of chemoat-
tractants is identiﬁed as a key pathway in aﬀecting cellular behaviour. Although no
correlation between maximum level of chemokine expression and cell displacement was
identiﬁed at hour twelve, a stronger correlation does become apparent in the following
24 hours, after which there is a clear trend between the value of this parameter and
cell behaviour (Figure 5.3b). An LTi cell response to chemokine expression follows a
similar pattern (Figure 5.3c). A combination of this and analyses in previous chapters
provides further support to the hypothesis that the development period may be split
into two phases, and now provides an indication of when these phases may change.
However whereas the inﬂuence of the chemokine pathway increases as the simulation
time elapses, the correlation between a cells response to adhesion factor expression and
cell displacement is initially stronger and steadily increases (Figure 5.2e), suggesting
an inﬂuence on cell displacement throughout the whole development period. Although
this is the case, interestingly no correlation becomes apparent between the level of
adhesion factor expression and cell displacement, at any time-point in development.
5.4.2 Parameter Value Sampling using eFAST Approach
Time-lapse responses were generated using the same eFAST parameter value sets gen-
erated to explore cell behaviour at 12 and 72 hours (sections 3.5.3 and 3.6.3). For
each parameter value set, 500 simulation runs were performed to mitigate the eﬀect
of aleatory uncertainty. Median cell response measures were calculated for each time-
point in each run, producing sets of 500 median cell behaviour responses. The medians
of these distributions was calculated to give a median cell response for the simulator un-
der those conditions, at that time-point. The eFAST approach was utilised to analyse
these results for each time-point, producing ﬁrst-order (Si) and total-order (STi) sen-
sitivity indexes that determine the proportion of variance in simulation response that
can be accounted for by that parameter, at that time-point. For each cell response,
the ﬁrst-order sensitivity indexes for each parameter, and each time-point, have been
plotted (Figure 5.4.2) to reveal if the proportion of variance that can be accounted for
by each parameter changes over simulation time.
For cell velocity responses, the analysis supports the conclusions drawn in the sec-
tion above (Figure 5.4a). The expression level of adhesion factors accounts for a sig-
niﬁcant amount of the variance in simulation results at twelve hours, yet this impact
reduces in a similar way to that observed in latin-hypercube analysis, again suggesting
an inﬂuence in early PP development but one that does not continue throughout the
development period. In contrast the proportion of variance explained by the probabil-
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ity an LTi cell responds to adhesion factor expression quickly increases after 12 hours,
and from 24 becomes the only signiﬁcant parameter that inﬂuences cell velocity. There
is no signiﬁcant change in Si value for all other parameters of interest.
The cell displacement responses again support results observed in latin-hypercube
analysis above, revealing a signiﬁcant change in LTi adhesion response and maximum
level of chemokine expression between 12 and 36 hours, after which the value stabilises
(Figure 5.4a). In contrast to the results in the previous section, no signiﬁcant increase
is observed in the Si value for LTi response to chemokine, a value that remains close to
constant throughout. For all time-points the proportion of variance accounted for by
that parameter is statistically signiﬁcant in comparison to the dummy parameter, sug-
gesting the parameter has an eﬀect but is not the major inﬂuence on cell displacement.
Again there is no signiﬁcant change in Si value for all other parameters.
5.5 Time-Lapse Analysis of Cells Away From a Developing
Peyer’s Patch
Statistical analyses throughout this thesis have focused on the behaviour of cells close
to a forming patch, to understand how each biological factor inﬂuences these cells such
that they behave diﬀerently to those further away (> 50 µm). However, the behaviour
of simulated cells both close to and far from a forming patch has been calibrated from
ex vivo data captured in the twelfth hour of development (Patel et al., 2012). Previous
studies in the literature suggest that chemoattractant expression has a key role in the
recruitment of LTi cells to a forming patch (Cyster, 1999; Luther et al., 2003), and
thus there may be a point in the simulation at which the interactions close to a patch
begin to aﬀect the behaviour of those further away. To examine this, the simulator
was run 500 times, and the behaviour of cells that are further than 50µm from an
LTo cell tracked at four hour intervals. The distribution of cell behaviour responses for
each time-point >=24 hours were then compared with those generated at the calibrated
twelve hour time-point using the Vargha-Delaney A-Test, to determine if cell behaviour
does become statistically signiﬁcantly diﬀerent to that at 12 hours.
The results of this analysis can be seen in Figure 5.5. Cell displacement remains
statistically similar to that seen at the 12 hour time-point until hour 36, after which
point there is a signiﬁcant change in cell behaviour. In fact by hour 48, the two
distributions are statistically completely diﬀerent (A-Test score = 1.0). Such a result
would suggest that under conditions created in calibration, chemokine expression does
not begin to aﬀect cells further than 50µm from a forming patch until hour 36. As
expression increases, the distance over which chemokines become inﬂuential increases,
and thus displacement becomes signiﬁcantly diﬀerent. However it is diﬃcult to draw
a ﬁrm biological conclusion based on this as the level of chemokine expression remains
unknown, and thus such an eﬀect may have become apparent through parameterisation.
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5.6 Discussion
5.6.1 Implementing a Time-Lapse Approach Through Simu-
lation and Sensitivity Analysis
This chapter has shown how a combination of a computer simulation and the range of
sensitivity analysis techniques in the spartan package (Marino et al., 2008; Read et al.,
2012; Saltelli et al., 2000) can reveal alterations in agent behaviour over time, and
suggest the biological factors that may be causing this change in behaviour. Although
biological explorations are increasingly being paired with computational modelling and
simulation, the application of the resultant simulator as a tool for performing a time-
lapse analysis of the captured process has not been widely utilised. Such an analysis
can then be used to target particular time-points to explore in the future laboratory
experiments.
The one-a-time parameter robustness technique (Read et al., 2012) has been ex-
tended in this chapter such that parameter robustness throughout the simulated time-
course can be examined. Currently the use of this technique in determining a level
of conﬁdence in parameter value over time is novel, and aids establishing a degree of
conﬁdence in the value assigned to that parameter over time. This is an important
consideration when assessing the eﬀect of parameter value uncertainty on results. For
example, Figure 5.2b reveals that there is a large degree of uncertainty in the value of
the parameter that captures maximum chemokine expression by an LTo cell at 12 and
24 hours. However 12 hours later in the simulation, this changes completely, and results
suggest that just a small change in just this parameter value has a signiﬁcant eﬀect on
simulation result. What the results in this chapter mean biologically is detailed in the
next section of this discussion, but from a technique point of view, one could now try
to establish what has caused this eﬀect to become apparent at that time-point. If cell
behaviour statistics were available from other time-points in the development process,
a robustness analysis could be used to ensure each simulation parameter is capturing
the correct biological dynamics at that time-point.
When considering use of global sensitivity analysis techniques over time, an explo-
ration of changes in Partial Rank Correlation Coeﬃcients is not novel, and has been
demonstrated in determining correlations between simulated biological factors and ex-
tracelluar bacterial load over a simulated time period in a model of TNF in controlling
tuberculosis in a granuloma (Ray et al., 2009). However no study has yet examined
the ﬁrst-order sensitivity indexes, generated using the eFAST technique (Saltelli, 2004;
Saltelli et al., 2000), over simulation time in the manner that has been presented here.
The remaining sections of this discussion examine the biological insight that results
using this approach suggest in relation to the formation of Peyer’s Patches through use
of the simulator as a time-lapse tool.
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5.6.2 Phases of Peyer’s Patch Development
Experimental work has generated the generally accepted hypothesis that there are
three phases of patch development (Adachi et al., 1997): the appearance of VCAM-1
stromal cells in the gut, the appearance of clusters of LTi cells around stromal cells,
and the recruitment of lymphocytes from E18.5. The simulation developed in this
thesis captures the ﬁrst two phases. Cell behaviour analysis in Chapter 3 suggest that
diﬀerent biological factors inﬂuence cell behaviour responses at diﬀerent time-points.
Thus, through use of simulation, it could be suggested that there may be additional
development phases inside the ﬁrst of the two generally accepted phases.
Analyses in Chapter 3, to determine the factors that cause the statistically sig-
niﬁcant change in cell behaviour observed ex vivo when a cell is in the vicinity of a
forming patch (Patel et al., 2012), determined that cell velocity during hour twelve of
development is inﬂuenced by the level of adhesion factor expression per stable contact
between hematopoietic and stromal cells. However analyses of behaviour responses
at hour 72 suggest no inﬂuential role for adhesion factors. Use of global sensitivity
analysis techniques at twelve hour intervals suggests that the inﬂuence at twelve hours
becomes statistically insigniﬁcant by hour 36 (Figure 5.3). This could suggest that an
initial phase could exist, mediated by cell adhesion factors, covering the ﬁrst 36 hours
of development, after which point the eﬀect of a change in adhesion factor expression
level reduces amid a growing inﬂuence of other factors.
In contrast, previous analyses revealed no role for chemokine expression at twelve
hours, and a signiﬁcant role at seventy-two as suggested in the literature (Cyster, 1999;
Luther et al., 2003; Ohl et al., 2003). Performing a sensitivity analysis over time has
been useful in determining the time-point in development when chemokine expression
and response becomes signiﬁcant. Each of the analyses performed, whether perturbing
expression parameters individually (Figures 5.1 and 5.2) or with other parameters
simultaneously (Figures 5.3 and 5.4), reveals a statistically signiﬁcant change in cell
displacement between hours 24 and 36, an eﬀect that then stabilises through until hour
72. The parameter that captures LTi response to chemokine also becomes inﬂuential on
cell behaviour after hour 24. As chemoattractant expression promotes cell migration
towards a forming patch (Cyster, 1999), it could be suggested that a new phase of
development begins between this time-point, one that moves from the triggering of
adhesion and chemoattractant expression to the aggregation of cells that comprise the
primordial PP observed at hour 72, mediated by chemokine expression and response.
Although the level of adhesion factor expression has been determined to only have a
signiﬁcant inﬂuence on cell behaviour for the ﬁrst 36 hours, the parameter that captures
LTin/LTi cell response to adhesion factors has been shown to be highly inﬂuential
throughout the time period. When the parameter is perturbed individually to the
set examined, a clear trend emerges between the simulation time and an alteration
in cell behaviour (Figures 5.1c and 5.2c). Thus the system dynamics captured within
5.6. DISCUSSION 165
the simulation are highly sensitive to LTi cell response to adhesion, a sensitivity that
increases over time. Global sensitivity analysis results support the emergence of this
trend although all parameters are being perturbed sequentially. This result suggests
that although there may be two distinct phases apparent in development, LTi response
to adhesion does have an inﬂuential role in both phases.
5.6.3 Uncertainty in Maximum Chemokine Expression Af-
fects Interpretation of Cells Far From Forming Patch
Tracking of cells ex vivo at the twelve hour time-point has produced results that deter-
mine how cells behave both close to and away from a forming PP (Patel et al., 2012),
and thus cell behaviour in the simulation has been calibrated based on those results.
A time-lapse analysis of the behaviour of cells that are 50µm or further from a forming
patch reveals a signiﬁcant change in cell displacement after hour 36. This result could
be used to suggest that chemoattractant expression becomes suﬃcient after that time-
point to induce chemotaxis across a large distance from a forming patch. However, this
eﬀect is determined by the value assigned to the parameter that captures the maximum
level of chemoattractant expression. The current simulator has been calibrated against
behaviour of these cells at twelve hours, and with no further experimental data avail-
able, there is a great deal of uncertainty in the true value of this parameter. Thus it is
diﬃcult to accept this result as representative of the biological system, rather it is an
artefact of parameterisation. For the simulator to be useful in determining the inﬂu-
ence of chemoattractant expression on these cells, further biological experimentation is
required, by performing either the same cell tracking experiment performed ex vivo but
at further time points and then calibrating chemoattractant parameters to replicate
the behaviour observed, or by obtaining a quantiﬁcation of chemokine expression over
time.
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Figure 5.1: An examination of parameter robustness over simulation time: Cell ve-
locity. The parameter values were perturbed independently as detailed in section 2.4.2,
and cell behaviour results captured at twelve hour intervals. These results were then
compared to the baseline simulation using the Vargha-Delaney A-Test to determine the
eﬀect a change in parameter value has had on cell velocity. Performing this analysis at
twelve hour intervals reveals if the change in parameter value has an eﬀect at a certain
timepoint.
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Figure 5.2: An examination of parameter robustness over simulation time: Cell dis-
placement. The parameter values were perturbed independently as detailed in section
2.4.2, and cell behaviour results captured at twelve hour intervals. These results were
then compared to the baseline simulation using the Vargha-Delaney A-Test to determine
the eﬀect a change in parameter value has had on cell displacement. Performing this
analysis at twelve hour intervals reveals if the change in parameter value has an eﬀect
at a certain timepoint.
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Figure 5.3: Partial Rank Correlation Coeﬃcients (PRCC) for each parameter under
examination, calculated at twelve hour intervals using the latin-hypercube analysis ap-
proach. Examining how the PRCC changes over time gives an indication of when a
parameter begins to become inﬂuential in aﬀecting cell velocity and displacement.
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Figure 5.4: eFAST First-Order Sensitivity Index (Si) for each parameter of interest,
calculated at twelve hour intervals. This shows the percentage of variance in simulation
result at that time-point can be explained by a particular parameter.
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Figure 5.5: An analysis of the behaviour of LTin and LTi cells away from a forming
Peyer’s Patch. The simulator has been calibrated such that the behaviour of the sim-
ulated cells at 12 hours matches that observed for the same time-point ex vivo. This
analysis reveals how the behaviour of these cells changes over time, a statistical com-
parison drawn using the Vargha-Delaney test (Vargha and Delaney, 2000).
Chapter 6
Discussion
The aims behind the work presented in this thesis were to construct and utilise com-
puter simulation and statistical tools to further understand lymphoid tissue organo-
genesis. This chapter provides a reﬂection of how this study addresses these aims.
However, the contribution of this study extends beyond furthering biological under-
standing, to a contribution to the ﬁeld of computational modelling and simulation,
with no discrimination towards the discipline in which modelling is being utilised.
6.1 Simulation as a Tool for Exploring Lymphoid Tissue Organo-
genesis
Chapter 2 of this thesis details the development of a simulation of Peyer’s Patch for-
mation, for use as a scientiﬁc instrument to explore lymphoid tissue organogenesis.
Through use of the CoSMoS framework reviewed in section 1.4.2 (Andrews et al.,
2010), a principled approach has been adopted in the design and implementation of
the simulation, in collaboration with experimental immunologists with expertise in
lymphoid tissue formation. This collaboration has proven to be a vital aspect in a
project to model a system where the biological understanding is incomplete and where
it is not viable to include every aspect of the biological system that is understood.
Constructing the domain and platform models with the insight of experimental immu-
nologists can be considered as the ﬁrst method by which conﬁdence in the simulators
representation of the domain can be judged.
The domain and platform modelling work in Chapter 2 is the end result of de-
tailed discussions with collaborating immunologists. It may not have been possible
to document this fully in that chapter, but this is the ﬁnal model of a large number
that were generated, and this is a time-consuming process. However, the modelling
process should be seen as time well spent, as the process highlighted areas where the
biological understanding was ambiguous or incomplete, and areas where simpliﬁcations
could be made. For example, an initial model included a cell response to two diﬀerent
chemokines expressed by an LTo cell, until it was decided that modelling one was suf-
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ﬁcient. This conclusion was drawn based on experimental results that suggest PP do
not form correctly in mice deﬁcient for CXCR5, the receptor for CXCL13, although
chemokines CCL19 and CCL21 are still present (Ansel et al., 2000). The speciﬁcation
of the biological system in the domain model, and the platform model speciﬁcation
of how that will be encoded as a computer simulation, has been veriﬁed by the do-
main experts and deemed to appropriately capture the biological system under study.
Thus, where assumptions and abstractions have been made, these have the support
and justiﬁcation from people with expertise in the ﬁeld.
The simulation has been constructed from the speciﬁcation in the platform model
(section 2.2.3), and through a process of calibration (section 2.2.6), parameter values
set such that cell behaviours emerge that are statistically similar to those observed
in Patel et al’s (2012) ex vivo investigations detailed in section 1.3.3. With these
results having a direct mapping back to the biological system, there is a greater level of
conﬁdence that the simulation is an adequate representation of the biology. The second
emergent behaviour captured in the model, the development of aggregations of cells
that mature to become PP, has been more diﬃcult to calibrate due to the environmental
representation used in the model (2D rather than 3D, see Figure 2.10) and the lack
of biological data that can be used to determine PP characteristics. Although there
is no direct link to the biology in this case, the simulation can still be used as a tool
for drawing qualitative conclusions on what inﬂuences patch formation, by examining
how aggregations that are formed by the simulation calibrated based on cell behaviour
alter when run under diﬀerent conditions.
The end result of the process of modelling, simulation implementation, and cali-
bration, is a tool that can be used to perform in silico experimentation. This can be
performed by altering the values that have been assigned to particular parameters, or
by setting boolean ﬂags that simulate a knock-out of a particular factor. The simula-
tion platform implemented in this thesis, described in Chapter 2, attempts to create a
visual look and feel that experimental immunologists are comfortable with using, in a
format that those performing the in silico experiment can relate to. Current laboratory
explorations utilise real-time imaging techniques to take snapshots or movies of a bio-
logical system under investigation, which can then be processed using specialised image
analysis software such as Volocity (PerkinElmer). This software has the capability of
identifying individual cells in each image and tracking cell behaviour across a number
of images from diﬀerent time-points, producing statistics that describe the behaviour of
that cell. The ex vivo data upon which this simulation is calibrated (Patel et al., 2012)
was generated in this way. To relate this simulation to such techniques, it is possible to
perform the same analysis, by specifying time-points in the simulation when snapshots
of the simulated gut should be taken: images that can then be processed by Volocity.
The in silico cell tracking image in Figure 2.14 was generated using that technique.
The results of in silico experimentation to replicate previously published laboratory
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investigations, seen in Figure 4.1, is a further example of the use of simulation snap-
shots to analyse results. For each of the investigations being replicated, the result of
the laboratory investigation was determined visually, and thus the same visual method
was applied to determine whether the simulation replicates that result.
For a more detailed, statistical analysis of the biological system captured in the
simulation, a variety of cell behaviour and patch characteristic responses are output
from the simulation as comma-separated value (CSV) ﬁles, that can be processed using
a variety of statistical techniques. The use of such techniques to provide biological
insight is examined later in this chapter.
Chapter 1 detailed numerous examples of the use of simulation as a tool to provide
insight into a particular biological system under study. However, it is unusual that the
tool developed is then released to the academic community for full scientiﬁc scrutiny.
The simulation developed in this thesis, and the domain and platform models associated
with it, are available on the internet at
http://www.cs.york.ac.uk/immunesims/frontiers, enabling the use of the tool to inform
laboratory investigations of others and allowing the community to critically comment
on the design and implementation. Thus, this thesis is not simply an exercise in
implementation and use of simulation as a tool for drawing conclusions on a biological
system, rather it is hoped that the tool developed contributes to ongoing investigations
of others in the ﬁeld.
6.2 Spartan : Statistical Techniques to Analyse Simulation
Behaviour
It has been noted in this thesis that no generic comprehensive toolkit exists to aid the
understanding of simulation results, in an attempt to ground a result in the domain
that it captures and thus inform future laboratory investigation. This may explain
why in a large number of cases in the literature, little attempt is made to reveal how
representative a simulation result is in terms of the captured biological system (Read
et al., 2012). The spartan toolkit developed in the course of study aims to ﬁll the void
in the availability of ready to use statistical analysis techniques, providing a mechanism
to aid the integration of simulation into wet-lab research, with the aim of ensuring in
silico results are interpreted with rigour. Although spartan was constructed alongside
the development of an agent-based simulation, the statistical techniques can also be
applied to simulation results generated using an ODE approach.
Figure 6.1 is a schematic of a generic simulation process. A domain of interest is
identiﬁed, in this case the development of secondary lymphoid organs. From this, a
process of modelling is adopted (such as the CoSMoS Process) resulting in the gen-
eration of a computer simulation that captures an abstraction of that domain. This
computer simulation provides the capacity to produce responses under a variety of pa-
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rameter value conditions, results that are analysed by the techniques included within
spartan. These analyses help determine the number of simulation runs required per
condition to generate a representative result, how robust the simulation is to a change
in individual parameter values, and can identify the biological pathways and compo-
nents that have a statistically signiﬁcant eﬀect on simulation behaviour by identifying
highly inﬂuential parameters. The conclusions drawn from these analysis may then in-
form future laboratory investigations, and thus the next iteration of the model. Section
1.4.2 noted that there are modelling frameworks and simulation packages available to
aid performing the ﬁrst two stages. The release of spartan provides a tool to perform
the ﬁnal stage, thus ensuring there are tools available for each component part of this
generic modelling schematic.
Spartan is open-source, has been developed and runs within the platform-independent
R statistical environment, and can be freely downloaded from the Comprehensive R
Archive Network (CRAN); thus, no restrictions have been placed on allowing others
to utilise or extend the functionality of the package. Utilising sample Peyer’s Patch
simulation data gathered in the course of this study, comprehensive tutorials have
been developed that exemplify how the techniques included within spartan can be ad-
vantageous in exploring the operation of a developed simulation. With all this taken
together, it is hoped that this provides a comprehensive set of tools that encourage
simulation developers to publish a full statistical analysis alongside any hypotheses
generated through simulation. Spartan remains in a state of ongoing development and
further analysis methods will be added when appropriate. It was noted in Section 1.4.2
that a number of software packages have been developed that ease simulation devel-
opment through use of drag and drop interfaces that remove some of the complexity
involved in simulation development. Similarly, a wizard interface for the spartan pack-
age is under development, a feature that will remove the complexity of running the
analysis in R, thus widening the potential usage of the package further.
6.3 Biological Hypotheses Generated Through Simulation
Through a process of calibration (section 2.2.6), it has been ensured that the simulator
produced responses that were statistically similar to that observed in the laboratory.
Explorations in preceding chapters utilised the simulator and the spartan statistical
toolkit to generate biological hypotheses. This section reﬂects on two predictions that
have been generated.
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Figure 6.1: Placing spartan in Simulation Development. The domain being captured
in the simulation is on the left. In this case, this is cell behaviour around a primordial
Peyer’s Patch (Image taken from Patel et al (2012)). A simulation is implemented,
potentially through a process of modelling (such as the CoSMoS Framework (Andrews
et al., 2010) adopted in this thesis), using either available simulation platforms or a
bespoke implementation. This produces simulation results that can be analysed using
the statistical techniques available within spartan . Results of this analysis can then
potentially inform future laboratory investigations that focus on the captured domain.
6.3.1 PP Development From E14.5 to E17.5 Could Be Bipha-
sic
The preceding chapters highlighted the currently accepted view that PP development
occurs in three distinct phases (Adachi et al., 1997). Chapter 3 utilised the simulation
and spartan statistical toolkit to examine cell behaviour during hours 12 (E15.0) (Sec-
tion 3.5) and 72 (E17.5) (Section 3.6), and suggested that diﬀerent biological factors
are inﬂuential at these two diﬀerent stages of development. Use of simulation as a
time-lapse tool in Chapter 5 took this a stage further, examining cell behaviour at 12
hour intervals, in an attempt to identify the time-point where a change in the inﬂuence
of simulation parameters occurs. Through a combination of both analyses, this thesis
has proposed that the 72 hour period between the accepted ﬁrst and second phases
of PP development could in turn be split in to two phases, a ﬁrst inﬂuenced by adhe-
sion factor expression and response, and a second mediated by chemokine expression
and response, which becomes inﬂuential between hours 24 and 36. This prediction is
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counter to the accepted claim that the 72 hour period is chemokine dependent (Cyster,
1999; Luther et al., 2003; Ohl et al., 2003).
This result demonstrates the advantages of pairing simulation and ongoing labora-
tory investigations. The ex vivo culture system study was conducted to examine cell
behaviour in the early stages of PP development (Patel et al., 2012), and has developed
biological hypotheses concerning the RET signalling pathway. The data produced has
directly informed the development of the simulator, resulting in a tool which replicates
cell behaviour that emerges ex vivo. From this, a range of in silico experimentation
has been performed to explore cell behaviour at a number of other time-points in de-
velopment, generating additional hypotheses to those formed in the laboratory. Thus,
through simulation, the original biological study has had a wider impact than that orig-
inally intended, with the potential to counter established views in the literature. In
turn, these predictions can inform future laboratory investigations that verify whether
the hypotheses generated hold. Methods to verify the hypothesis that PP development
is biphasic are examined later in this chapter.
6.3.2 Variation in Peyer’s Patch Development
Data presented in Figure 1.2 suggests there is a large variation in location, number,
and size of PP in genetically identical mice, reasons for which remains unknown. Inves-
tigations in Chapter 4 utilised the simulator to perform novel in silico experimentation
to examine factors that could be causing this variation.
It was noted in Chapter 4 that although it has been suggested that LTin cells have
a role in early initiation of PP development (Patel et al., 2012; Veiga-Fernandes et al.,
2007), the role of LTin cells in PP formation and physical characteristics is not fully
understood. Simulation results have suggested that a change in the number of LTin
cells and the rate of LTin cell migration could limit the number of PP that develop and
inﬂuence the size of the aggregations that do form (sections 4.4.2 and 4.4.3). Thus it
could be suggested that variation observed between diﬀerent mice is caused by variation
in the number of LTin cells produced in the foetal liver.
As LTin cells are known to express RET (Veiga-Fernandes et al., 2007) and LTo
cells express RET ligand, the initial interaction between an LTin and LTo cell has
previously been suggested as the trigger of PP development (Patel et al., 2012; Veiga-
Fernandes et al., 2007). However, ﬂow cytometry results have been used to estimate
that at E15.5 (24 hour time-point in development), 20% of the gut surface could be
occupied by LTo cells, thus there must be a factor that is limiting the triggering event.
The ﬁndings noted in the previous paragraph suggest that LTin cell migration rate
and cell number could be the limiting factor, as an alteration in cell number has been
shown to aﬀect patch size and number. Yet it is also unclear as to whether each of the
LTo cells in the gut has the capability to diﬀerentiate and interact with LTin and LTi
cells. For example, a restriction in expression of the ligand for RET could also be the
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limiting factor. Such a restriction was examined in silico in section 4.4.4. It has been
suggested that PP tend to form on or near the anti-mesenteric border (van de Pavert
and Mebius, 2010; Randall et al., 2008), leading to the hypothesis that an LTo cell
could receive a signal, potentially from the blood stream, that causes an upregulation
of RET ligand expression, limiting where PP form and thus the number that do form.
Laboratory work would have to be undertaken to verify whether this was the case.
Potentially variation in PP development could be explained by a combination of
these two hypotheses. A restriction of RET ligand expression by a yet unknown mecha-
nism could control PP number, while variation in the number of LTin cells that migrate
from the foetal liver could then inﬂuence the size of the PP that develops.
6.4 Factors Aﬀecting These Hypotheses
In his study of conﬁdence in simulation results, Read (2011) notes that conﬁdence is
not boolean but established to varying degrees. Conﬁdence in the biological hypotheses
that have been generated through simulation, detailed in the previous section, could
be aﬀected by a number of factors.
As noted in the ﬁrst section of this discussion, the model on which the simulation is
based is an abstraction of the real system, and this must be considered when analysing
what the result means in terms of the system being explored. In this study, the
assumptions made in the creation of the simulation are documented in Tables 2.1-2.3.
As these assumptions include the methods by which chemokines and adhesion factors
are expressed, the results of statistical analyses that suggest these are the two inﬂuential
factors in development may be subject to a degree of scepticism. In the case of the
model presented in this thesis, the domain and platform models have been veriﬁed
by two experimental immunologists with expertise in lymphoid organ development.
Thus the assumptions made to model chemokine and adhesion factor expression could
potentially impact the conclusions that are drawn, but these have been justiﬁed by
those with domain speciﬁc expertise.
However scepticism in the assumptions that have been made should not necessarily
be seen as a negative, but the start of a conversation that could improve the simula-
tion further in the next iteration. Full transparency in the design of the simulation
allows those in the ﬁeld to assess the model and contribute their opinions and ﬁndings,
potentially informing their own investigations as well as informing the development of
the simulator. In the case of the Peyer’s Patch simulation, the full simulation design
(Domain and Platform Models), assumption tables, and the implemented simulator
are available online at http://www.cs.york.ac.uk/immunesims/frontiers for this rea-
son, opening this work to full scientiﬁc scrutiny.
Prior to any further iteration that seeks to add complexity to the current model and
simulation and increase conﬁdence in results generated, an evaluation should be per-
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formed that details whether such an addition would provide any extra insight. Whereas
biologists traditionally take a reductionist approach that focuses on the role of each
factor in the system, the focus of models such as the one developed in this thesis is
on the observable high-level behaviour, and how this emerges through interactions be-
tween individual biological factors (Germain et al., 2011). Although the interaction
may trigger a number of events that are both observable and implicit (such as inter-
cellular pathways), the observable result is the focus, and thus implicit pathways can
be assumed and abstracted from the model, as their inclusion would have no impact
on the result. This needs to be taken into consideration when additions are suggested.
The implementation of chemokine expression and response in this model is a good
example, where three chemokines and two receptors have been captured as one. An
obvious extension could be to add an additional chemokine and determine the eﬀect
this has on simulation result. However, previous laboratory studies have suggested
that one chemokine, CXCL13, has a dominant role in the recruitment of LTi cells, and
blocking CXCL13 response has a signiﬁcant impact on patch formation (Luther et al.,
2003). The authors note that PP do form where CXCL13 response is inhibited, but
these lack the structural characteristics of wild-type PP. Thus, it would be diﬃcult to
justify adding further chemokine complexity when the end result cannot be classiﬁed
as a PP.
The implementation of the simulation using an agent-based approach introduces
uncertainty that could also have an aﬀect on the meaning of results generated (Helton,
2008), and thus these predictions. Agent-based simulations are inherently stochastic,
and diﬀerent results can be generated for the same parameter conditions (Read et al.,
2012). Through use of the consistency analysis technique developed by Read et al
(2012), it has been assured that predictions made have been developed from simulation
results that are representative of the condition on which the simulation has been run.
This increases conﬁdence that the results presented are robust, and the eﬀect of inherent
stochasticity is mitigated. With the exclusion of this study and Read’s simulation of
EAE (Read, 2011), evidence that such an analysis has been performed for other agent-
based simulations in the literature is not apparent. This is not to say that a similar
analysis technique has not been performed, but if this is the case results from such
analyses have not been published. The examples in this thesis, Read’s study (2011),
and the release of the spartan toolkit constructed in the course of this study, could
encourage more simulation developers to perform this analysis and ensure that results
being presented are a robust representation of the exploration that was performed.
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6.5 Simulating Peyer’s Patch Formation Could Provide In-
sight on Lymphoid Organ Development
The accepted biological model of Peyer’s Patch development has much in common
with the formation of other lymphoid organs (Randall et al., 2008). Thus it could
be suggested that the predictions generated for Peyer’s Patch development could also
be applicable to the development of other secondary lymphoid organs such as lymph
nodes and the spleen, and tertiary lymphoid organs that form during chronic infection
(van de Pavert and Mebius, 2010).
Although the formation of lymph nodes does diﬀer as development is encapsulated
within the lymphatic epithelium (Randall et al., 2008), primitive lymph nodes are
aggregations of LTi cells around VCAM-1+ LTo cells (Yoshida et al., 2002) analogous
to Peyer’s Patch formation. Similarly to the PP model, ligation of LTβR on the LTo
cell by LTαβ on the LTi cell leads to the upregulation of chemokines CXCL13, CCL19,
and CCL21 and adhesion factors VCAM-1, ICAM-1 and MAdCAM (Mebius, 2003). A
clustering of LTi cells around VCAM-1 cells has also been detected in the developing
spleen from E13, in the same lymphotoxin dependent manner (Withers et al., 2007).
With this similarity, it could be suggested that, if expression patterns were identical, the
predictions generated through LTi and LTo cell interaction in the PP model could hold
for lymphoid organ development in general, including the prediction that formation
could be biphasic.
Such a hypothesis does not take the diﬀerence in physical environments into ac-
count. Yet a future iteration of the simulation could examine the eﬀect the environ-
ment has on lymphoid tissue development. The simulation that has been implemented
examines system behaviour at an interaction focused, higher-level, therefore certain
pathways can be abstracted. Although there are diﬀerences between signalling path-
ways involved in PP, lymph node, and spleen development (the activation of LTαβ by
IL-7 in PP and TRANCE in lymph nodes being one (Cupedo et al., 2004; Yoshida
et al., 2002)), such diﬀerences are lower level and are thus abstracted, leaving the be-
haviour that is similar between the three biological models of development. Predictions
on the environmental eﬀect on the formation of diﬀerent secondary lymphoid organs
could thus be drawn by altering just the simulation environment.
6.6 Novel use of Statistical Analysis Tools
The development of the spartan package, and the contribution this makes to the ﬁeld
of computer modelling and simulation, was noted in a previous section of this chapter.
This section notes that this thesis has presented two novel applications of techniques
within the spartan package.
The ﬁrst of these is the application of the Extended Fourier Amplitude Sampling
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Test (eFAST) (Saltelli, 2004; Saltelli and Bollardo, 1998) to results generated from an
agent-based model. There are a number of examples in the literature of the eFAST
technique, or its predecessor FAST (Cukier, 1973; McRae et al., 1982) upon which
eFAST is based, providing insight into results generated through simulation (King and
Perera, 2007; Lu and Mohanty, 2001; Marino et al., 2008). However none of the pub-
lished examples applied the technique alongside an agent-based implementation. As
was noted in the description of eFAST in section 2.4.4, this technique can be com-
putationally expensive, especially for simulations with a large number of parameters
(Ratto et al., 2007; Tarantola et al., 2006). In the case of the cell behaviour analysis in
Chapter 3, eFAST produced 1,365 parameter value sets on which simulations needed
to be run. As it was determined that each simulation needed to be run 500 times
to mitigate aleatory uncertainty (section 3.3), the analysis required 682,500 simulation
runs. Fortunately, simulation work conducted in this study could be run on a computer
cluster, but if this was not available this analysis may not have been viable. Thus, the
application of the technique is novel, but does come with a heavy resource cost.
The techniques in the spartan package have also been used to analyse simulated
cell tracking data from a number of diﬀerent time-points (Chapter 5), to understand
whether the inﬂuence of certain parameters changes over the course of simulation time.
The only example of such an analysis being performed previously is by Ray et al
(2009), who examined how a calculated Partial Rank Correlation Coeﬃcient changes
over the course of simulation time in their model of TNF in controlling tuberculosis in
a granuloma. The application of both the one-at-a-time robustness technique (Read
et al., 2012) and eFAST (Saltelli, 2004; Saltelli and Bollardo, 1998) over simulation
time in this thesis is however novel. Functionality has been provided within the spartan
toolkit to analyse simulation results captured at diﬀerent time-points, thus the adoption
of the package by the simulation developers may make such time-lapse analyses more
common.
6.7 Future Directions
6.7.1 Investigating Cellular Mechanisms
In this study a variety of techniques, such as argument-based validation, calibration,
and sensitivity analysis techniques, have been utilised to build conﬁdence in the sim-
ulation as a tool representative of the biological domain that it captures. In their
respective studies on conﬁdence in simulation, both Bauer et al (2009) and Read et
al (2011) note that the best practice in building conﬁdence in predictions generated
through simulation is to verify that prediction in the laboratory. Such an approach
is also encouraged in the CoSMoS Framework (Andrews et al., 2010) that has been
adopted in this study. For the predictions that have been generated in the preceding
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chapters, the loop is yet to be closed, as these have yet to be veriﬁed experimentally.
The prediction that the 72 hour period of PP formation may be biphasic has been
generated by examining simulated cell behaviour at diﬀerent time-points in the devel-
opment period. The ﬁrst time-point examined, 12 hours, is an in silico replication of
an ex vivo investigation (Patel et al., 2012). A similar culture system could be used
to examine cell behaviour at a number of points from 12 hours onwards, producing
responses that can be compared to those generated from the simulator. A statisti-
cal similarity between the simulation predictions and ex vivo data from a number of
time-points would suggest the simulation parameters have been calibrated such that
the emerging cell behaviour is correctly captured. A statistical diﬀerence may lead
to some concern in the viability of the predictions that have been generated, yet it
is important to recall that these predictions were formed based on the data available
upon simulation construction. Data from numerous time-points could inform a new
iteration of the modelling process, and if replicated by the simulator lead to stronger
predictions in the long run. Although the prediction may not have proven correct, the
simulation result has been used to inform biological exploration.
The above prediction could also be examined through performing experiments that
block adhesion factor VCAM-1. Data presented in this thesis has suggested an im-
portant role for adhesion factor response and expression in the early stages, but this
inﬂuence decreases as chemokines become inﬂuential between hours 24 and 36. It would
be interesting to study the eﬀect of inhibiting VCAM-1 at diﬀerent time-points in the
development period. To support the data presented in preceding chapters, one would
expect to see no aggregations of hematopoietic cells if VCAM-1 is blocked in the early
stages of development. However, if this factor was inhibited from hour 36 onwards,
aggregations may still form, as the phase inﬂuenced by adhesion factors has elapsed.
Such a result would strengthen both the hypothesis and conﬁdence in the simulation
as an adequate representation of the biological system.
Other predictions generated within this thesis, such as the role of LTin cells and
the biological factors aﬀecting the size of 2D cell aggregations that are formed, have a
link to the number of hematopoietic (LTin/LTi) cells that are present in the gut. The
current simulation bases cell number on estimates informed by ﬂow cytometry results.
A linear input rate is calculated such that the simulation creates the required number
of cells with each time-step to meet this estimated number at E15.5. With no further
data available, this rate has been continued through until E17.5, the end of the 72 hour
development period. If ﬂow cytometry could be performed on foetal intestines from
more time-points, further estimates could be made such that the migration rate of LTin
and LTi cells could be set more accurately. A more accurate number of cells would in
turn lead to a more accurate number of cells in each aggregation, aﬀecting predictions
made on both number and 2D area of aggregations formed in simulation. It would then
be possible to explore whether it is cell number that is a factor in limiting the number
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of PP that are formed. The eﬀect of altering LTin cell migration rate was investigated
in silico in Chapter 4, by exploring two alternative migration rate functions, both set
such that the required number of simulated cells were present at E15.5 (Figure 4.4a).
Although this proved useful in suggesting that LTin migration rate could potentially
have a role in limiting PP formation, this result is still based on the assumption that
cell migration is constant throughout the period. A ﬂow cytometry analysis would help
reveal if this indeed is the case.
6.7.2 Statistical Analysis
The statistical analyses in the preceding chapters have examined the inﬂuence of sim-
ulation parameters for which a value is unknown (Table 3.1). These are parameters
where the value cannot be directly translated from the biological system. For example,
two of these are constants used in the sigmoid curve that captures chemokine expres-
sion (as detailed in Figure 2.8). The analyses have revealed how robust the simulation
is to alterations in the value of these parameters, and determined the parameters in
this subset that inﬂuence emergent behaviours. Future work could consider extending
the application of sensitivity analysis techniques to a wider number of parameters in
the simulation.
In his study of building conﬁdence in a simulation of EAE, Read (2011) explores
how robust the simulation is to an alteration in all parameter values, including those
for which a biological value can be derived. Such an analysis could potentially reveal
further insight into how robust PP formation is to changes in biological as well as the
implementation speciﬁc parameters. Including parameters such as the LTin and LTi
number estimates in a full global sensitivity analysis could give a statistical indication of
how inﬂuential cell number is in both cell behaviour and patch characteristic simulation
responses, in comparison to all other factors. However, with this simulation being
agent-based, and thus requiring a large number of replicate result sets for each condition
on which it is run, one would have to deduce whether such results are worthy of a time
and resource heavy analysis. For example, altering the parameters that capture the
range in which an LTin and LTi cell speed exists would potentially have an impact
on the result, as this change would directly inﬂuence the cell displacement response.
Performing thousands of simulation runs would verify that hypothesis yet not generate
a result that oﬀers any insight. It may be more beneﬁcial to ascertain the level of
uncertainty in the biological parameter ﬁrst, and include this in any future analysis if
deemed to be high.
6.7.3 Extending the Simulation
The simulation presented in this thesis captures an abstraction of the current under-
standing of PP development gathered both from the literature and through collabora-
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tion with experimental immunologists. Through use of statistical techniques included
in the spartan toolkit, the simulator has been used to generate predictions on the fac-
tors that inﬂuence cell behaviours and aggregation characteristics that emerge during
the 72 hour period. There may however be scope to extend the simulations predictive
capabilities further. One such example is detailed below.
Secondary lymphoid organogenesis occurs during foetal development, alongside the
development of other biological systems. In this instance, PP formation may be oc-
curring alongside the development of the enteric nervous system (ENS) within the gut,
a process dependent on interactions between RET expressing neural crest cells and
stromal cells on the intestine wall (Patel et al., 2012). As both these neural crest cells
and LTin cells express RET (Patel et al., 2012; Veiga-Fernandes et al., 2007), there
could be potential for neural crest cells to inﬂuence the development of PP. Although
there is little biological evidence to support such a hypothesis, a new iteration of the
model could include the addition of additional non-LTin RET ligand expressing cells, to
determine the eﬀect the existence of such cells could potentially have on PP formation.
184 CHAPTER 6. DISCUSSION
Glossary
antimesenteric Area of small intestine opposite the mesentery (that attaches the
small intestine to the abdomen).
agent-based modelling A modelling approach where each individual entity, such as
a cell, is represented explicitly, and can thus maintain its own
attributes and cell state. Agent behaviour is speciﬁed as rules that
determine the set of states an agent may exist within, and the event
that must occur for an agent to change state.
domain The system of interest that is being modelled, for example the foetal
development of a PP.
domain model The current scientiﬁc understanding of the dynamics of the system to
be modelled.
ex vivo A procedure in which an organ, cells, or tissue are taken out of a living
body for an experimental procedure. The experiment utilises the tissue
rather than artiﬁcial medias, as performed in vitro.
Goal-Structuring Notation A visual notation for performing Argument-Based
Validation, providing a method of structuring such an analysis to
ensure each step in an implementation is validated, the reasoning
behind the inclusion or exclusion of a feature or assumption is
provided, and evidence given as to why this conclusion has been drawn.
in silico Method of performing an exploration on a computer via a simulation
tool rather than in the laboratory.
in vitro An experimental procedure performed outside of a living organism,
such as in a test tube or laboratory dish.
in vivo An experimental procedure performed within a living organism.
latin-hypercube Parameter sampling approach that selects values for each parameter
from the value space, aiming to reduce any possible correlations while
ensuring eﬃcient coverage of the space over a minimal number of
samples.
185
186 DEFINITIONS
LTi Lymphoid Tissue Inducer Cell. Hematopoietic cell that migrates from
the fetal liver into the small intestine. Believed to be responsible for
initiating PP development.
LTin Lymphoid Tissue Initiator Cells. Hematopoietic cell that migrates from
the fetal liver into the small intestine. Can respond to chemokine
expression and thus form most of the aggregation of cells within a
forming PP.
LTo Lymphoid Tissue Organiser Cells. Non-hematopoietic cell that is
expressed on the epithelium of the small intestine. Diﬀerentiates on
stable bind with an LTin and LTi cell
Mann-Whitney U-Test Non-parametric statistical test for comparing two
distributions. Null hypothesis is that the two distributions could have
been taken from the same sample.
organogenesis The process of organ development, in this case secondary lymphoid
organs
ODE Ordinary Diﬀerential Equations. Used to explore the dynamics of a
population of biological factors (such as target and infected cells in
inﬂuenza) using a series of diﬀerential equations. An equation is
compiled that speciﬁes the impact each factor has on the size of the
population of its complementary factors.
PP Peyer’s Patches. Secondary lymphoid organs located in the small
intestine that trigger adaptive immune responses to antigen.
platform model Model that describes how the information in the domain model will
be encoded as a computer simulation.
PRCC Partial Rank Correlation Coeﬃcient. A robust measure for quantifying
non-linear relationships between an input and output.
secondary lymphoid organ Organs located at drainage points in lymphatic vessels
that initiate protective immune responses to antigens from peripheral
tissues.
sensitivity analysis The application of statistical techniques to examine how a
system responds to an alteration in input parameter values.
Si eFAST First-Order Sensitivity Index. Indicates the fraction of output
variance that can be explained by the value assigned to a parameter.
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STi eFAST Total-Order Sensitivity Index. Indicates the variance caused by
higher-order non-linear eﬀects between that parameter and the others
explored.
UML Uniﬁed Modelling Language. A diagram notation widely used in
software engineering, that has also found application in the
speciﬁcation of models of biological systems.
Vargha-Delaney A-Test An eﬀect magnitude test used to examine and quantify the
diﬀerence between two distributions.
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